Home
  >  
Section 54

EurekaMag Full Text Articles Chapter 53,954



References:

Piparsania, S.; Rajput, N.; Bhatambare, G. 2012: Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii--case report and review of literature. Turkish Journal of Pediatrics 54(5): 548-554
Li, Z.; Wang, R.; Li, S.; Wei, J.; Zhang, Z.; Li, G.; Dou, W.; Wei, Y.; Feng, M. 2008: Intraventricular pre-treatment with rAAV-VEGF induces intracranial hypertension and aggravates ischemic injury at the early stage of transient focal cerebral ischemia in rats. Neurological Research 30(8): 868-875
Guerra, M.; Brás-Silva, C.; Amorim, M.J.; Moura, C.; Bastos, P.; Leite-Moreira, A.F. 2013: Intraventricular pressure gradients in heart failure. Physiological Research 62(5): 479-487
Guerra, M.; Amorim, Mário.Jorge.; Brás-Silva, Cármen.; Leite-Moreira, A.F. 2013: Intraventricular pressure gradients throughout the cardiac cycle: effects of ischaemia and modulation by afterload. Experimental Physiology 98(1): 149-160
Firstenberg, M.S. 2013: Intraventricular pressure gradients: the often ignored question of how and why does the ventricle suck. Experimental Physiology 98(1): 46-47
De Assis, J.L.; Tenuto, R.A. 1948: Intraventricular racemose cysticercus; surgical excision. Arquivos de Neuro-Psiquiatria 6(3): 247-253
Goh, K.Y.; Hsiang, J.N.; Zhu, X.L.; Poon, W.S. 1999: Intraventricular recombinant tissue plasminogen activator for treatment of spontaneous intraventricular haemorrhage in pregnancy. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 6(2): 158-159
McMaster, J.; Ng, T.; Dexter, M. 2007: Intraventricular rhabdoid meningioma. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 14(7): 672-675
Twombley, K.; Pokala, H.; Ardura, M.I.; Harker-Murray, P.; Johnson-Welch, S.F.; Weinberg, A.; Seikaly, M. 2012: Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation. Pediatric Transplantation 16(6): E201-E209
Benedict, W.J.; Brown, H.G.; Sivarajan, G.; Prabhu, V.C. 2008: Intraventricular schwannoma in a 15-year-old adolescent: a case report. Child's Nervous System: Chns: Official Journal of the International Society for Pediatric Neurosurgery 24(4): 529-532
Alberione, F.; Welter, D.; Peralta, Bén.; Schulz, J.; Asmus, H.; Brennan, W. 2013: Intraventricular schwannoma of the choroid plexus. Case report and review of the literature. Neurocirugia 24(6): 272-276
Lévêque, M.; Gilliard, C.; Godfraind, C.; Ruchoux, M-M.; Gustin, T. 2007: Intraventricular schwannoma: a case report. Neuro-Chirurgie 53(5): 383-386
Jedliński, I.; Bugajski, Pł.; Kasprzak, Jław.D.; Jarząbek, Jław.; Greberski, K.; Słomczyński, M.; Kalawski, R.; Poprawski, K. 2010: Intraventricular septum rending from inferoposterior left ventricular wall during myocardial infarction. Kardiologia Polska 68(12): 1380-3; Discussion 1384
Chang, C-Chen.; Chang, H-Shiu.; Toh, C.Hong. 2013: Intraventricular silicone oil. Journal of Neurosurgery 118(5): 1127-1129
Joost, A.; Hunold, P.; Weil, J. 2011: Intraventricular stent loss after interventional treatment of a coronary dissection--a case report. Journal of Invasive Cardiology 23(9): E211-E213
Zebian, B.; Williams, D.; Mallucci, C. 2014: Intraventricular stent migration--a problem solved by the use of subcutaneous reservoirs. Acta Neurochirurgica 156(7): 1421-1422
Whitelaw, A.; Odd, D.E. 2007: Intraventricular streptokinase after intraventricular hemorrhage in newborn infants. Cochrane Database of Systematic Reviews 4: Cd000498
Mammis, A.; Agarwal, N.; Eloy, J.A.; Liu, J.K. 2013: Intraventricular tension pneumocephalus after endoscopic skull base surgery. Journal of Neurological Surgery. Part a Central European Neurosurgery 74(Suppl 1): E96-E99
Ruiz-Juretschke, F.; Mateo-Sierra, O.; Iza-Vallejo, B.; Carrillo-Yagüe, R. 2007: Intraventricular tension pneumocephalus after transsphenoidal surgery: a case report and literature review. Neurocirugia 18(2): 134-137
Semenkov, O.G.; Gramashov, I.A.; Iova, A.S.; Kriukov, E.I.; Shchugareva, L.M. 2009: Intraventricular thrombolysis and liquor filtration in treatment of newborns with severe intraventricular hemorrhages. Vestnik Khirurgii Imeni I. I. Grekova 168(4): 57-60
Jorens, P.G.; Menovsky, T.M.; Voormolen, M.H.; Van Den Brande, E.; Parizel, P.M. 2009: Intraventricular thrombolysis for massive intraventricular hemorrhage due to periventricular arteriovenous malformations: no absolute contraindications as rescue therapy prior to surgical repair or embolization?. Clinical Neurology and Neurosurgery 111(6): 544-550
Moradiya, Y.; Murthy, S.B.; Newman-Toker, D.E.; Hanley, D.F.; Ziai, W.C. 2014: Intraventricular thrombolysis in intracerebral hemorrhage requiring ventriculostomy: a decade-long real-world experience. Stroke 45(9): 2629-2635
Dunatov, S.; Antoncic, I.; Bralic, M.; Jurjevic, A. 2011: Intraventricular thrombolysis with rt-PA in patients with intraventricular hemorrhage. Acta Neurologica Scandinavica 124(5): 343-348
Keefe, K.; Kebriaei, M.; Gard, A.; Patil, A.-A. 2014: Intraventricular tissue plasminogen activator for intraventricular hemorrhage caused by an arteriovenous malformation. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 21(3): 526-529
Ramakrishna, R.; Sekhar, L.N.; Ramanathan, D.; Temkin, N.; Hallam, D.; Ghodke, B.V.; Kim, L.J. 2010: Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 67(1): 110-7; Discussion 117
Kramer, A.H.; Roberts, D.J.; Holodinsky, J.; Todd, S.; Hill, M.D.; Zygun, D.A.; Faris, P.; Wong, J.H. 2014: Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial. Neurocritical Care 21(2): 275-284
Gaberel, T.; Emery, E. 2011: Intraventricular tissue plasminogen activator toxicity. Neurosurgery 68(1): E288
Eiland, L.S.; Luedtke, S.A.; Chuachingco, J.C. 2004: Intraventricular tobramycin in a premature infant with pseudomonas meningitis. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 9(1): 55-62
Walker, J.; Schultz, D.; Grisdale, K.; Groves, M. 2012: Intraventricular topotecan for the treatment of neoplastic meningitis: five case studies. Journal of the Advanced Practitioner in Oncology 3(4): 237-241
Gönül, E.; Yetişer, Sç.; Sirin, S.; Coşar, A.; Tasar, M.; Birkent, H. 2007: Intraventricular traumatic tension pneumocephalus: a case report. Kulak Burun Bogaz Ihtisas Dergisi: Kbb 17(4): 231-234
Silva, D.O.A.; Matis, G.K.; Costa, L.F.; Kitamura, M.A.P.; Birbilis, T.A.; Azevedo Filho, H.R.C. 2011: Intraventricular trigonal meningioma: Neuronavigation? No, thanks!. Surgical Neurology International 2: 113
Morelli, M.; Fera, F.; Bono, F.; Fratto, A.; Arabia, G.; Quattrone, A. 2014: Intraventricular tumor presenting as progressive supranuclear palsy-like phenotype. Neurology 83(10): 948
Schroeder, H.W.S. 2013: Intraventricular tumors. World Neurosurgery 79(2 Suppl): S17.E15-9
Huddle, L.N.; Fuller, C.; Powell, T.; Hiemenga, J.A.; Yan, J.; Deuell, B.; Lyders, E.M.; Bodurtha, J.N.; Papenhausen, P.R.; Jackson-Cook, C.K.; Pandya, A.; Jaworski, M.; Tye, G.W.; Ritter, A.M. 2012: Intraventricular twin fetuses in fetu. Journal of Neurosurgery. Pediatrics 9(1): 17-23
Al-Jeraisy, M.; Phelps, S.J.; Christensen, M.L.; Einhaus, S. 2004: Intraventricular vancomycin in pediatric patients with cerebrospinal fluid shunt infections. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 9(1): 36-42
Domenichini, F.; Pedrizzetti, G. 2011: Intraventricular vortex flow changes in the infarcted left ventricle: numerical results in an idealised 3D shape. Computer Methods in Biomechanics and Biomedical Engineering 14(1): 95-101
Bermejo, J.; Benito, Y.; Alhama, M.; Yotti, R.; Martínez-Legazpi, P.; Del Villar, C.P.ér.; Pérez-David, E.; González-Mansilla, A.; Santa-Marta, C.; Barrio, A.; Fernández-Avilés, F.; Del Álamo, J.C. 2014: Intraventricular vortex properties in nonischemic dilated cardiomyopathy. American Journal of Physiology. Heart and Circulatory Physiology 306(5): H718-H729
Rocque, B.G.; Leland Albright, A. 2012: Intraventricular vs intrathecal baclofen for secondary dystonia: a comparison of complications. Neurosurgery 70(2 Suppl Operative): 321-325; Discussion: 325-326
González-Piña, R.; Alfaro-Rodríguez, A.; Bueno-Nava, A.; Ávila-Luna, A. 2013: Intraventricular yohimbine infusion induces noradrenergic changes in motor cerebral injured rats and enhances motor recovery. Cirugia y Cirujanos 81(1): 28-32
Sher, F.; Amor, S.; Gerritsen, W.; Baker, D.; Jackson, S.L.; Boddeke, E.; Copray, S. 2012: Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice. Cell Transplantation 21(9): 1883-1897
Sundberg, M.L.; Sundberg, C.A. 2011: Intraverbal behavior and verbal conditional discriminations in typically developing children and children with autism. Analysis of Verbal Behavior 27(1): 23-43
Vargas, E.A. 1982: Intraverbal behavior: the codic, duplic and sequelic subtypes. Vb News 1: 5-7
Polson, D.A.; Grabavac, D.M.; Parsons, J.A. 1997: Intraverbal stimulus-response reversibility: Fluency, familiarity effects, and implications for stimulus equivalence. Analysis of Verbal Behavior 14: 19-40
Do Amaral, S.H.; Silva, M.N.; Giraldi, M.; Viterbo, M.B.S.; de Brito Pereira, C.A. 2009: Intravertebral abscess in a patient with spinal tuberculosis. Journal of Neurosurgery. Spine 10(2): 160
Kotwicki, T.; Napiontek, M. 2008: Intravertebral deformation in idiopathic scoliosis: a transverse plane computer tomographic study. Journal of Pediatric Orthopedics 28(2): 225-229
Matsukubo, Y.; Kashiwagi, N.; Uemura, M.; Tatsumi, S.; Takahashi, H.; Hyodo, T.; Tomiyama, N.; Ashikaga, R.; Ishii, K.; Murakami, T. 2013: Intravertebral pneumatocysts of the cervical spine. Neuroradiology 55(11): 1341-1344
Oppenlander, M.E.; Bina, R.; Snyder, L.A.; Dickman, C.A. 2014: Intravertebral polymethylmethacrylate augmentation of anterior cervical discectomy fusion and plating in the setting of osteoporosis. Journal of Spinal Disorders and Techniques 27(3): 185-188
Weisskopf, M.; Weikopf, M.; Ohnsorge, Jörg.Axel.Klaus.; Niethard, F.Uwe. 2008: Intravertebral pressure during vertebroplasty and balloon kyphoplasty: an in vitro study. Spine 33(2): 178-182
Buy, X.; Alberti, N.; Pointillart, V.; Loiseau, H.; Palussière, J. 2014: Intravertebral pseudomeningocele: an unusual complication after disc surgery. Spine Journal: Official Journal of the North American Spine Society 14(11): E1-E4
Gomes-Giacoia, E.; Miyake, M.; Goodison, S.; Sriharan, A.; Zhang, G.; You, L.; Egan, J.O.; Rhode, P.R.; Parker, A.S.; Chai, K.X.; Wong, H.C.; Rosser, C.J. 2014: Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion. Plos one 9(6): E96705
Kamat, A.M. 2008: Intravesical BCG for bladder cancer: how much is enough?. Cancer 113(4): 674-676
Petropoulou, A.D.; Lapusan, S.; Marie, J-Pierre.; Rio, B. 2008: Intravesical Bacillus Calmette-Guerin for the treatment of superficial bladder cancer following hematopoietic stem cell transplantation. Leukemia and Lymphoma 49(8): 1627-1629
Aghamir, S.M.K.; Mohseni, M.G.; Arasteh, S. 2007: Intravesical Bacillus Calmette-Guerin for treatment of refractory interstitial cystitis. Urology Journal 4(1): 18-23
Bonarriba, C.R.; de la Cruz-Ruiz, M.; Gómez-Marqués, G. 2013: Intravesical Bacillus Calmette-Guérin in immunosuppressed patients with carcinoma in situ. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 33(3): 429-431
Shang, P.F.; Kwong, J.; Wang, Z.P.; Tian, J.; Jiang, L.; Yang, K.; Yue, Z.J.; Tian, J.Q. 2011: Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer. Cochrane Database of Systematic Reviews 5: Cd006885
Di Stasi, S.M.; Dutto, L.; Verri, C. 2008: Intravesical Electromotive Drug Administration®(EMDA)with Mitomycin-C for non-muscle invasive bladder cancer. Urologia 75(4): 214-220
Jin, L-Hu.; Han, J-Uk.; Park, C-Shin.; Shin, H-Yeon.; Yoon, S-Min.; Lee, T. 2010: Intravesical PGE2 Administration in Conscious Rats as an Experimental Model of Detrusor Overactivity Observed by Simultaneous Registrations of Intravesical and Intraabdominal Pressures. International Neurourology Journal 14(2): 69-77
Kerr, J.M. 1921: Intravesical Repair of Inaccessible Vesico-vaginal Fistulae. Proceedings of the Royal Society of Medicine 14(Obstet Gynaecol Sect): 193-195
Kerr, J.M. 1921: Intravesical Repair of Inaccessible Vesico-vaginal Fistulæ. Proceedings of the Royal Society of Medicine 14(Obstet Gynaecol Sect): 193-195
Merrill, L.; Vizzard, M.A. 2014: Intravesical TRPV4 blockade reduces repeated variate stress-induced bladder dysfunction by increasing bladder capacity and decreasing voiding frequency in male rats. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 307(4): R471-R480
Hayashi, T.; Crain, B.; Corr, M.; Chan, M.; Cottam, H.B.; Maj, R.; Barberis, A.; Leoni, L.; Carson, D.A. 2010: Intravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer. International Journal of Urology: Official Journal of the Japanese Urological Association 17(5): 483-490
Iizuka, K.; Sano, K. 2009: Intravesical acetic acid instillation to detect malignant changes in the bladder mucosa: preliminary report. International journal of urology: official journal of the Japanese Urological Association 16(2): 220
Kirchgesner, T.; Danse, E.; Tombal, B. 2013: Intravesical active prostate bleeding diagnosed in B-mode ultrasound. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 23(10): 906-908
Yuasa, T.; Sato, K.; Ashihara, E.; Takeuchi, M.; Maita, S.; Tsuchiya, N.; Habuchi, T.; Maekawa, T.; Kimura, S. 2008: Intravesical administration of gammadelta T cells successfully prevents the growth of bladder cancer in the murine model. Cancer Immunology Immunotherapy: Cii 58(4): 493-502
Rosenberg, S.; Horowitz, R.; Coppenhagen-Glazer, S.; Pizov, G.; Elia, A.; Gofrit, O.N.; Ginsburg, I.; Pode, D. 2014: Intravesical administration of green tea extract attenuates the inflammatory response of bacterial cystitis--a rat model. Bju International 114(4): 601-607
Arakawa, M.; Nakamura, K.; Yamada, Y.; Kato, K.; Katsuda, R.; Tobiume, M.; Zennami, K.; Watanabe, M.; Kato, Y.; Nishikawa, G.; Yoshizawa, T.; Aoki, S.; Taki, T.; Mitsui, K.; Honda, N.; Saito, H.; Hasegawa, T. 2011: Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effect. Experimental and Therapeutic Medicine 2(5): 901-905
Chen, S.-C.; Henry, D.O.; Hicks, D.G.; Reczek, P.R.; Wong, M.K.K. 2009: Intravesical administration of plasminogen activator inhibitor type-1 inhibits in vivo bladder tumor invasion and progression. Journal of Urology 181(1): 336-342
Nickel, J.C.; Moldwin, R.; Lee, S.; Davis, E.L.; Henry, R.A.; Wyllie, M.G. 2009: Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. Bju International 103(7): 910-918
Pfost, B.; Seidl, C.; Autenrieth, M.; Saur, D.; Bruchertseifer, F.; Morgenstern, A.; Schwaiger, M.; Senekowitsch-Schmidtke, R. 2009: Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 50(10): 1700-1708
Zhang, Z.; Xu, X.-l.; Ma, L.; Li, J.-l.; Hu, Z.-m.; Gao, J.-m. 2012: Intravesical anchoring of streptavidin-tagged interleukin-4 fusion protein for immunotherapy of mouse superficial bladder cancer. Zhonghua Zhong Liu Za Zhi 34(5): 331-335
Branco, A.W.; Stunitz, L.; Nichele, S.; Douat, P.H.; Luiz, M.; Tha Nassif, L. 2013: Intravesical and transperitoneal laparoscopy in the management of tumor in the residual ureter. International Braz J Urol: Official Journal of the Brazilian Society of Urology 39(2): 291; Discussion 292
Adamopoulos, V.G.; Filiadis, I.; Konstandinidis, E. 2008: Intravesical anesthesia for bladder tissue biopsies. Comparison of two methods. International Braz J Urol: Official Journal of the Brazilian Society of Urology 34(3): 277-281; Discussion: 281-282
Washburn, D.J. 2007: Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge. Clinical Journal of Oncology Nursing 11(4): 553-559
Funahashi, Y.; Yoshida, M.; Yamamoto, T.; Majima, T.; Takai, S.; Gotoh, M. 2014: Intravesical application of rebamipide promotes urothelial healing in a rat cystitis model. Journal of Urology 192(6): 1864-1870
Funahashi, Y.; Yoshida, M.; Yamamoto, T.; Majima, T.; Takai, S.; Gotoh, M. 2014: Intravesical application of rebamipide suppresses bladder inflammation in a rat cystitis model. Journal of Urology 191(4): 1147-1152
Herr, H.W. 2011: Intravesical bacille Calmette-Guerin in patients with asymptomatic bacteriuria. JAMA 305(14): 1413-1414
Herr, H.W. 2013: Intravesical bacille Calmette-Guérin eradicates bacteriuria in antibiotic-naïve bladder cancer patients. European Urology 63(5): 832-835
Skolarus, T.A.; Lee, E.W.; Virgo, K.S.; Katz, M.D.; Hudson, M.'l.A.; Kibel, A.S.; Grubb, R.L. 2009: Intravesical bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: effects of concurrent statin therapy. Journal of the American College of Surgeons 209(2): 248-253
Kiely, B.; McLaughlin, A.M.; Lynch, T.H.; Keane, J. 2011: Intravesical bacille Calmette-Guérin-induced multiorgan failure after treatment for transitional cell carcinoma. Scandinavian Journal of Urology and Nephrology 45(4): 278-280
Okamura, T.; Akita, H.; Ando, R.; Kawai, Y.; Tozawa, K.; Kohri, K. 2010: Intravesical bacillus Calmette-Guerin (BCG) instillation for primary and recurring T1G3 bladder cancers. Asian Pacific Journal of Cancer Prevention: Apjcp 11(4): 1107-1110
Madbouly, K. 2013: Intravesical bacillus Calmette-Guerin for bladder cancer: what is known? what is not? what is next?. Urology Annals 5(2): 108-109
Martínez-Girón, R. 2009: Intravesical bacillus Calmette-Guérin effects in voided urine cytology. Diagnostic Cytopathology 37(6): 425-426
Ferrari, K.L.; de Camargo, J.A.; Rocha, G.Z.; Carvalheira, J.é B.C.; Saad, M.ár.J.A.; Billis, A.; Reis, L.O. 2015: Intravesical bacillus Calmette-Guérin efficiently reduces p70S6K1 but not 4E-BP1 phosphorylation in nonmuscle invasive bladder cancer. Journal of Urology 193(2): 682-689
Swietek, N.; Waldert, M.; Susani, M.; Schatzl, G.; Klatte, T. 2013: Intravesical bacillus Calmette-Guérin instillation therapy for non-muscle-invasive bladder cancer following solid organ transplantation. Wiener Klinische Wochenschrift 125(7-8): 189-195
Herr, H.W. 2012: Intravesical bacillus Calmette-Guérin outcomes in patients with bladder cancer and asymptomatic bacteriuria. Journal of Urology 187(2): 435-437
Wallace, E.; Twomey, M.; Victory, R.; O'Reilly, M. 2013: Intravesical baclofen, bupivacaine, and oxycodone for the relief of bladder spasm. Journal of Palliative Care 29(1): 49-51
Camilot, D.; Pizzolitto, S.; DeMaglio, G.; Falconieri, G. 2007: Intravesical botryoid adenocarcinoma of the prostate: report of an unusual growth pattern of prostatic carcinoma simulating a urinary bladder tumor. Annals of Diagnostic Pathology 11(6): 413-416
Chuang, Y.-C.; Yoshimura, N.; Huang, C.-C.; Wu, M.; Chiang, P.-H.; Chancellor, M.B. 2009: Intravesical botulinum toxin a administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats. European Urology 56(1): 159-166
Tirumuru, S.; Al-Kurdi, D.; Latthe, P. 2010: Intravesical botulinum toxin a injections in the treatment of painful bladder syndrome/interstitial cystitis: a systematic review. International Urogynecology Journal 21(10): 1285-1300
Namazi, H. 2008: Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis: a molecular mechanism. Urology 72(2): 463-4; author reply 464
Lee, C.-L.; Kuo, H.-C. 2013: Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis. Pain Physician 16(2): 109-116
John Drake, M. 2010: Intravesical botulinum toxin for lower urinary tract dysfunction. F1000 Medicine Reports 2
Ramsay, A.K.; Small, D.R.; Conn, I.G. 2007: Intravesical botulinum toxin type a in chronic interstitial cystitis: results of a pilot study. Surgeon: Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 5(6): 331-333
Bilensoy, E.; Sarisozen, C.; Esendağli, Güneş.; Doğan, A.Lale.; Aktaş, Yşim.; Sen, M.; Mungan, N.Aydin. 2009: Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors. International Journal of Pharmaceutics 371(1-2): 170-176
Leopardo, D.; Cecere, S.C.; Di Napoli, M.; Cavaliere, C.; Pisano, C.; Striano, S.; Marra, L.; Menna, L.; Claudio, L.; Perdonà, S.; Setola, S.; Berretta, M.; Franco, R.; Tambaro, R.; Pignata, S.; Facchini, G. 2013: Intravesical chemo-immunotherapy in non muscle invasive bladder cancer. European Review for Medical and Pharmacological Sciences 17(16): 2145-2158
Curotto, A.G. 2013: Intravesical chemotherapy. Urologia 80(Suppl 21): 20-23
Wallerand, H. 2009: Intravesical chemotherapy and bladder cancer. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 19(12): 868-871
Akaza, H.; Kurth, K.H.; Williams, R.; Hinotsu, S.; Jewett, M.A.; Naito, K.; Okada, K.; Schellhammer, P.F.; van Velthoven, R.F.; Witjes, J.A. 1998: Intravesical chemotherapy and immunotherapy for superficial tumors Basic mechanism of action and future direction. Urologic Oncology 4(4-5): 121-129
Hadaschik, B.A.; Adomat, H.; Fazli, L.; Fradet, Y.; Andersen, R.J.; Gleave, M.E.; So, A.I. 2008: Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(5): 1510-1518
Engles, C.D.; Hauser, P.J.; Abdullah, S.N.; Culkin, D.J.; Hurst, R.E. 2012: Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis. Urology 79(2): 483.E13-17
Volkow-Fernández, P.; Rodríguez, C.Franco.; Cornejo-Juárez, P. 2012: Intravesical colistin irrigation to treat multidrug-resistant Acinetobacter baumannii urinary tract infection: a case report. Journal of Medical Case Reports 6: 426
Matsui, Y.; Hadaschik, B.A.; Fazli, L.; Andersen, R.J.; Gleave, M.E.; So, A.I. 2009: Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancer. Molecular Cancer Therapeutics 8(8): 2402-2411
Lazarus, J.; Kaestner, L. 2011: Intravesical condylomata accuminata in HIV positive patient. Canadian Journal of Urology 18(2): 5663-5665
Fang, J.-Y.; Wu, P.-C.; Fang, C.-L.; Chen, C.-H. 2010: Intravesical delivery of 5-aminolevulinic acid from water-in-oil nano/submicron-emulsion systems. Journal of Pharmaceutical Sciences 99(5): 2375-2385
Seager, C.M.; Puzio-Kuter, A.M.; Patel, T.; Jain, S.; Cordon-Cardo, C.; Mc Kiernan, J.; Abate-Shen, C. 2009: Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer. Cancer Prevention Research 2(12): 1008-1014
Kang, M.Rim.; Yang, G.; Place, R.F.; Charisse, K.; Epstein-Barash, H.; Manoharan, M.; Li, L-Cheng. 2012: Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Research 72(19): 5069-5079
Kim, R.; Liu, W.; Chen, X.; Kreder, K.J.; Luo, Y. 2011: Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models. Journal of Biomedicine and Biotechnology 2011: 937061
GuhaSarkar, S.; Banerjee, R. 2010: Intravesical drug delivery: Challenges, current status, opportunities and novel strategies. Journal of Controlled Release: Official Journal of the Controlled Release Society 148(2): 147-159
Kajbafzadeh, A.-M.; Ahmadi, H.; Montaser-Kouhsari, L.; Sharifi-Rad, L.; Nejat, F.; Bazargan-Hejazi, S. 2011: Intravesical electromotive botulinum toxin type a administration--part II: Clinical application. Urology 77(2): 439-445
Kajbafzadeh, A.-M.; Montaser-Kouhsari, L.; Ahmadi, H.; Sotoudeh, M. 2011: Intravesical electromotive botulinum toxin type a administration: part I--Experimental study. Urology 77(6): 1460-1464
Di Stasi, S.M.; Liberati, E.; Dutto, L.; Verri, C. 2008: Intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer. Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 80(4): 157-161
Chartier-Kastler, E.; Ruffion, A. 2007: Intravesical electrostimulation. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(3): 540-541
Glybochko, P.V.; Aboian, I.A.; Valiev, A.Z.; Surikov, V.N.; Raĭgorodskiĭ, I.M. 2010: Intravesical electrostimulation and magnetophoresis in overactive bladder in females: efficacy of Amus-01-Intramag device with Intrastim attachment. Urologiia 5: 61-65
Sharkov, S.M.; Iatsik, S.P.; Bolotova, N.V.; Raĭgorodskiĭ, I.M.; Konova, O.M.; Tkacheva, E.N. 2011: Intravesical electrostimulation and magnetotherapy in chronic pyelonephritis and cystitis in children with urodynamic disorders. Urologiia 6: 92; 94-97
Mohammadzadeh Rezaee, M. 2006: Intravesical explosion during endoscopic transurethral resection of prostate. Urology Journal 3(2): 109-110
Dieckmann, K-P.; Gehrckens, R.; Biesewig, A-K. 2008: Intravesical explosion with rupture of the bladder wall during transurethral resection. Der Urologe. Ausg. a 47(7): 860-862
Oğuz, G.; Subaşı, D.; Kaya, Mşure.; Güven, Oğuz.; Ünver, Süheyla. 2013: Intravesical explosion: a rare complication of transurethral resection of prostate. Journal of Anesthesia 27(1): 145-146
Irekpita, E.; Imomoh, P.; Kesieme, E.; Onuora, V. 2011: Intravesical foreign bodies: a case report and a review of the literature. International Medical Case Reports Journal 4: 35-39
Rafique, M. 2008: Intravesical foreign bodies: review and current management strategies. Urology Journal 5(4): 223-231
Kamal, F.; Clark, A.T.D.; Lavallée, L.T.; Roberts, M.; Watterson, J. 2008: Intravesical foreign body-induced bladder calculi resulting in obstructive renal failure. Canadian Urological Association Journal 2(5): 546-548
Sharma, U.K.; Rauniyar, D.; Shah, W.F. 2006: Intravesical foreign body: case report. Kathmandu University Medical Journal 4(3): 342-344
Thatte, A.; Rajendran, S.; Murphy, L.; Allen, M. 2014: Intravesical foreign body: clinical features and diagnostic clues. BMJ Case Reports
Sternberg, I.A.; Dalbagni, G.; Chen, L.Y.; Donat, S.M.; Bochner, B.H.; Herr, H.W. 2013: Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure. Journal of Urology 190(5): 1686-1691
Shelley, M.D.; Jones, G.; Cleves, A.; Wilt, T.J.; Mason, M.D.; Kynaston, H.G. 2012: Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review. Bju International 109(4): 496-505
Van Nieuwkoop, C.; den Exter, P.L.; Elzevier, H.W.; den Hartigh, J.; van Dissel, J.T. 2010: Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation. International Journal of Antimicrobial Agents 36(6): 485-490
Bradley, A.M.; Lappin, M.R. 2014: Intravesical glycosaminoglycans for obstructive feline idiopathic cystitis: a pilot study. Journal of Feline Medicine and Surgery 16(6): 504-506
Iacovelli, V.; Topazio, L.; Gaziev, G.; Bove, P.; Vespasiani, G.; Finazzi Agrò, E. 2013: Intravesical glycosaminoglycans in the management of chronic cystitis. Minerva Urologica e Nefrologica 65(4): 249-262
Margreiter, M.; Sharma, V.; Schauer, I.; Klingler, H.-C. 2013: Intravesical hemostatic gelatin matrix instillation in the management of intractable hematuria. Urology 82(3): 724-728
Generali, J.A.; Cada, D.J. 2013: Intravesical heparin: interstitial cystitis (painful bladder syndrome). Hospital Pharmacy 48(10): 822-824
Lv, Y.-S.; Zhou, H.-L.; Mao, H.-P.; Gao, R.; Wang, Y.-D.; Xue, X.-Y. 2012: Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis. International Urogynecology Journal 23(12): 1715-1720
Cervigni, M.; Natale, F.; Nasta, L.; Mako, A. 2012: Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results. International Urogynecology Journal 23(9): 1187-1192
Lv, Y.S.; Yao, Y.S.; Rong, L.; Lin, M.E.; Deng, B.H.; Xie, Y.; Huang, H.; Lin, T.X.; Xu, K.W.; Huang, J. 2014: Intravesical hyaluronidase causes chronic cystitis in a rat model: a potential model of bladder pain syndrome/interstitial cystitis. International Journal of Urology: Official Journal of the Japanese Urological Association 21(6): 601-607
Alfred Witjes, J.; Hendricksen, K.; Gofrit, O.; Risi, O.; Nativ, O. 2009: Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo working party. World Journal of Urology 27(3): 319-324
Chuang, Y.-C.; Tyagi, P.; Huang, H.-Y.; Yoshimura, N.; Wu, M.; Kaufman, J.; Chancellor, M.B. 2011: Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide-induced inflammatory cystitis. Neurourology and Urodynamics 30(3): 421-427
Zaharoff, D.A.; Hoffman, B.S.; Hooper, H.B.; Benjamin, C.J.; Khurana, K.K.; Hance, K.W.; Rogers, C.J.; Pinto, P.A.; Schlom, J.; Greiner, J.W. 2009: Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12. Cancer Research 69(15): 6192-6199
Safari, S.; Jamali, S.; Habibollahi, P.; Arshadi, H.; Nejat, F.; Kajbafzadeh, A.-M. 2010: Intravesical injections of botulinum toxin type a for management of neuropathic bladder: a comparison of two methods. Urology 76(1): 225-230
Zhou, J.; Xie, S.; Guo, X.; Mo, Z. 2007: Intravesical instillation in pure line LEW rats and nude mice. Journal of Huazhong University of Science and Technology. Medical Sciences 27(3): 288-290
Torres, A.R.; Cooke, K. 2014: Intravesical instillation of amikacin for treatment of a lower urinary tract infection caused by Pseudomonas aeruginosa in a dog. Journal of the American Veterinary Medical Association 245(7): 809-811
Krhut, J.; Zvara, P. 2011: Intravesical instillation of botulinum toxin A: an in vivo murine study and pilot clinical trial. International Urology and Nephrology 43(2): 337-343
Jeong, K.-C.; Kim, K.-T.; Seo, H.-H.; Shin, S.-P.; Ahn, K.-O.; Ji, M.-J.; Park, W.S.; Kim, I.-H.; Lee, S.-J.; Seo, H.K. 2014: Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth. Journal of Urology 191(2): 510-518
Shao, Y.; Shen, Z.-J.; Rui, W.-B.; Zhou, W.-L. 2010: Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. Urology 75(3): 547-550
Lander, E.B.; See, J.R. 2014: Intravesical instillation of pentosan polysulfate encapsulated in a liposome nanocarrier for interstitial cystitis. American Journal of Clinical and Experimental Urology 2(2): 145-148
Harper, L.; Semjen, F.; Bordes, M.; Lavrand, F.; Herault, A.-L.; Vergnes, P.; Dobremez, E. 2007: Intravesical instillation of ropivacaine reduces bladder spasms following paediatric ureteroneocystostomy. Journal of Pediatric Urology 3(4): 301-304
Segawa, N.; Nishida, T.; Takahara, K.; Nomi, H.; Azuma, H.; Katsuoka, Y. 2008: Intravesical instillation with epirubicin as a prophylactic treatment for superficial bladder cancer--using two different schedules. Hinyokika Kiyo. Acta Urologica Japonica 54(11): 711-716
Guy, L.; Quintens, H.; Pfister, C. 2009: Intravesical instillations in the elderly subject. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 19(Suppl 3): S133-S134
Garcés-Jimeno, B.; Tomasa-Irriguible, T.M.; Moreno-Molina, J.A. 2015: Intravesical instillations of colistin in urine infections with multiresistant pathogens. Medicina Intensiva 39(2): 125-126
Bonfili, P.; Franzese, P.; Marampon, F.; La Verghetta, M.E.; Parente, S.; Cerasani, M.; Di Genova, D.; Mancini, M.; Vittorini, F.; Gravina, G.L.; Ruggieri, V.; Di Staso, M.; Popov, V.M.; Tombolini, V.; Di Cesare, E. 2014: Intravesical instillations with polydeoxyribonucleotides reduce symptoms of radiation-induced cystitis in patients treated with radiotherapy for pelvic cancer: a pilot study. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 22(5): 1155-1159
Matsumoto, K.; Kikuchi, E.; Horinaga, M.; Takeda, T.; Miyajima, A.; Nakagawa, K.; Oya, M. 2011: Intravesical interleukin-15 gene therapy in an orthotopic bladder cancer model. Human Gene Therapy 22(11): 1423-1432
Sujijantararat, P. 2007: Intravesical knotting of a feeding tube used as a urinary catheter. Journal of the Medical Association of Thailand 90(6): 1231-1233
Kumar, A.; Singh, B.P.; Paul, S.; Sankhwar, S. 2014: Intravesical knotting of guide wire during insertion of Foley catheter. BMJ Case Reports
Liu, S.-j.; Ye, H.-y.; Li, Q.; Xu, K.-x.; Zhang, X.-p.; Yu, L.-p.; Wang, X.-f. 2010: Intravesical laparoscopic repair of vesicovaginal fistula. Beijing da Xue Xue Bao. Yi Xue Ban 42(4): 458-460
Taneja, R. 2010: Intravesical lignocaine in the diagnosis of bladder pain syndrome. International Urogynecology Journal 21(3): 321-324
Baumgarten, A.S.; Emtage, J.B.; Wilder, R.B.; Biagioli, M.C.; Gupta, S.; Spiess, P.E. 2014: Intravesical lipiodol injection technique for image-guided radiation therapy for bladder cancer. Urology 83(4): 946-950
Tyagi, P.; Kashyap, M.P.; Kawamorita, N.; Yoshizawa, T.; Chancellor, M.; Yoshimura, N. 2014: Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndrome. Isrn Pharmacology 2014: 601653
Chuang, Y.-C.; Lee, W.-C.; Lee, W.-C.; Chiang, P.-H. 2009: Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. Journal of Urology 182(4): 1393-1400
Moore, C.R.; Shirodkar, S.P.; Avallone, M.A.; Castle, S.M.; Gorin, M.A.; Gorbatiy, V.; Leveillee, R.J. 2012: Intravesical methylene blue facilitates precise identification of the diverticular neck during robot-assisted laparoscopic bladder diverticulectomy. Journal of Laparoendoscopic and Advanced Surgical Techniques. Part a 22(5): 492-495
Mora, E.R.; Galí, O.B.; Garin, J.śe.A.L.; Arango, O. 2010: Intravesical migration and spontaneous expulsion of a Hem-o-lok polymer ligating clip after laparoscopic radical prostatectomy. Urology 75(6): 1317
Tosun, M.; Celik, H.; Yavuz, E.; Cetinkaya, M.B. 2010: Intravesical migration of an intrauterine device detected in a pregnant woman. Canadian Urological Association Journal 4(5): E141-E143
Matsuta, Y.; Terai, A.; Arai, Y. 2011: Intravesical migration of intrauterine contraceptive device (IUCD) with stone formation. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 102(3): 603-606
El Ammari, J.E.; El Fassi, M.J.; Farih, M.H. 2009: Intravesical migration of intrauterine devices. Presse Medicale 38(7-8): 1185-1188
Halachmi, S.; Moskovitz, B.; Maffezzini, M.; Conti, G.; Verweij, F.; Kedar, D.; Sandri, S.D.; Nativ, O.; Colombo, R. 2011: Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder. Urologic Oncology 29(3): 259-264
Maffezzini, M.; Campodonico, F.; Canepa, G.; Manuputty, E.E.; Tamagno, S.; Puntoni, M. 2014: Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progression. Cancer ChemoTherapy and Pharmacology 73(5): 925-930
Andreu-Barasoain, M.; Gómez de la Fuente, E.; Pinedo, F.; Nuño, A.; López-Estebaranz, J.L. 2012: Intravesical mitomycin C-induced generalized pustular folliculitis. Journal of the American Academy of Dermatology 67(4): E142-E143
Delto, J.C.; Kacker, R.; Bubley, G.; DeWolf, W.C. 2014: Intravesical mitomycin therapy for stage T1 and tis high-grade squamous cell carcinoma of the bladder. Clinical Genitourinary Cancer 12(1): E35-E36
Wada, H.; Nakano, Y.; Yamada, H.; Saiga, T.; Yamanaka, A.; Sakai, N. 2010: Intravesical mitomycin-C-induced interstitial pneumonia. Respiration; International Review of Thoracic Diseases 80(3): 256-259
Morales, A.; Phadke, K.; Steinhoff, G. 2009: Intravesical mycobacterial cell wall-DNA complex in the treatment of carcinoma in situ of the bladder after standard intravesical therapy has failed. Journal of Urology 181(3): 1040-1045
Chung, S.-D.; Kuo, Y.-C.; Kuo, H.-C. 2012: Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome. Pain Physician 15(3): 197-202
So, A.; Rennie, P.S.; Jia, W. 2012: Intravesical oncoviral therapy for bladder cancer. Journal of Urology 188(6): 2039-2040
Polido Júnior, A.; Costa, J.é M.; Munhoz, T.ân.; Sampaio, F.J.é; Cardoso, L.E.M.; Amaro, J.ão.L. 2010: Intravesical oxybutynin protects the vesical wall against functional and smooth muscle changes in rabbits with detrusor overactivity. International Urogynecology Journal 21(12): 1539-1544
Lu, B.-X.; Han, R.-F.; Tang, Y.; Lei, M.-d.; Li, S.-Z. 2008: Intravesical perfusion of recombinant adeno-associated virus-endostatin in treatment of bladder cancer: experiments with mice. Zhonghua Yi Xue Za Zhi 88(44): 3157-3158
Lee, S.Don.; Akbal, C.; Jung, C.; Kaefer, M. 2006: Intravesical pressure induces hyperplasia and hypertrophy of human bladder smooth muscle cells mediated by muscarinic receptors. Journal of Pediatric Urology 2(4): 271-276
Lee, C.Ho.; Ha, H.Koo. 2014: Intravesical prostatic protrusion as a predictor of early urinary continence recovery after laparoscopic radical prostatectomy. International Journal of Urology: Official Journal of the Japanese Urological Association 21(7): 653-656
Lieber, M.M.; Jacobson, D.J.; McGree, M.E.; St Sauver, J.L.; Girman, C.J.; Jacobsen, S.J. 2009: Intravesical prostatic protrusion in men in Olmsted County, Minnesota. Journal of Urology 182(6): 2819-2824
Kim, J.W.; Oh, M.M.; Park, H.S.; Cheon, J.; Lee, J.G.; Kim, J.J.; Moon, D.G. 2014: Intravesical prostatic protrusion is a risk factor for bladder stone in patients with benign prostatic hyperplasia. Urology 84(5): 1026-1029
Lee, L.S.; Sim, H.G.; Lim, K.B.; Wang, D.; Foo, K.T. 2010: Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment. International Journal of Urology: Official Journal of the Japanese Urological Association 17(1): 69-74
Di Pierro-Giovanni, B.; Danuser, H.; Mattei, A. 2012: Intravesical protrusion of retropubic osteophyte mimicking an urinary bladder tumour. Actas Urologicas Espanolas 36(7): 446-447
Reis, L.O.; Barreiro, G.C.; Baracat, J.; Prudente, A.; D'Ancona, C.A. 2008: Intravesical protrusion of the prostate as a predictive method of bladder outlet obstruction. International Braz J Urol: Official Journal of the Brazilian Society of Urology 34(5): 627
Sengottayan, V.K.; Vasudeva, P.; Dalela, D. 2008: Intravesical real-time imaging and staging of bladder cancer: use of optical coherence tomography. Indian Journal of Urology: Iju: Journal of the Urological Society of India 24(4): 592-593
Hirano, D.; Okada, Y.; Nagane, Y.; Satoh, K.; Mochida, J.; Yamanaka, Y.; Hirakata, H.; Yamaguchi, K.; Kawata, N.; Takahashi, S.; Henmi, A. 2012: Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract. Urologia Internationalis 89(1): 71-77
Karzar, S.H.; Hasanzadeh, K.; Goldust, M.; Karzar, N.H. 2012: Intravesical residual urine of patients with benign prostate hyperplasia, sonography accuracy. Pakistan Journal of Biological Sciences: Pjbs 15(22): 1090-1093
Guo, C.; Yang, B.; Gu, W.; Peng, B.; Xia, S.; Yang, F.; Wen, D.; Geng, J.; Zhang, Y.; Zheng, J. 2013: Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis. Plos one 8(12): E82591
Fuller, A.; Vanderhaeghe, L.; Nott, L.; Martin, P.R.; Pautler, S.E. 2013: Intravesical ropivacaine as a novel means of analgesia post-robot-assisted radical prostatectomy: a randomized, double-blind, placebo-controlled trial. Journal of Endourology 27(3): 313-317
Li, Q.K.; Pavlovich, C.P.; Zhang, H.; Kinsinger, C.R.; Chan, D.W. 2019: Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): a critical step towards the personalized care of renal cancers. Seminars in Cancer Biology 55: 8-15
Sesmero, J.H.A.ón.; Redondo, C.C.; Delgado, M.C.; Royo, F.át.C.; Tesedo, V.ón.R.íg.; Oceja, J.é M.M.ín.-S. 2010: Intravesical sealing of the distal ureter in nephroureterectomy. Archivos Espanoles de Urologia 63(3): 223-229
Ito, A.; Shintaku, I.; Satoh, M.; Ioritani, N.; Tochigi, T.; Numata, I.; Namima, T.; Kambe, K.; Kyan, A.; Ueno, S.; Katoh, S.; Adachi, H.; Yamashita, S.; Yamaguchi, T.; Arai, Y.; Aizawa, M.; Kawamura, S.; Aoki, H.; Takeda, A.; Namiki, S.; Ikeda, Y.; Tokuyama, S.; Orikasa, K.; Ishidoya, S. 2013: Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial. Japanese Journal of Clinical Oncology 43(11): 1139-1144
Lu, C-Ming. 2013: Intravesical stone formation several years after hysterectomy: a case report. Journal of Medical Case Reports 7: 230
Zakri, R.H.; Patel, A.K.; John, B.S.; Shrotri, N.C. 2011: Intravesical tension-free vaginal tape removal: is there a single solution?. Isrn Urology 2011: 343850
Logan, C.; Brown, M.; Hayne, D. 2012: Intravesical therapies for bladder cancer - indications and limitations. Bju International 110(Suppl 4): 12-21
Williams, S.K.; Hoenig, D.M.; Ghavamian, R.; Soloway, M. 2010: Intravesical therapy for bladder cancer. Expert Opinion on PharmacoTherapy 11(6): 947-958
Shelley, M.D.; Mason, M.D.; Kynaston, H. 2010: Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treatment Reviews 36(3): 195-205
Manoharan, M. 2011: Intravesical therapy for urothelial carcinoma of the bladder. Indian Journal of Urology: Iju: Journal of the Urological Society of India 27(2): 252-261
Chade, D.C.; Shariat, S.F.; Dalbagni, G. 2009: Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review. International Braz J Urol: Official Journal of the Brazilian Society of Urology 35(6): 640
Simon, J.; Finter, F.; Schnöller, T.; Hautmann, R.; Rinnab, L. 2009: Intravesical therapy in non-muscle-invasive bladder cancer: indications and practical considerations. Der Urologe. Ausg. a 48(11): 1263-1264; 1266-8; 1270-1272
Matsuo, T.; Shida, Y.; Hayashida, Y.; Sakai, H. 2011: Intravesical therapy of heparin and lidocaine for interstitial cystitis : a case report. Hinyokika Kiyo. Acta Urologica Japonica 57(9): 513-516
Vom Dorp, F.; Tschirdewahn, S.; Lümmen, G. 2012: Intravesical therapy of non-muscle invasive bladder tumors. Der Urologe. Ausg. a 51(2): 257-264
Pugliese, J.M.; Greene, R.N.; Peterson, A.C. 2009: Intravesical therapy use in the high risk patient: practice patterns in an equal access healthcare institution before and after national guidelines. Canadian Journal of Urology 16(6): 4927-4931
Verri, C.; Liberati, E.; Celestino, F.; De Carlo, F.; Torelli, F.; Di Stasi, S.M. 2013: Intravesical therapy with mitomycin through electromotive drug administration. Urologia 80(2): 105-111
García Rodríguez, J.; Fernández Gómez, J.ús.M.ía.; Escaf Barmadah, S.; Alvarez Múgica, M.; Rodríguez Robles, L.; Martín Benito, J.é L.; San Martín Blanco, A.; Regadera Sejas, J. 2007: Intravesical therapy: Influence on superficial bladder cancer progression. Archivos Espanoles de Urologia 60(1): 31-35
García Rodríguez, J.; Fernández Gómez, J.ús.M.ía.; Escaf Barmadah, S.; González Alvarez, R.C.; Jalón Monzón, A.; Martínez Gómez, F.J.; Sánchez Trilla, A.; Regadera Sejas, J. 2007: Intravesical therapy: Influence on superficial bladder cancer recurrence. Archivos Espanoles de Urologia 60(1): 36-43
Milla, P.; Fiorito, C.; Soria, F.; Arpicco, S.; Cattel, L.; Gontero, P. 2014: Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients. Cancer ChemoTherapy and Pharmacology 73(3): 503-509
Eguíluz Lumbreras, P.; Palacios Hernández, A.; Heredero Zorzo, O.; Grinard De León, E.Ariel.; Martín Parada, A.; Gómez Zancajo, V.Ramón.; Urrutia Avisrror, M. 2012: Intravesical thermometer. Archivos Espanoles de Urologia 65(2): 269
Dellis, A.; Papatsoris, A.G. 2014: Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections. Expert Opinion on Investigational Drugs 23(6): 751-757
Matsuoka, P.K.; Haddad, J.M.; Pacetta, A.M.; Baracat, E.C. 2012: Intravesical treatment of painful bladder syndrome: a systematic review and meta-analysis. International Urogynecology Journal 23(9): 1147-1153
Sinha, S. 2012: Intravesical treatment of painful bladder syndrome: the potential pitfalls of meta-analyses. International Urogynecology Journal 23(9): 1145-1146
Cicione, A.; Cantiello, F.; Ucciero, G.; Salonia, A.; Torella, M.; De Sio, M.; Autorino, R.; Carbone, A.; Romancik, M.; Tomaskin, R.; Damiano, R. 2014: Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey. Canadian Urological Association Journal 8(9-10): E721-E727
Dawson, T.E.; Jamison, J. 2007: Intravesical treatments for painful bladder syndrome/ interstitial cystitis. Cochrane Database of Systematic Reviews 4: Cd006113
Svatek, R.S.; Clinton, T.N.; Wilson, C.A.; Kamat, A.M.; Grossman, H.B.; Dinney, C.P.; Shah, J.B. 2014: Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy. Urology 84(5): 1147-1151
Dinney, C.P.N.; Greenberg, R.E.; Steinberg, G.D. 2013: Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guérin. Urologic Oncology 31(8): 1635-1642
Slagt, I.K.B.; Klop, K.W.J.; Ijzermans, J.N.M.; Terkivatan, T.ür. 2012: Intravesical versus extravesical ureteroneocystostomy in kidney transplantation: a systematic review and meta-analysis. Transplantation 94(12): 1179-1184
Hadaschik, B.A.; Jackson, J.; Fazli, L.; Zoubeidi, A.; Burt, H.M.; Gleave, M.E.; So, A.I. 2008: Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer. Bju International 102(5): 610-616
Mohanty, N.K.; Nayak, R.L.; Vasudeva, P.; Arora, R.P. 2008: Intravesicle gemcitabine in management of BCG refractory superficial TCC of urinary bladder-our experience. Urologic Oncology 26(6): 616-619
Camacho, M.; Machado, J.é D.; Alvarez, J.; Borges, R. 2008: Intravesicular calcium release mediates the motion and exocytosis of secretory organelles: a study with adrenal chromaffin cells. Journal of Biological Chemistry 283(33): 22383-22389
Rao, K.V.; Buie, L.W.; Shea, T.; Gabriel, D.A.; Comeau, T.; Irons, R.; Serody, J.; Eron, B.; Epstein, S. 2009: Intravesicular cidofovir for the management of BK virus-associated cystitis. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 15(3): 391-392
Borges, R.; Pereda, D.; Beltrán, B.; Prunell, M.; Rodríguez, M.; Machado, J.é D. 2010: Intravesicular factors controlling exocytosis in chromaffin cells. Cellular and Molecular Neurobiology 30(8): 1359-1364
Vernooij, M.W.; Ikram, M.A.; Vincent, A.J.P.E.; Breteler, M.M.B.; van der Lugt, A. 2008: Intravestibular lipoma: an important imaging diagnosis. Archives of Otolaryngology--Head and Neck Surgery 134(11): 1225-1228
Li, W.; Nava, R.G.; Bribriesco, A.C.; Zinselmeyer, B.H.; Spahn, J.H.; Gelman, A.E.; Krupnick, A.S.; Miller, M.J.; Kreisel, D. 2012: Intravital 2-photon imaging of leukocyte trafficking in beating heart. Journal of Clinical Investigation 122(7): 2499-2508
Nobis, M.; McGhee, E.J.; Morton, J.P.; Schwarz, J.P.; Karim, S.A.; Quinn, J.; Edward, M.; Campbell, A.D.; McGarry, L.C.; Evans, T.R.J.; Brunton, V.G.; Frame, M.C.; Carragher, N.O.; Wang, Y.; Sansom, O.J.; Timpson, P.; Anderson, K.I. 2013: Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer. Cancer Research 73(15): 4674-4686
Janssen, A.; Beerling, E.; Medema, R.é; van Rheenen, J. 2013: Intravital FRET imaging of tumor cell viability and mitosis during chemotherapy. Plos one 8(5): E64029
Wang, Y.; Chen, L.; Wier, W.G.; Zhang, J. 2013: Intravital Förster resonance energy transfer imaging reveals elevated [Ca2+]i and enhanced sympathetic tone in femoral arteries of angiotensin II-infused hypertensive biosensor mice. Journal of Physiology 591(21): 5321-5336
Masedunskas, A.; Porat-Shliom, N.; Rechache, K.; Aye, M.-P.'; Weigert, R. 2012: Intravital Microscopy Reveals Differences in the Kinetics of Endocytic Pathways between Cell Cultures and Live Animals. Cells 1(4): 1121-1132
Mitrofanova, L.B.; Mitrofanov, N.A.; Grokhotova, V.V.; Gordeeva, M.V.; Pakhomov, A.V.; Tatarskiĭ, R.B.; Lebedev, D.S.; Koval'skiĭ, G.B. 2013: Intravital and postmortem morphological studies and magnetic resonance imaging of arrhythmogenic right ventricular dysplasia. Arkhiv Patologii 75(6): 9-15
Luo, J.; Guo, X.-R.; Tang, X.-J.; Sun, X.-Y.; Yang, Z.-S.; Zhang, Y.; Dai, L.-J.; Warnock, G.L. 2014: Intravital biobank and personalized cancer therapy: the correlation with omics. International Journal of Cancer 135(7): 1511-1516
Bal, U.; Andresen, V.; Baggett, B.; Utzinger, U. 2013: Intravital confocal and two-photon imaging of dual-color cells and extracellular matrix mimics. Microscopy and Microanalysis: the Official Journal of Microscopy Society of America Microbeam Analysis Society Microscopical Society of Canada 19(1): 201-212
Van Ham, T.J.; Brady, C.A.; Kalicharan, R.D.; Oosterhof, N.; Kuipers, J.; Veenstra-Algra, A.; Sjollema, K.A.; Peterson, R.T.; Kampinga, H.H.; Giepmans, B.N.G. 2014: Intravital correlated microscopy reveals differential macrophage and microglial dynamics during resolution of neuroinflammation. Disease Models and Mechanisms 7(7): 857-869
Tanaka, K.; Morimoto, Y.; Toiyama, Y.; Okugawa, Y.; Inoue, Y.; Uchida, K.; Kimura, K.; Mizoguchi, A.; Kusunoki, M. 2012: Intravital dual-colored visualization of colorectal liver metastasis in living mice using two photon laser scanning microscopy. Microscopy Research and Technique 75(3): 307-315
Hickerson, R.P.; Gonzalez-Gonzalez, E.; Vlassov, A.V.; Li, M.; Lara, M.Fernanda.; Contag, C.H.; Kaspar, R.L. 2012: Intravital fluorescence imaging of small interfering RNA-mediated gene repression in a dual reporter melanoma xenograft model. Nucleic Acid Therapeutics 22(6): 438-443
Jaffer, F.A. 2011: Intravital fluorescence microscopic molecular imaging of atherosclerosis. Methods in Molecular Biology 680: 131-140
Fay, W.P. 2011: Intravital fluorescence microscopy improves thrombosis phenotype scoring in mice. Arteriosclerosis Thrombosis and Vascular Biology 31(6): 1253-1254
Esguerra, M.; Fink, H.; Laschke, M.W.; Jeppsson, A.; Delbro, D.; Gatenholm, P.; Menger, M.D.; Risberg, B. 2010: Intravital fluorescent microscopic evaluation of bacterial cellulose as scaffold for vascular grafts. Journal of Biomedical Materials Research. Part a 93(1): 140-149
Khurana, M.; Moriyama, E.H.; Mariampillai, A.; Wilson, B.C. 2008: Intravital high-resolution optical imaging of individual vessel response to photodynamic treatment. Journal of Biomedical Optics 13(4): 040502
Pittet, M.J.; Weissleder, R. 2011: Intravital imaging. Cell 147(5): 983-991
Makale, M. 2007: Intravital imaging and cell invasion. Methods in Enzymology 426: 375-401
Giampieri, S.; Pinner, S.; Sahai, E. 2010: Intravital imaging illuminates transforming growth factor beta signaling switches during metastasis. Cancer Research 70(9): 3435-3439
Niklass, S.; Stoyanov, S.; Garz, C.; Bueche, C.Z.; Mencl, S.; Reymann, K.; Heinze, H.-J.; Carare, R.O.; Kleinschnitz, C.; Schreiber, S. 2014: Intravital imaging in spontaneously hypertensive stroke-prone rats-a pilot study. Experimental and Translational Stroke Medicine 6(1): 1
Son, S.W.; Kim, J.H.; Kim, S.H.; Kim, H.; Chung, A.-Y.; Choo, J.B.; Oh, C.H.; Park, H.-C. 2009: Intravital imaging in zebrafish using quantum dots. Skin Research and Technology: Official Journal of International Society for Bioengineering and the Skin and International Society for Digital Imaging of Skin and International Society for Skin Imaging 15(2): 157-160
Li, N.; Wang, J.; Han, H.; Huang, L.; Shao, F.; Li, X. 2014: Intravital imaging of Bacillus thuringiensis Cry1A toxin binding sites in the midgut of silkworm. Analytical Biochemistry 447: 90-97
Mempel, T.R.; Bauer, C.A. 2009: Intravital imaging of CD8+ T cell function in cancer. Clinical and Experimental Metastasis 26(4): 311-327
Coppieters, K.; Amirian, N.; von Herrath, M. 2012: Intravital imaging of CTLs killing islet cells in diabetic mice. Journal of Clinical Investigation 122(1): 119-131
Toiyama, Y.; Mizoguchi, A.; Okugawa, Y.; Koike, Y.; Morimoto, Y.; Araki, T.; Uchida, K.; Tanaka, K.; Nakashima, H.; Hibi, M.; Kimura, K.; Inoue, Y.; Miki, C.; Kusunoki, M. 2010: Intravital imaging of DSS-induced cecal mucosal damage in GFP-transgenic mice using two-photon microscopy. Journal of Gastroenterology 45(5): 544-553
Hu, S.; Yan, P.; Maslov, K.; Lee, J.-M.; Wang, L.V. 2009: Intravital imaging of amyloid plaques in a transgenic mouse model using optical-resolution photoacoustic microscopy. Optics Letters 34(24): 3899-3901
Zal, T.; Chodaczek, G. 2010: Intravital imaging of anti-tumor immune response and the tumor microenvironment. Seminars in Immunopathology 32(3): 305-317
Kawakami, N.; Bartholomäus, I.; Pesic, M.; Kyratsous, N.I. 2013: Intravital imaging of autoreactive T cells in living animals. Methods in Cell Biology 113: 149-168
Kagawa, Y.; Maeda, S.; Mori, M.; Ishii, M. 2012: Intravital imaging of cancer cell dynamics. Nihon Geka Gakkai Zasshi 113(2): 171-176
Zomer, A.; Ellenbroek, S.I.J.; Ritsma, L.; Beerling, E.; Vrisekoop, N.; Van Rheenen, J. 2013: Intravital imaging of cancer stem cell plasticity in mammary tumors. Stem Cells 31(3): 602-606
Aguirre, A.D.; Vinegoni, C.; Sebas, M.; Weissleder, R. 2014: Intravital imaging of cardiac function at the single-cell level. Proceedings of the National Academy of Sciences of the United States of America 111(31): 11257-11262
Faleo, G.; Berggren, P.-O.; Pileggi, A. 2014: Intravital imaging of cytotoxic T lymphocytes. Methods in Molecular Biology 1186: 121-129
Lin, K.L.; Fulton, L.M.; Berginski, M.; West, M.L.; Taylor, N.A.; Moran, T.P.; Coghill, J.M.; Blazar, B.R.; Bear, J.E.; Serody, J.S. 2014: Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD. Blood 123(10): 1604-1614
Pinto-Teixeira, F.; Muzzopappa, M.; Swoger, J.; Mineo, A.; Sharpe, J.; López-Schier, H.án. 2013: Intravital imaging of hair-cell development and regeneration in the zebrafish. Frontiers in Neuroanatomy 7: 33
Wu, J.W.; Runnels, J.M.; Lin, C.P. 2014: Intravital imaging of hematopoietic stem cells in the mouse skull. Methods in Molecular Biology 1185: 247-265
Steinmetz, N.F.; Ablack, A.L.; Hickey, J.L.; Ablack, J.; Manocha, B.; Mymryk, J.S.; Luyt, L.G.; Lewis, J.D. 2011: Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors. Small 7(12): 1664-1672
Teo, G.Sock.Leng.; Yang, Z.; Carman, C.V.; Karp, J.M.; Lin, C.P. 2015: Intravital imaging of mesenchymal stem cell trafficking and association with platelets and neutrophils. Stem Cells 33(1): 265-277
Oh, G.; Yoo, S.W.; Jung, Y.; Ryu, Y.-M.; Park, Y.; Kim, S.-Y.; Kim, K.H.; Kim, S.; Myung, S.-J.; Chung, E. 2014: Intravital imaging of mouse colonic adenoma using MMP-based molecular probes with multi-channel fluorescence endoscopy. Biomedical Optics Express 5(5): 1677-1689
Honda, M.; Takeichi, T.; Asonuma, K.; Tanaka, K.; Kusunoki, M.; Inomata, Y. 2013: Intravital imaging of neutrophil recruitment in hepatic ischemia-reperfusion injury in mice. Transplantation 95(4): 551-558
Megens, R.T.A.; Kemmerich, K.; Pyta, J.; Weber, C.; Soehnlein, O. 2011: Intravital imaging of phagocyte recruitment. Thrombosis and Haemostasis 105(5): 802-810
Burford, J.L.; Villanueva, K.; Lam, L.; Riquier-Brison, A.; Hackl, M.J.; Pippin, J.; Shankland, S.J.; Peti-Peterdi, J.án. 2014: Intravital imaging of podocyte calcium in glomerular injury and disease. Journal of Clinical Investigation 124(5): 2050-2058
Lohela, M.; Werb, Z. 2010: Intravital imaging of stromal cell dynamics in tumors. Current Opinion in Genetics and Development 20(1): 72-78
Liou, H.L.R.; Myers, J.T.; Barkauskas, D.S.; Huang, A.Y. 2012: Intravital imaging of the mouse popliteal lymph node. Journal of Visualized Experiments: Jove 2012(60)
Caetano, S.S.; Teixeira, T.; Tadokoro, C.E. 2012: Intravital imaging of the mouse thymus using 2-photon Microscopy. Journal of Visualized Experiments: Jove 59: E3504
Kuijpers, M.J.E.; Heemskerk, J.W.M. 2012: Intravital imaging of thrombus formation in small and large mouse arteries: experimentally induced vascular damage and plaque rupture in vivo. Methods in Molecular Biology 788: 3-19
Hess, I.; Boehm, T. 2012: Intravital imaging of thymopoiesis reveals dynamic lympho-epithelial interactions. Immunity 36(2): 298-309
Zhou, F.; Xing, D.; Wu, S.; Chen, W.R. 2010: Intravital imaging of tumor apoptosis with FRET probes during tumor therapy. Molecular Imaging and Biology 12(1): 63-70
Deguine, J.; Breart, B.éa.; Lemaître, F.; Di Santo, J.P.; Bousso, P. 2010: Intravital imaging reveals distinct dynamics for natural killer and CD8(+) T cells during tumor regression. Immunity 33(4): 632-644
Lohela, M.; Casbon, A.-J.; Olow, A.; Bonham, L.; Branstetter, D.; Weng, N.; Smith, J.; Werb, Z. 2014: Intravital imaging reveals distinct responses of depleting dynamic tumor-associated macrophage and dendritic cell subpopulations. Proceedings of the National Academy of Sciences of the United States of America 111(47): E5086-E5095
Egen, J.G.; Rothfuchs, A.Gigliotti.; Feng, C.G.; Horwitz, M.A.; Sher, A.; Germain, R.N. 2011: Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity 34(5): 807-819
Pinner, S.; Jordan, P.; Sharrock, K.; Bazley, L.; Collinson, L.; Marais, R.; Bonvin, E.; Goding, C.; Sahai, E. 2009: Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Research 69(20): 7969-7977
Kilarski, W.W.; Güç, E.; Teo, J.C.M.; Oliver, S.R.; Lund, A.W.; Swartz, M.A. 2013: Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis. Plos one 8(2): E57135
Holzgrabe, U. 2007: Two flies with one blow--platencin, an new antibiotic. Pharmazie in Unserer Zeit 36(6): 418-419
Shevelkin, A.V.; Nikitin, V.P.; Sherstnev, V.V. 2009: Intravital investigation of the effects of serotonin and glutamate on the dynamics of DNA activity in L-RPl1 neurons of edible snail. Bulletin of Experimental Biology and Medicine 148(4): 563-567
Kawakami, N. 2013: Intravital live imaging of effector autoreactive T cells. Nihon Rinsho. Japanese Journal of Clinical Medicine 71(5): 766-769
Bagher, P.; Davis, M.J.; Segal, S.S. 2011: Intravital macrozoom imaging and automated analysis of endothelial cell calcium signals coincident with arteriolar dilation in Cx40(BAC) -GCaMP2 transgenic mice. Microcirculation 18(4): 331-338
Feindel, W.H.; Allison, A.C. 1949: Intravital methylene blue as a method for staining degenerating fibres in the central nervous system. Journal of Anatomy 83(Part 1): 78
Frisch, T.; Bretlau, P.; Sorensen, M.S. 2008: Intravital microlesions in the human otic capsule. Detection, classification and pathogenetic significance revisited. Orl; Journal for Oto-Rhino-Laryngology and its Related Specialties 70(3): 195-201
He, C.; Agharkar, P.; Chen, B. 2008: Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy. Pharmaceutical Research 25(8): 1873-1880
Hotz, B.; Buhr, H.J.; Hotz, H.G. 2008: Intravital microscopic characterization of suramin effects in an orthotopic immunocompetent rat model of pancreatic cancer. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 12(5): 900-906
Ebert, M.; Ebert, J.; Berger, G. 2013: Intravital microscopic research of microembolization with degradable starch microspheres. Journal of Drug Delivery 2013: 242060
Holstein, J.H.; Becker, S.C.; Fiedler, M.; Garcia, P.; Histing, T.; Klein, M.; Laschke, M.W.; Corsten, M.; Pohlemann, T.; Menger, M.D. 2011: Intravital microscopic studies of angiogenesis during bone defect healing in mice calvaria. Injury 42(8): 765-771
Soares, A.C.; Araújo, R.N.; Carvalho-Tavares, J.; Gontijo, N.d.F.; Pereira, M.H.ác. 2014: Intravital microscopy and image analysis of Rhodnius prolixus (Hemiptera: Reduviidae) hematophagy: the challenge of blood intake from mouse skin. Parasitology International 63(1): 229-236
Amornphimoltham, P.; Masedunskas, A.; Weigert, R. 2011: Intravital microscopy as a tool to study drug delivery in preclinical studies. Advanced Drug Delivery Reviews 63(1-2): 119-128
Bellard, E.; Markelc, B.; Pelofy, S.; Le Guerroué, F.ço.; Sersa, G.; Teissié, J.; Cemazar, M.; Golzio, M. 2012: Intravital microscopy at the single vessel level brings new insights of vascular modification mechanisms induced by electropermeabilization. Journal of Controlled Release: Official Journal of the Controlled Release Society 163(3): 396-403
Koschwanez, H.E.; Reichert, W.M.; Klitzman, B. 2010: Intravital microscopy evaluation of angiogenesis and its effects on glucose sensor performance. Journal of Biomedical Materials Research. Part a 93(4): 1348-1357
Masedunskas, A.; Porat-Shliom, N.; Tora, M.; Milberg, O.; Weigert, R. 2013: Intravital microscopy for imaging subcellular structures in live mice expressing fluorescent proteins. Journal of Visualized Experiments: Jove 2013(79)
Choe, S-woon.; Acharya, A.P.; Keselowsky, B.G.; Sorg, B.S. 2010: Intravital microscopy imaging of macrophage localization to immunogenic particles and co-localized tissue oxygen saturation. Acta Biomaterialia 6(9): 3491-3498
Murooka, T.T.; Mempel, T.R. 2013: Intravital microscopy in BLT-humanized mice to study cellular dynamics in HIV infection. Journal of Infectious Diseases 208(Suppl 2): S137-S144
Baron, V.ér.T.; Welsh, J.; Abedinpour, P.; Borgström, P. 2011: Intravital microscopy in the mouse dorsal chamber model for the study of solid tumors. American Journal of Cancer Research 1(5): 674-686
Leunig, M.; Messmer, K. 1995: Intravital microscopy in tumor biology - current status and future perspectives (review). International Journal of Oncology 6(2): 413-417
Hak, S.; Reitan, N.K.; Haraldseth, O.; de Lange Davies, C. 2010: Intravital microscopy in window chambers: a unique tool to study tumor angiogenesis and delivery of nanoparticles. Angiogenesis 13(2): 113-130
Eckmann, D.M. 2011: Intravital microscopy methods in microvascular blood flow and tissue oxygenation. Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 38(6): 479-482
Kokhuis, T.J.A.; Skachkov, I.; Naaijkens, B.A.; Juffermans, L.J.M.; Kamp, O.; Kooiman, K.; van der Steen, A.F.W.; Versluis, M.; de Jong, N. 2015: Intravital microscopy of localized stem cell delivery using microbubbles and acoustic radiation force. Biotechnology and Bioengineering 112(1): 220-227
Schwenninger, D.; Runck, H.; Schumann, S.; Haberstroh, J.ör.; Meissner, S.; Koch, E.; Guttmann, J. 2011: Intravital microscopy of subpleural alveoli via transthoracic endoscopy. Journal of Biomedical Optics 16(4): 046002
Hiebl, B.; Mrowietz, C.; Braune, S.; Franke, R.P.; Plendl, J.; Jung, F. 2009: Intravital microscopy of the capillary perfusion in the corium limbi of the third toe of the minipig. Clinical Hemorheology and Microcirculation 43(1-2): 173-179
Sellers, S.L.; Payne, G.W. 2011: Intravital microscopy of the inguinal lymph node. Journal of Visualized Experiments: Jove 2011(50)
Donndorf, P.; Ludwig, M.; Wildschütz, F.; Useini, D.; Kaminski, A.; Vollmar, B.; Steinhoff, G. 2013: Intravital microscopy of the microcirculation in the mouse cremaster muscle for the analysis of peripheral stem cell migration. Journal of Visualized Experiments: Jove 81: E50485
Cabrales, P.; Carvalho, L.J.M. 2010: Intravital microscopy of the mouse brain microcirculation using a closed cranial window. Journal of Visualized Experiments: Jove 2010(45)
Kowalewska, P.M.; Burrows, L.L.; Fox-Robichaud, A.E. 2011: Intravital microscopy of the murine urinary bladder microcirculation. Microcirculation 18(8): 613-622
Ferrer, M.; Martin-Jaular, L.; Calvo, M.; del Portillo, H.A. 2012: Intravital microscopy of the spleen: quantitative analysis of parasite mobility and blood flow. Journal of Visualized Experiments: Jove 2012(59)
Koehl, G.E.; Gaumann, A.; Geissler, E.K. 2009: Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies. Clinical and Experimental Metastasis 26(4): 329-344
Ritsma, L.; Steller, E.J.A.; Beerling, E.; Loomans, C.J.M.; Zomer, A.; Gerlach, C.; Vrisekoop, N.; Seinstra, D.ël.; van Gurp, L.; Schäfer, R.; Raats, D.ël.A.; de Graaff, A.; Schumacher, T.N.; de Koning, E.J.P.; Rinkes, I.H.B.; Kranenburg, O.; van Rheenen, J. 2012: Intravital microscopy through an abdominal imaging window reveals a pre-micrometastasis stage during liver metastasis. Science Translational Medicine 4(158): 158ra145
Masedunskas, A.; Sramkova, M.; Parente, L.; Weigert, R. 2013: Intravital microscopy to image membrane trafficking in live rats. Methods in Molecular Biology 931: 153-167
Pinho, V.; Coelho, F.M.; Menezes, G.B.; Cara, D.C. 2011: Intravital microscopy to study leukocyte recruitment in vivo. Methods in Molecular Biology 689: 81-90
Weigert, R.; Sramkova, M.; Parente, L.; Amornphimoltham, P.; Masedunskas, A. 2010: Intravital microscopy: a novel tool to study cell biology in living animals. Histochemistry and Cell Biology 133(5): 481-491
Masedunskas, A.; Milberg, O.; Porat-Shliom, N.; Sramkova, M.; Wigand, T.; Amornphimoltham, P.; Weigert, R. 2012: Intravital microscopy: a practical guide on imaging intracellular structures in live animals. Bioarchitecture 2(5): 143-157
Beerling, E.; Ritsma, L.; Vrisekoop, N.; Derksen, P.W.B.; van Rheenen, J. 2011: Intravital microscopy: new insights into metastasis of tumors. Journal of Cell Science 124(Part 3): 299-310
Choong, F.X.; Regberg, J.; Udekwu, K.I.; Richter-Dahlfors, A. 2012: Intravital models of infection lay the foundation for tissue microbiology. Future Microbiology 7(4): 519-533
Hjortnaes, J.; Gottlieb, D.; Figueiredo, J.-L.; Melero-Martin, J.; Kohler, R.H.; Bischoff, J.; Weissleder, R.; Mayer, J.E.; Aikawa, E. 2010: Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study. Tissue Engineering. Part C Methods 16(4): 597-607
Ring, A.; Tilkorn, D.; Ottomann, C.; Geomelas, M.; Steinstraesser, L.; Langer, S.; Goertz, O. 2011: Intravital monitoring of microcirculatory and angiogenic response to lactocapromer terpolymer matrix in a wound model. International Wound Journal 8(2): 112-117
Khomeriki, S.G.; Il'chenko, L.I.; Iakimchuk, G.N.; Golovanova, E.V.; Nikanorov, A.V. 2007: Intravital morphological examination of the liver. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 40-44
Gehlsen, U.; Hüttmann, G.; Steven, P. 2010: Intravital multidimensional real-time imaging of the conjunctival immune system. Developments in Ophthalmology 45: 40-48
Oshima, Y.; Horiuch, H.; Honkura, N.; Hikita, A.; Ogata, T.; Miura, H.; Imamura, T. 2014: Intravital multiphoton fluorescence imaging and optical manipulation of spinal cord in mice, using a compact fiber laser system. Lasers in Surgery and Medicine 46(7): 563-572
Patsialou, A.; Bravo-Cordero, J.J.; Wang, Y.; Entenberg, D.; Liu, H.; Clarke, M.; Condeelis, J.S. 2013: Intravital multiphoton imaging reveals multicellular streaming as a crucial component of in vivo cell migration in human breast tumors. Intravital 2(2): E25294
Thorling, C.A.; Liu, X.; Burczynski, F.J.; Fletcher, L.M.; Roberts, M.S.; Sanchez, W.Y. 2013: Intravital multiphoton microscopy can model uptake and excretion of fluorescein in hepatic ischemia-reperfusion injury. Journal of Biomedical Optics 18(10): 101306
Kikuta, J.; Ishii, M. 2014: Intravital multiphoton microscopy for dissecting cellular dynamics in arthritic inflammation and bone destruction. Methods in Molecular Biology 1142: 1-10
Lu, L.; Wang, X. 2010: Intravital observation technology of dorsal microcirculatory chamber and its application. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 27(3): 688-691
Wang, Y.; Yamamoto, S.; Miyakawa, A.; Sakurai, T.; Ibaraki, K.; Terakawa, S. 2010: Intravital oxygen radical imaging in normal and ischemic rat cortex. Neurosurgery 67(1): 118-127; Discussion: 127-128
Goertz, O.; Hirsch, T.; Buschhaus, B.ör.; Daigeler, A.; Vogelpohl, J.; Langer, S.; Steinau, H.U.; Ring, A. 2011: Intravital pathophysiologic comparison of frostbite and burn injury in a murine model. Journal of Surgical Research 167(2): E395-E401
De Moraes, L.V.; Tadokoro, C.E.; Gómez-Conde, I.án.; Olivieri, D.N.; Penha-Gonçalves, C. 2013: Intravital placenta imaging reveals microcirculatory dynamics impact on sequestration and phagocytosis of Plasmodium-infected erythrocytes. Plos Pathogens 9(1): E1003154
Bae, Y.H. 2011: Intravital real-time confocal laser scanning imaging of PEGylated gene vectors. Journal of Controlled Release: Official Journal of the Controlled Release Society 151(2): 103
Milstein, D.M.J.; Lindeboom, J.ér.ôm.A.H.; Ince, C. 2010: Intravital sidestream dark-field (SDF) imaging is used in a rabbit model for continuous noninvasive monitoring and quantification of mucosal capillary regeneration during wound healing in the oral cavity: a pilot study. Archives of Oral Biology 55(5): 343-349
Arranz, A.; Androulidaki, A.; Mol, B.; Tsentelierou, E.; Stathopoulos, E.N.; Tsatsanis, C.; Ripoll, J. 2010: Intravital spectral imaging as a tool for accurate measurement of vascularization in mice. Journal of Angiogenesis Research 2: 22
Vaiman, M.; Sarfaty, S.; Gavriel, H.; Kraus, M.; Kaplan, D.; Puterman, M. 2010: Intravital staining with methylene blue in tympanoplasty. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 267(9): 1351-1354
Celli, S.; Bousso, P. 2007: Intravital two-photon imaging of T-cell priming and tolerance in the lymph node. Methods in Molecular Biology 380: 355-363
Park, C.; Hwang, I.-Y.; Kehrl, J.H. 2009: Intravital two-photon imaging of adoptively transferred B lymphocytes in inguinal lymph nodes. Methods in Molecular Biology 571: 199-207
Choong, F.X.; Richter-Dahlfors, A. 2014: Intravital two-photon imaging to understand bacterial infections of the mammalian host. Methods in Molecular Biology 1197: 87-100
Ishii, T.; Ishii, M. 2011: Intravital two-photon imaging: a versatile tool for dissecting the immune system. Annals of the Rheumatic Diseases 70(Suppl 1): I113-I115
Imamura, R.; Isaka, Y.; Sandoval, R.M.; Ori, A.; Adamsky, S.; Feinstein, E.; Molitoris, B.A.; Takahara, S. 2010: Intravital two-photon microscopy assessment of renal protection efficacy of siRNA for p53 in experimental rat kidney transplantation models. Cell Transplantation 19(12): 1659-1670
Steven, P.; Bock, F.; Hüttmann, G.; Cursiefen, C. 2011: Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels. Plos one 6(10): E26253
Hägerling, Ré.; Pollmann, C.; Kremer, L.; Andresen, V.; Kiefer, F. 2011: Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse. Biochemical Society Transactions 39(6): 1674-1681
Harris, N.R.; Watts, M.N.; Leskova, W. 2013: Intravital video microscopy measurements of retinal blood flow in mice. Journal of Visualized Experiments: Jove 82: 51110
Korobelnik, J.-F.ço.; Holz, F.G.; Roider, J.; Ogura, Y.; Simader, C.; Schmidt-Erfurth, U.; Lorenz, K.; Honda, M.; Vitti, R.; Berliner, A.J.; Hiemeyer, F.; Stemper, B.; Zeitz, O.; Sandbrink, R. 2014: Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study. Ophthalmology 121(1): 202-208
Velez-Montoya, R.; Rascón-Vargas, D.; Mieler, W.F.; Fromow-Guerra, J.; Morales-Cantón, V. 2010: Intravitreal Ampicillin Sodium for Antibiotic-Resistant Endophthalmitis: Streptococcus uberis First Human Intraocular Infection Report. Journal of Ophthalmology 2010
Zaman, Y.; Rehman, A.-U.; Memon, A.F. 2013: Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy. Pakistan Journal of Medical Sciences 29(2): 590-592
Arevalo, J.Fernando.; Sanchez, J.G.; Lasave, A.F.; Wu, L.; Maia, M.; Bonafonte, S.; Brito, M.; Alezzandrini, A.A.; Restrepo, N.; Berrocal, M.H.; Saravia, M.; Farah, M.Eid.; Fromow-Guerra, J.; Morales-Canton, V.; Wu, L.; Arevalo, J.F.; Sanchez, J.G.; Espinoza, J.V.; Lasave, A.F.; Farah, M.; Maia, M.; Aggio, F.B.; Morales-Canton, V.; Quiroz-Mercado, H.; Fromow-Guerra, J.; Guerrero-Naranjo, J.L.; Rodriguez, F.J.; Infante, R.; Medina, D.; Berrocal, M.H.; Cruz-Villegas, V.; Graue-Wiechers, F.; Lozano-Rech, D.; Robledo, V.; Rodriguez-Loaiza, J.L.; Roca, J.A.; Reategui, G.; Saravia, M.J.; Martinez-Cartier, M.; Avila, M.; Cardillo, J.; Costa, R.A.; Verdaguer T, J.; Carpentier, C.; Verd 2010: Intravitreal Bevacizumab (Avastin(®)) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture. Current Diabetes Reviews 6(5): 313-322
Arevalo, J.Fernando.; Sanchez, J.G.; Lasave, A.F.; Wu, L.; Maia, M.; Bonafonte, S.; Brito, M.; Alezzandrini, A.A.; Restrepo, N.; Berrocal, M.H.; Saravia, M.; Farah, M.Eid.; Fromow-Guerra, J.; Morales-Canton, V. 2011: Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture. Journal of Ophthalmology 2011: 584238
Moon, S.J.; Misch, D.M. 2010: Intravitreal Bevacizumab for Macular Edema from Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 2010: 1-3
Alomran, M.S. 2010: Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 2010: 1-3
Krzyzanowska-Berkowska, P.; Barć, A.; Oficjalska, J. 2011: Intravitreal Bevacizumab injections in a child with choroidal neovascularization--case report. Klinika Oczna 113(1-3): 60-63
Riazi-Esfahani, M.; Ahmadieh, H.; Faghihi, H.; Piri, N.; Taei, R.; Karkhaneh, R.; Alami-Harandi, Z.; Lashay, A.; Mirshahi, A.; Nili-Ahmadabadi, M.; Soheilian, M.; Sanagou, M. 2008: Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. Journal of Ophthalmic and Vision Research 3(2): 95-101
Shoeibi, N.; Ahmadieh, H.; Entezari, M.; Yaseri, M. 2013: Intravitreal Bevacizumab with or without Triamcinolone for Refractory Diabetic Macular Edema: Long-term Results of a Clinical Trial. Journal of Ophthalmic and Vision Research 8(2): 99-106
Soheilian, M.; Eskandari, A.; Ramezani, A.; Rabbanikhah, Z.; Esmaeilpour, N.F.; Soheilian, R. 2013: Intravitreal Diclofenac versus Intravitreal Triamcinolone for the Treatment of Uveitic Cystoid Macular Edema. Retina 2013
Nourinia, R.; Bonyadi, M.H.J.; Ahmadieh, H. 2010: Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration. Journal of Ophthalmic and Vision Research 5(3): 168-174
Patel, P.; Ahmed, E.; Subramanian, M.L. 2010: Intravitreal Foscarnet Therapy for Acyclovir-Resistant Acute Retinal Necrosis After Herpes Simplex Encephalitis. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 2010: 1-3
Takeyama, M.; Iwaki, M.; Zako, M. 2012: Intravitreal Injection of Bevacizumab to Treat a Macular Edema Caused by Leber's Miliary Aneurysm. Case Reports in Ophthalmology 3(3): 392-395
Fenicia, V.; Balestrieri, M.; Perdicchi, A.; Maraone, G.; Recupero, S.M. 2013: Intravitreal Injection of Dexamethasone Implant in Serous Macular Detachment Associated with Waldenström's Disease. Case Reports in Ophthalmology 4(2): 64-69
Hombrebueno, J.R.; Luo, C.; Guo, L.; Chen, M.; Xu, H. 2014: Intravitreal Injection of Normal Saline Induces Retinal Degeneration in the C57BL/6J Mouse. Translational Vision Science and Technology 3(2): 3
Sivilia, S.; Giuliani, A.; Fernández, M.; Turba, M.E.; Forni, M.; Massella, A.; De Sordi, N.; Giardino, L.; Calzà, L. 2009: Intravitreal NGF administration counteracts retina degeneration after permanent carotid artery occlusion in rat. Bmc Neuroscience 10: 52
Shelke, N.B.; Kadam, R.; Tyagi, P.; Rao, V.R.; Kompella, U.B. 2011: Intravitreal Poly(L-lactide) Microparticles Sustain Retinal and Choroidal Delivery of TG-0054, a Hydrophilic Drug Intended for Neovascular Diseases. Drug Delivery and Translational Research 1(1): 76-90
Makri, O.E.; Psachoulia, C.; Exarchou, A.; Georgakopoulos, C.D. 2016: Intravitreal Ranibizumab as Palliative Therapy for Iris Metastasis Complicated with Refractory Secondary Glaucoma. Journal of Glaucoma 25(1): E53-E55
Heidary, F.; Hitam, W.H.W.; Ngah, N.F.; George, T.M.; Hashim, H.; Shatriah, I. 2011: Intravitreal Ranibizumab for Choroidal Neovascularization in Best's Vitelliform Macular Dystrophy in a 6-Year-Old Boy. Journal of Pediatric Ophthalmology and Strabismus 48 Online: E19-E22
Cascavilla, M.L.; Querques, G.; Querques, L.; Codenotti, M.; Bandello, F. 2013: Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade. European Journal of Ophthalmology 23(6): 913-916
Zhu, M.; Chew, J.K.; Broadhead, G.K.; Luo, K.; Joachim, N.; Hong, T.; Syed, A.; Chang, A.A. 2015: Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes. Graefe's Archive for Clinical and Experimental Ophthalmology 253(8): 1217-1225
Mitropoulos, P.G.; Chatziralli, I.P.; Peponis, V.G.; Drakos, E.; Parikakis, E.A. 2015: Intravitreal Ranibizumab for the Treatment of Irvine-Gass Syndrome. Ocular Immunology and Inflammation 23(3): 225-231
Schwartz, S.G.; Flynn, H.W.; Beer, P. 2010: Intravitreal Triamcinolone Acetonide use in Diabetic Macular Edema: Illustrative Cases. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 2010: 1-6
Moschos, M.M.; Gatzioufas, Z.; Margetis, I. 2010: Intravitreal Triamcinolone Acetonide for Macular Edema in HLA-B27 Negative Ankylosing Spondylitis. Case Reports in Ophthalmology 1(2): 105-109
Androudi, S.; Tsironi, E.; Kalogeropoulos, C.; Theodoridou, A.; Brazitikos, P. 2010: Intravitreal adalimumab for refractory uveitis-related macular edema. Ophthalmology 117(8): 1612-1616
Viita, H.; Kinnunen, K.; Eriksson, E.; Lähteenvuo, J.; Babu, M.; Kalesnykas, G.; Heikura, T.; Laidinen, S.; Takalo, T.; Ylä-Herttuala, S. 2009: Intravitreal adenoviral 15-lipoxygenase-1 gene transfer prevents vascular endothelial growth factor A-induced neovascularization in rabbit eyes. Human Gene Therapy 20(12): 1679-1686
Li, M.; Yasumura, D.; Ma, A.A.K.; Matthes, M.T.; Yang, H.; Nielson, G.; Huang, Y.; Szoka, F.C.; Lavail, M.M.; Diamond, M.I. 2013: Intravitreal administration of HA-1077, a ROCK inhibitor, improves retinal function in a mouse model of huntington disease. Plos one 8(2): E56026
Yang, C.; Jiang, L.; Bu, S.; Zhang, L.; Xie, X.; Zeng, Q.; Zhu, D.; Zheng, Y. 2013: Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases. Journal of Biomedical Nanotechnology 9(9): 1617-1623
Thackaberry, E.A.; Farman, C.; Bantseev, V.; Schuetz, C.; Baker, J.F.; Brown, M.H.; Learn, D.B. 2015: Intravitreal administration of known phototoxicants in the rabbit fails to produce phototoxicity: implications for phototoxicity testing of intravitreally administered small molecule therapeutics. Cutaneous and Ocular Toxicology 34(4): 265-270
Theodossiadis, P.G.; Liarakos, V.S.; Sfikakis, P.P.; Charonis, A.; Agrogiannis, G.; Kavantzas, N.; Vergados, I.A. 2009: Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit. Graefe's Archive for Clinical and Experimental Ophthalmology 247(2): 273-281
Theodossiadis, P.G.; Liarakos, V.S.; Sfikakis, P.P.; Vergados, I.A.; Theodossiadis, G.P. 2009: Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration. American Journal of Ophthalmology 147(5): 825
Frimpong-Boateng, A.; Varde, M.A.; Rüfer, F.; Bunse, A.; Roider, J. 2008: Intravitreal administration of triamcinolone and bevacizumab for pigment epithelial detachment in conjunction with AMD. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 105(7): 661-668
Yang, L.P.H.; McKeage, K. 2014: Intravitreal aflibercept (Eylea(®)): a review of its use in patients with macular oedema secondary to central retinal vein occlusion. Drugs and Aging 31(5): 395-404
Korobelnik, J.-F.ço.; Do, D.V.; Schmidt-Erfurth, U.; Boyer, D.S.; Holz, F.G.; Heier, J.S.; Midena, E.; Kaiser, P.K.; Terasaki, H.; Marcus, D.M.; Nguyen, Q.D.; Jaffe, G.J.; Slakter, J.S.; Simader, C.; Soo, Y.; Schmelter, T.; Yancopoulos, G.D.; Stahl, N.; Vitti, R.; Berliner, A.J.; Zeitz, O.; Metzig, C.; Brown, D.M. 2014: Intravitreal aflibercept for diabetic macular edema. Ophthalmology 121(11): 2247-2254
Campochiaro, P.A.; Clark, W.L.; Boyer, D.S.; Heier, J.S.; Brown, D.M.; Vitti, R.; Kazmi, H.; Berliner, A.J.; Erickson, K.; Chu, K.W.; Soo, Y.; Cheng, Y.; Haller, J.A. 2015: Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study. Ophthalmology 122(3): 538-544
Xu, D.; Kaiser, P.K. 2013: Intravitreal aflibercept for neovascular age-related macular degeneration. ImmunoTherapy 5(2): 121-130
Miura, M.; Iwasaki, T.; Goto, H. 2013: Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis. Clinical Ophthalmology 7: 1591-1595
Chang, A.A.; Li, H.; Broadhead, G.K.; Hong, T.; Schlub, T.E.; Wijeyakumar, W.; Zhu, M. 2014: Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration. Ophthalmology 121(1): 188-192
Heier, J.S.; Clark, W.L.; Boyer, D.S.; Brown, D.M.; Vitti, R.; Berliner, A.J.; Kazmi, H.; Ma, Y.; Stemper, B.; Zeitz, O.; Sandbrink, R.; Haller, J.A. 2014: Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study. Ophthalmology 121(7): 1414-1420.E1
Brown, D.M.; Heier, J.S.; Clark, W.L.; Boyer, D.S.; Vitti, R.; Berliner, A.J.; Zeitz, O.; Sandbrink, R.; Zhu, X.; Haller, J.A. 2013: Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. American Journal of Ophthalmology 155(3): 429-437.E7
Ohr, M.; Kaiser, P.K. 2012: Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration. Expert Opinion on PharmacoTherapy 13(4): 585-591
Schmidt-Erfurth, U.; Kaiser, P.K.; Korobelnik, J.-F.ço.; Brown, D.M.; Chong, V.; Nguyen, Q.D.; Ho, A.C.; Ogura, Y.; Simader, C.; Jaffe, G.J.; Slakter, J.S.; Yancopoulos, G.D.; Stahl, N.; Vitti, R.; Berliner, A.J.; Soo, Y.; Anderesi, M.; Sowade, O.; Zeitz, O.; Norenberg, C.; Sandbrink, R.; Heier, J.S. 2014: Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology 121(1): 193-201
Tsaousis, K.T.; Konidaris, V.E.; Banerjee, S.; Empeslidis, T. 2015: Intravitreal aflibercept treatment of retinal angiomatous proliferation: a pilot study and short-term efficacy. Graefe's Archive for Clinical and Experimental Ophthalmology 253(4): 663-665
Ekdawi, N.S.; Pulido, J.S.; Itty, S.; Marler, R.J.; Herman, D.C.; Hardwig, P.; Mohney, B.G.; Valyi-Nagy, T.; Shukla, D. 2009: Intravitreal alemtuzumab penetrates full-thickness retina in rabbit eyes. Retina 29(10): 1532-1534
Olson, J.L.; Courtney, R.J.; Rouhani, B.; Mandava, N.; Dinarello, C.A. 2009: Intravitreal anakinra inhibits choroidal neovascular membrane growth in a rat model. Ocular Immunology and Inflammation 17(3): 195-200
Dell'Omo, R.; Kulkarni, A.; Franks, W.A. 2008: Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity. Acta Ophthalmologica 86(6): 698-700
Ennouri, A.; Makhoul, D.; Nubourgh, I.; Mistryh, S.; Caspers, L.; Willermain, F. 2014: Intravitreal and intravenous steroids in a case of Idiopathic Retinitis, Vasculitis and Neuroretinitis (IRVAN) syndrome. Journal Francais d'Ophtalmologie 37(1): E5-E8
Roesel, M.; Gutfleisch, M.; Heinz, C.; Heimes, B.; Zurek-Imhoff, B.; Heiligenhaus, A. 2009: Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study. Ophthalmic Research 42(2): 81-86
Choudhry, S.; Ghosh, S. 2007: Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema. Clinical and Experimental Ophthalmology 35(8): 713-718
Shah, N.V.; Pham, D.G.; Murray, T.G.; Decatur, C.; Hernandez, E.; Shah, N.N.; Cavalcante, M.; Houston, S.K. 2014: Intravitreal and subconjunctival melphalan for retinoblastoma in transgenic mice. Journal of Ophthalmology 2014: 829879
Barge, S.; Rothwell, R.; Sepúlveda, P.; Agrelos, L.ís. 2013: Intravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema. Case Reports in Ophthalmological Medicine 2013: 591681
Finger, P.T.; Mukkamala, S.K. 2011: Intravitreal anti-VEGF bevacizumab (Avastin) for external beam related radiation retinopathy. European Journal of Ophthalmology 21(4): 446-451
Chelala, E.; Dirani, A.; Fadlallah, A. 2013: Intravitreal anti-VEGF injection for the treatment of progressive juxtapapillary retinal capillary hemangioma: a case report and mini review of the literature. Clinical Ophthalmology 7: 2143-2146
Jain, S.; Kishore, K.; Sharma, Y.R. 2013: Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration. Indian Journal of Ophthalmology 61(9): 490-496
Nakao, S.; Arima, M.; Ishikawa, K.; Kohno, R.; Kawahara, S.; Miyazaki, M.; Yoshida, S.; Enaida, H.; Hafezi-Moghadam, A.; Kono, T.; Ishibashi, T. 2012: Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis. Investigative Ophthalmology and Visual Science 53(7): 4323-4328
Ruiz-Moreno, J.M.; Arias, L.; Montero, J.A.; Carneiro, A.; Silva, R. 2013: Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcome. British Journal of Ophthalmology 97(11): 1447-1450
Cleary, C.A.; Sharaznayan, D.; Hickey-Dwyer, M. 2011: Intravitreal anti-VEGF therapy for neovascular age-related macular degeneration and the risk of stroke. Irish Medical Journal 104(5): 146-149
Giansanti, F.; Bacherini, D.; Giacomelli, G.; Virgili, G.; Finocchio, L.; Fiore, T.; Vannozzi, L.; Menchini, U. 2014: Intravitreal anti-VEGF therapy for vascularized pigment epithelium detachment in age-related macular degeneration. European Journal of Ophthalmology 24(3): 402-408
Schaal, K.B.; Engler, C.; Schütt, F.; Scheuerle, A.; Dithmar, S. 2008: Intravitreal anti-VEGF therapy with bevacizumab for neovascular AMD. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 105(6): 538-543
Sun, J.K. 2011: Intravitreal anti-VEGF therapy with prompt or deferred laser compared with steroid with prompt laser and prompt laser alone for treatment of diabetic macular edema. Current Diabetes Reports 11(4): 227-229
Carifi, G.; Zygoura, V.; Kopsachilis, N. 2014: Intravitreal anti-VEGF treatment as adjunctive treatment in the management of diabetic retinopathy. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 30(4): 303
Rotsos, T.; Sagoo, M.S.; daCruz, L.; Andrews, R.; Dowler, J. 2010: Intravitreal anti-VEGF treatment in eyes with combined choroidal neovascularisation and vitreomacular traction syndrome. British Journal of Ophthalmology 94(9): 1205-1210
Yoon, J.U.; Byun, Y.J.; Koh, H.J. 2010: Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization. Retina 30(3): 418-424
Kaul, S.; Uparkar, M.; Mody, K.; Walinjkar, J.; Kothari, M.; Natarajan, S. 2010: Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children. Indian Journal of Ophthalmology 58(1): 76-78
Hu, J.; Hoang, Q.V.; Chau, F.Y.; Blair, M.P.; Lim, J.I. 2014: Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis. Retinal Cases and Brief Reports 8(1): 24-29
Wang, E.; Chen, Y. 2013: Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization secondary to pathologic myopia: systematic review and meta-analysis. Retina 33(7): 1375-1392
Gharbiya, M.; Parisi, F.; Cruciani, F.; Bozzoni-Pantaleoni, F.; Pranno, F.; Abdolrahimzadeh, S. 2014: Intravitreal anti-vascular endothelial growth factor for retinal angiomatous proliferation in treatment-naive eyes: long-term functional and anatomical results using a modified PrONTO-style regimen. Retina 34(2): 298-305
Kim, J.H.; Chang, Y.S.; Kim, J.W.; Kim, C.G.; Yoo, S.J.; Cho, H.J. 2014: Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization. Ophthalmology 121(4): 926-935
Kapoor, K.G.; Bakri, S.J. 2013: Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization due to Sorsby macular dystrophy. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 29(4): 444-447
Nielsen, J.S.; Fick, T.A.; Saggau, D.D.; Barnes, C.H. 2012: Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina 32(3): 468-472
Saito, W.; Kase, S.; Ohgami, K.; Mori, S.; Ohno, S. 2010: Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema. Acta Ophthalmologica 88(3): 377-380
Park, S.-U.; Lee, S.-J.; Kim, M. 2014: Intravitreal anti-vascular endothelial growth factor versus observation in acute central serous chorioretinopathy: one-year results. Korean Journal of Ophthalmology: Kjo 28(4): 306-313
Jonas, J.B.; Witzens-Harig, M.; Arseniev, L.; Ho, A.D. 2010: Intravitreal autologous bone-marrow-derived mononuclear cell transplantation. Acta Ophthalmologica 88(4): E131-E132
Elsawy, M.F. 2012: Intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema. Clinical Ophthalmology 6: 2063-2068
Díaz-Llopis, M.; Udaondo, P.; Salom, D.; García-Delpech, S.; Romero, F.J. 2008: Intravitreal autologous plasmin without associated-vitrectomy. Pharmacological vitreolysis, a perfeccionated method using urokinase. Archivos de la Sociedad Espanola de Oftalmologia 83(5): 291-292
Querques, G.; Bux, A.V.; Prascina, F.; Noci, N.D. 2010: Intravitreal avastin for choroidal neovascularization associated with stargardt-like retinal abnormalities in pseudoxanthoma elasticum. Middle East African Journal of Ophthalmology 17(4): 387-389
Yang, C.-S.; Hung, K.-C.; Huang, Y.-M.; Hsu, W.-M. 2013: Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 29(6): 550-555
Fong, K.C.S.; Barry, C.; McAllister, I.L. 2009: Intravitreal bevacizumab (Avastin) as a treatment of the neovascular complications of laser-induced chorioretinal anastomosis for nonischaemic central retinal vein occlusion. Clinical and Experimental Ophthalmology 37(5): 485-489
Ben Yahia, S.; Herbort, C.P.; Jenzeri, S.; Hmidi, K.; Attia, S.; Messaoud, R.; Khairallah, M. 2008: Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis. International Ophthalmology 28(4): 311-316
Mandal, S.; Venkatesh, P.; Sampangi, R.; Garg, S. 2007: Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization. European Journal of Ophthalmology 17(4): 620-626
Babalola, O.E. 2010: Intravitreal bevacizumab (Avastin) associated with secondary hyphaema in a case of proliferative sickle cell retinopathy. BMJ Case Reports
Donati, M.C.; Virgili, G.; Bini, A.; Giansanti, F.; Rapizzi, E.; Giacomelli, G.; Menchini, U. 2009: Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: a case series. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 223(1): 24-27
Prager, F.; Michels, S.; Kriechbaum, K.; Georgopoulos, M.; Funk, M.; Geitzenauer, W.; Polak, K.; Schmidt-Erfurth, U. 2009: Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. British Journal of Ophthalmology 93(4): 452-456
Chan, W.-M.; Lai, T.Y.Y.; Liu, D.T.L.; Lam, D.S.C. 2009: Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study. British Journal of Ophthalmology 93(2): 150-154
Pedersen, K.B.; Sjølie, A.K.; Møller, F. 2009: Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patients. Acta Ophthalmologica 87(7): 714-719
Fong, K.C.S.; Kirkpatrick, N.; Mohamed, Q.; Johnston, R.L. 2008: Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment. Clinical and Experimental Ophthalmology 36(8): 748-755
Cintra, L.és.P.; Costa, R.ér.A.; Ribeiro, J.A.S.; Calucci, D.; Scott, I.U.; Messias, A.é; Jorge, R. 2013: Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study): 1-year results. Retina 33(6): 1109-1116
Sangtam, T.; Vinekar, A.; Maheshwar, B.; Dogra, M.R.; Eong, K-Guan.Au. 2007: Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian Journal of Ophthalmology 55(4): 317; Author Reply 317-8
Arriola-Villalobos, P.; Donate-López, J.; Calvo-González, C.; Reche-Frutos, J.; Alejandre-Alba, N.ás.; Díaz-Valle, D. 2008: Intravitreal bevacizumab (Avastin) for radiation retinopathy neovascularization. Acta Ophthalmologica 86(1): 115-116
Madhusudhana, K.C.; Hannan, S.R.; Williams, C.P.R.; Goverdhan, S.V.; Rennie, C.; Lotery, A.J.; Luff, A.J.; Newsom, R.S.B. 2007: Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases. British Journal of Ophthalmology 91(12): 1716-1717
Mirshahi, A.; Namavari, A.; Djalilian, A.; Moharamzad, Y.; Chams, H. 2009: Intravitreal bevacizumab (Avastin) for the treatment of cystoid macular edema in Behçet disease. Ocular Immunology and Inflammation 17(1): 59-64
Shaikh, S. 2008: Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy. Indian Journal of Ophthalmology 56(3): 259
Sachdev, N.; Vishwanathan, K.; Gupta, V.; Singh, R.; Gupta, A. 2007: Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks. Indian Journal of Ophthalmology 55(6): 457-458
Akesbi, J.; Brousseaud, F.ço.X.; Adam, R.ël.; Rodallec, T.; Nordmann, J.P. 2010: Intravitreal bevacizumab (Avastin) in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis. Acta Ophthalmologica 88(2): E40-E41
Minnella, A.M.; Savastano, C.M.; Ziccardi, L.; Scupola, A.; Falsini, B.; Balestrazzi, E. 2008: Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy. Acta Ophthalmologica 86(6): 683-687
Rabena, M.D.; Pieramici, D.J.; Castellarin, A.A.; Nasir, M'an.A.; Avery, R.L. 2007: Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 27(4): 419-425
Gutiérrez, J.C.M.; Barquet, L.A.; Caminal, J.M.; Mitjana; Almolda, S.P.; Domènech, N.ùr.P.; Goita, O.P.; Caso, M.R.; Ginebreda, J.A. 2008: Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion. Clinical Ophthalmology 2(4): 787-791
Lazić, R.; Gabrić, N.; Dekaris, I.; Sarić, B.; Gavrić, M. 2007: Intravitreal bevacizumab (Avastin) in treatment of neovascular age-related macular degeneration. Collegium Antropologicum 31(Suppl): 77-81
Mackiewicz, J.; Mańkowska, A.; Dolar-Szczasny, J.; Zubilewicz, A.; Oleszczuk, A.; Nowomiejska, K.; Rejdak, R.; Zagórski, Z. 2007: Intravitreal bevacizumab (Avastin) iniections for neovascular age-related macular degeneration (AMD)--preliminary results. Klinika Oczna 109(4-6): 146-149
Yazdani, S.; Hendi, K.; Pakravan, M. 2007: Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. Journal of Glaucoma 16(5): 437-439
Costagliola, C.; Cipollone, U.; Rinaldi, M.; della Corte, M.; Semeraro, F.; Romano, M.R. 2008: Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up. British Journal of Clinical Pharmacology 66(5): 667-673
Amselem, L.; Montero, J.; Diaz-Llopis, M.; Pulido, J.S.; Bakri, S.J.; Palomares, P.; Garcia-Delpech, S. 2007: Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome. American Journal of Ophthalmology 144(1): 122-124
Yuzbasioglu, E.; Artunay, O.; Rasier, R.; Sengul, A.; Bahcecioglu, H. 2009: Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa. Current Eye Research 34(3): 231-237
Mason, J.O.; Yunker, J.J.; Vail, R.; McGwin, G. 2008: Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy. Retina 28(9): 1319-1324
Wiegand, T.W.; Rogers, A.H.; McCabe, F.; Reichel, E.; Duker, J.S. 2009: Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks. British Journal of Ophthalmology 93(1): 47-51
Lee, S.J.; Lee, J.J.; Kim, S.Y.; Kim, S.D. 2009: Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome. Korean Journal of Ophthalmology: Kjo 23(2): 132-134
Schmucker, C.; Loke, Y.K.; Ehlken, C.; Agostini, H.T.; Hansen, L.L.; Antes, G.; Lelgemann, M. 2011: Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review. British Journal of Ophthalmology 95(3): 308-317
Schmucker, C.; Ehlken, C.; Hansen, L.L.; Antes, G.; Agostini, H.T.; Lelgemann, M. 2010: Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review. Current Opinion in Ophthalmology 21(3): 218-226
Shields, C.L.; Salazar, P.F.; Demirci, H.; Benson, W.E.; Shields, J.A. 2008: Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma. Retinal Cases and Brief Reports 2(1): 18-20
Lim, J.Won.; Park, J.Hyun. 2011: Intravitreal bevacizumab (avastin) as an adjuvant for the treatment of posterior scleritis. Korean Journal of Ophthalmology: Kjo 25(4): 282-284
Ghanem, A.A.; El-Kannishy, A.M.; El-Wehidy, A.S.; El-Agamy, A.F. 2009: Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma. Middle East African Journal of Ophthalmology 16(2): 75-79
Tano, R.; Kakurai, K.; Sakurai, T.; Fujiwara, R.; Mano, T.; Maeno, T. 2012: Intravitreal bevacizumab (avastin) combined with vitrectomy for recurrences of proliferative vitreoretinopathy in Von Hippel-Lindau disease. Acta Ophthalmologica 90(2): E157-E158
Duval, R.; Olivier, S.éb. 2011: Intravitreal bevacizumab (avastin) for choroidal neovascularization associated with deferoxamine retinopathy. Retinal Cases and Brief Reports 5(3): 233-236
Mandal, S.; Naithani, P.; Venkatesh, P.; Garg, S. 2011: Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma. Indian Journal of Ophthalmology 59(3): 248-251
Kim, S.J.; Hubbard, G.B. 2007: Intravitreal bevacizumab (avastin) for radiation retinopathy 53 years after treatment of retinoblastoma. Retinal Cases and Brief Reports 1(4): 198-201
Levy, J.; Shneck, M.; Rosen, S.; Klemperer, I.; Rand, D.; Weinstein, O.; Pitchkhadze, A.; Belfair, N.; Lifshitz, T. 2009: Intravitreal bevacizumab (avastin) for subfoveal neovascular age-related macular degeneration. International Ophthalmology 29(5): 349-357
Sundaram, N.; Uparkar, M.; Athale, A.; Mahindrakar, A. 2007: Intravitreal bevacizumab (avastin) in a pediatric case of pathologic myopia. Retinal Cases and Brief Reports 1(4): 192-194
Hung, K.-H.; Lee, S.-M.; Lee, S.-Y.; Lee, F.-L.; Yang, C.-S. 2010: Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 26(1): 85-90
Hirashima, T.; Chihara, T.; Bun, T.; Utsumi, T.; Hirose, M.; Oh, H. 2014: Intravitreal bevacizumab alone or combined with macular laser photocoagulation for recurrent or persistent macular edema secondary to branch retinal vein occlusion. Journal of Ophthalmology 2014: 173084
Marey, H.M.; Ellakwa, A.F. 2011: Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema. Clinical Ophthalmology 5: 1011-1016
Rudnisky, C.J.; Liu, C.; Ng, M.; Weis, E.; Tennant, M.T.S. 2010: Intravitreal bevacizumab alone versus combined verteporfin photodynamic therapy and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration: visual acuity after 1 year of follow-up. Retina 30(4): 548-554
Lee, S.J.; Kim, E.T.; Moon, Y.S. 2011: Intravitreal bevacizumab alone versus combined with macular photocoagulation in diabetic macular edema. Korean Journal of Ophthalmology: Kjo 25(5): 299-304
Lim, J.Yoon.; Lee, S.Young.; Kim, J-Gone.; Lee, J.Yong.; Chung, H.; Yoon, Y.Hee. 2012: Intravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical study. Acta ophthalmologica 90(1): 61-67
Zhang, H.-T.; Yang, Y.-X.; Xu, Y.-Y.; Yang, R.-M.; Wang, B.-J.; Hu, J.-X. 2014: Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma. International Journal of Ophthalmology 7(5): 837-842
Selid, P.D.; Jundt, M.C.; Fortney, A.C.; Beal, J.R. 2014: Intravitreal bevacizumab and aflibercept for the treatment of exudative age-related macular degeneration. Ophthalmic Surgery Lasers and Imaging Retina 45(4): 275-281
Eid, T.M.; Radwan, A.; el-Manawy, W.; el-Hawary, I. 2009: Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 44(4): 451-456
Lim, J.W. 2011: Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 225(3): 150-154
Joob, B.; Wiwanitkit, V. 2012: Intravitreal bevacizumab and diabetic papillopathy with macular edema. Oman Journal of Ophthalmology 5(1): 68
Huang, Y.-H.; Yeh, P.-T.; Chen, M.-S.; Yang, C.-H.; Yang, C.-M. 2009: Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage. Retina 29(8): 1134-1140
Fong, D.S.; Custis, P.; Howes, J.; Hsu, J-Wen. 2010: Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study. Ophthalmology 117(2): 298-302
Fecko, A.M.; Ho, L.Y.; Walsh, M.K.; Williams, G.A. 2011: Intravitreal bevacizumab and ranibizumab for choroidal neovascularization secondary to endogenous endophthalmitis. Retinal Cases and Brief Reports 5(3): 229-232
Cakir, M.; Cekiç, O.; Yilmaz, O.F. 2009: Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease. Journal of Aapos: the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus 13(1): 94-96
Solaiman, K.A.M.; Diab, M.M.; Abo-Elenin, M. 2010: Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema. Retina 30(10): 1638-1645
Cheema, R.A.; Mushtaq, J.; Cheema, M.A. 2011: Intravitreal bevacizumab as a primary treatment for idiopathic choroidal neovascularization. Middle East African Journal of Ophthalmology 18(3): 220-223
Peiretti, E.; Vinci, M.; Fossarello, M. 2012: Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 47(1): 28-33
Law, J.C.; Recchia, F.M.; Morrison, D.G.; Donahue, S.P.; Estes, R.L. 2010: Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. Journal of Aapos: the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus 14(1): 6-10
Bansal, R.; Beke, N.; Sharma, A.; Gupta, A. 2013: Intravitreal bevacizumab as an adjunct in the management of a vascular choroidal granuloma. BMJ Case Reports
Hasanreisoglu, M.; Weinberger, D.; Mimouni, K.; Luski, M.; Bourla, D.; Kramer, M.; Robinson, A.; Axer-Siegel, R. 2009: Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma. European Journal of Ophthalmology 19(4): 607-612
El-Batarny, A.M. 2008: Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy. Clinical Ophthalmology 2(4): 709-716
Arevalo, J.F. 2013: Intravitreal bevacizumab as anti-vascular endothelial growth factor in the management of complications of proliferative diabetic retinopathy. Medical Hypothesis Discovery and Innovation Ophthalmology Journal 2(1): 20-24
Julián, K.; Terrada, C.él.; Fardeau, C.; Cassoux, N.; Français, C.; LeHoang, P.; Bodaghi, B. 2011: Intravitreal bevacizumab as first local treatment for uveitis-related choroidal neovascularization: long-term results. Acta Ophthalmologica 89(2): 179-184
Gharbiya, M.; Allievi, F.; Recupero, V.; Martini, D.; Mazzeo, L.; Gabrieli, C.B. 2009: Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Retina 29(6): 740-749
Zhang, H.; Liu, Z.-L.; Sun, P.; Gu, F. 2012: Intravitreal bevacizumab as primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy: results of a 1-year prospective trial. Retina 32(6): 1106-1113
Bancalari M, A.; Schade Y, R.; Peña Z, R.én.; Pavez P, N.ás. 2014: Intravitreal bevacizumab as single drug therapy for retinopathy of prematurity in 12 patients. Archivos Argentinos de Pediatria 112(2): 160-163
Axer-Siegel, R.; Snir, M.; Ron, Y.; Friling, R.; Sirota, L.; Weinberger, D. 2011: Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity. Retina 31(7): 1239-1247
Salinas-Alamán, A.; Zarranz-Ventura, J.; Caire González-Jauregui, J.M.; Sádaba-Echarri, L.M.; Barrio-Barrio, J.ús.; García-Layana, A. 2011: Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion. European Journal of Ophthalmology 21(4): 434-439
Shah, S.U.; Shields, C.L.; Bianciotto, C.G.; Iturralde, J.; Al-Dahmash, S.A.; Say, E.Anthony.T.; Badal, J.; Mashayekhi, A.; Shields, J.A. 2014: Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology 121(1): 269-275
Jirawison, C.; Ittipunkul, N. 2012: Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study. Journal of the Medical Association of Thailand 95 Suppl. 4: S136-S142
Farese, E.; Cennamo, G.; Velotti, N.; Traversi, C.; Rinaldi, M.; De Crecchio, G. 2014: Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion. European Journal of Ophthalmology 24(5): 761-770
Freitas, L.Guilherme.Azevedo.de.; Isaac, D.Leonardo.Cruvinel.; Tannure, W.Thomas.; Gabriel, Lís.Alexandre.Rassi.; Reis, R.Gomes.dos.; Rassi, A.Ricardo.; Freitas, C.Arcoverde.de.; Ávila, M.Pereira.de. 2013: Intravitreal bevacizumab combined with infliximab in the treatment of choroidal neovascularization secondary to age-related macular degeneration: case report series. Arquivos Brasileiros de Oftalmologia 76(3): 180-184
Tao, Y.; Jonas, J.B. 2010: Intravitreal bevacizumab combined with intravitreal triamcinolone for therapy-resistant exudative age-related macular degeneration. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 26(2): 207-212
Ciftci, S.; Sakalar, Y.B.; Unlu, K.; Keklikci, U.; Caca, I.; Dogan, E. 2009: Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma. European Journal of Ophthalmology 19(6): 1028-1033
Houston, S.K.; Shah, N.V.; Decatur, C.; Lonngi, M.; Feuer, W.; Markoe, A.M.; Murray, T.G. 2013: Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment. Clinical Ophthalmology 7: 193-198
Wang, Y.-S.; Li, X.; Wang, H.-Y.; Zhang, Z.-F.; Li, M.-H.; Su, X.-N. 2011: Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema. Chinese Medical Journal 124(3): 352-358
Windisch, R.; Kozousek, V. 2008: Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 43(4): 489-490
Tarantola, R.M.; Folk, J.C.; Boldt, H.C.; Mahajan, V.B. 2010: Intravitreal bevacizumab during pregnancy. Retina 30(9): 1405-1411
Dınc, E.; Yıldırım, O.; Necat Yılmaz, S.; Canacankatan, N.; Ayaz, L.; Ozcan, T.; Temel, G.O. 2014: Intravitreal bevacizumab effects on VEGF levels in distant organs: an experimental study. Cutaneous and Ocular Toxicology 33(4): 275-282
Moreno-López, M.; Regueras, A. 2009: Intravitreal bevacizumab followed by focal laser for diffuse diabetic macular edema of recent progression. a clinical case. Archivos de la Sociedad Espanola de Oftalmologia 84(4): 209-212
Pinarci, E.Y.; Karacal, H.; Demirel, B. 2012: Intravitreal bevacizumab followed by laser photocoagulation for retinal capillary hemanginoblastomas. Retinal Cases and Brief Reports 6(1): 76-79
Erol, N.; Gürsoy, H.üs.; Sahin, A.; Basmak, H. 2010: Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity. Journal of Pediatric Ophthalmology and Strabismus 47 Online: E1-E4
Milani, P.; Pece, A.; Moretti, G.; Lino, P.; Scialdone, A. 2009: Intravitreal bevacizumab for CNV-complicated tilted disk syndrome. Graefe's Archive for Clinical and Experimental Ophthalmology 247(9): 1179-1182
Introini, U.; Casalino, G.; Cardani, A.; Scotti, F.; Finardi, A.; Candiani, M.; Bandello, F. 2012: Intravitreal bevacizumab for a subfoveal myopic choroidal neovascularization in the first trimester of pregnancy. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 28(5): 553-555
Montero, J.A.; Ruiz-Moreno, J.M.; De La Vega, C. 2007: Intravitreal bevacizumab for adult-onset vitelliform dystrophy: a case report. European Journal of Ophthalmology 17(6): 983-986
Takahashi, M.; Sato, T.; Kishi, S. 2010: Intravitreal bevacizumab for age-related macular degeneration with good visual acuity. Japanese Journal of Ophthalmology 54(6): 565-570
Sothornwit, N. 2008: Intravitreal bevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report. Journal of the Medical Association of Thailand 91 Suppl. 1: S162-S165
de la Barquera Cordero, Aída.Sánchez.; Hidalgo, R.Alfredo.Cano. 2010: Intravitreal bevacizumab for choroidal metastasis of lung carcinoma; a case report. Journal of Ophthalmic and Vision Research 5(4): 265-268
Rishi, E.; Rishi, P.; Mahajan, S. 2010: Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy. Indian Journal of Ophthalmology 58(2): 160-162
Parodi, M.B.; Iacono, P.; La Spina, C.; Knutsson, K.A.; Mansour, A.; Arevalo, J.F.; Bandello, F. 2014: Intravitreal bevacizumab for choroidal neovascularisation in serpiginous choroiditis. British Journal of Ophthalmology 98(4): 519-522
Vossmerbaeumer, U.; Spandau, U.H.M.; V Baltz, S.; Wickenhaeuser, A.; Jonas, J.B. 2008: Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner choroidopathy. Clinical and Experimental Ophthalmology 36(3): 292-294
Velazquez-Villoria, D.; Macià Badia, C.; Rigo Quera, J.; Velez-Escola, L.; Arcos-Algaba, G.; Martínez-Castillo, V.; García-Arumí, J. 2014: Intravitreal bevacizumab for choroidal neovascularization associated with Best's disease. Archivos de la Sociedad Espanola de Oftalmologia 89(10): 405-407
Chiang, A.; Bianciotto, C.; Maguire, J.I.; Park, C.H.; Baker, P.S.; Shields, J.A.; Shields, C.L. 2012: Intravitreal bevacizumab for choroidal neovascularization associated with choroidal nevus. Retina 32(1): 60-67
Ikuno, Y.; Sayanagi, K.; Soga, K.; Sawa, M.; Tsujikawa, M.; Gomi, F.; Tano, Y. 2009: Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results. American Journal of Ophthalmology 147(1): 94-100.E1
Dithmar, S.; Schaal, K.B.; Höh, A.E.; Schmidt, S.; Schütt, F. 2009: Intravitreal bevacizumab for choroidal neovascularization due to pathological myopia. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 106(6): 527-530
Dib, J.G.; Abdulmohsin, S. 2008: Intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. International Journal of Pharmaceutical Compounding 12(1): 9-14
Guthoff, R.; Goebel, W. 2009: Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis. Acta Ophthalmologica 87(6): 688-690
Chhablani, J.; Jalali, S. 2012: Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child. European Journal of Ophthalmology 22(4): 677-679
Wu, L.; Evans, T.; Saravia, M.; Schlaen, A.; Couto, C. 2009: Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome. Japanese Journal of Ophthalmology 53(1): 57-60
Rosina, C.; Romano, M.; Cigada, M.; de Polo, L.; Staurenghi, G.; Bottoni, F. 2015: Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: a long-term follow-up study. European Journal of Ophthalmology 25(1): 47-50
Song, W.K.; Koh, H.J.; Kwon, O.W.; Byeon, S.H.; Lee, S.C. 2009: Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma. Acta Ophthalmologica 87(1): 100-101
Wolf, A.; Thurau, S.; Kook, D.; Hoeing, A.; Priglinger, S.; Kampik, A.; Haritoglou, C. 2010: Intravitreal bevacizumab for choroidal neovascularization secondary to inflammation. Acta Ophthalmologica 88(7): E295-E296
Pikkel, J.; Rumelt, S. 2012: Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathy. European Journal of Ophthalmology 22(3): 488-491
Salehipour, M.; Vafi, N.; Doozande, A.; Yaseri, M. 2010: Intravitreal bevacizumab for choroidal neovascularization secondary to non-age-related macular degeneration. Journal of Ophthalmic and Vision Research 5(1): 10-19
Ehrlich, R.; Ciulla, T.A.; Maturi, R.; Kheradiya, N.S.; Hrisomalos, N.; Shulman, S.; Guess, M.G.; Coyle, E.; Harris, A. 2009: Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome. Retina 29(10): 1418-1423
Niegel, M.F.; Schrage, N.F.; Christmann, S.; Degenring, R.F. 2008: Intravitreal bevacizumab for chronic central serous chorioretinopathy. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 105(10): 943-945
Mansour, A.M.; Alameddine, R. 2012: Intravitreal bevacizumab for consecutive multiple choroidal breast metastatic lesions. BMJ Case Reports
Gondo, M.; Sakai, T.; Tsuneoka, H.; Kanehira, C. 2011: Intravitreal bevacizumab for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer. Clinical Ophthalmology 5: 1217-1219
Bonini-Filho, M.; Costa, R.ér.A.; Calucci, D.; Jorge, R.; Melo, L.A.S.; Scott, I.U. 2009: Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study. American Journal of Ophthalmology 147(6): 1022-1030; 1030.E1-5
Ornek, K.; Oğurel, T. 2010: Intravitreal bevacizumab for diabetic papillopathy. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 26(2): 217-218
Arevalo, J.F.; Garcia-Amaris, R.A. 2009: Intravitreal bevacizumab for diabetic retinopathy. Current Diabetes Reviews 5(1): 39-46
De Benedetto, U.; Battaglia Parodi, M.; Knutsson, K.A.; Librando, A.; Bandello, F.; Lanzetta, P.; Iacono, P. 2012: Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 28(5): 550-552
Parodi, M.B.; Iacono, P.; Papayannis, A.; Kontadakis, S.; Cascavilla, M.L.; Zucchiatti, I.; Bandello, F. 2013: Intravitreal bevacizumab for extrafoveal choroidal neovascularization secondary to pathologic myopia. Retina 33(3): 593-597
Jonas, J.B.; Tao, Y.; Schlichtenbrede, F.C. 2011: Intravitreal bevacizumab for exudative age-related macular degeneration in clinical practice. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 27(5): 467-470
Tao, Y.; Jonas, J.B. 2010: Intravitreal bevacizumab for exudative age-related macular degeneration: effect on different subfoveal membranes. Retina 30(9): 1426-1431
Ehmann, D.; Greve, M. 2014: Intravitreal bevacizumab for exudative retinal detachment post laser therapy for retinopathy of prematurity. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 49(2): 228-231
Nomura, Y.; Obata, R.; Yanagi, Y. 2012: Intravitreal bevacizumab for iatrogenic choroidal neovascularization due to laser photocoagulation in central serous chorioretinopathy. Japanese Journal of Ophthalmology 56(3): 245-249
Cakir, M.; Cekiç, O.; Yilmaz, O.F. 2009: Intravitreal bevacizumab for idiopathic choroidal neovascularization. Journal of Aapos: the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus 13(3): 296-298
Shah, P.K.; Bachu, S.; Narendran, V.; Kalpana, N.; David, J.; Srinivas, C.R. 2013: Intravitreal bevacizumab for incontinentia pigmenti. Journal of Pediatric Ophthalmology and Strabismus 50 Online: E52-E54
Arevalo, J.Fernando.; Adan, A.; Berrocal, M.H.; Espinoza, J.V.; Maia, M.; Wu, L.; Roca, J.A.; Quiroz-Mercado, H.; Ruiz-Moreno, J.M.; Serrano, M.A.; Wu, L.; Arevalo, J.F.; Sanchez, J.G.; Espinoza, J.V.; Lasave, A.F.; Serrano, M.A.; Farah, M.; Maia, M.; Aggio, F.B.; Morales-Canton, V.; Quiroz-Mercado, H.; Fromow-Guerra, J.; Guerrero-Naranjo, J.L.; Rodriguez, F.J.; Infante, R.; Medina, D.; Berrocal, M.H.; Cruz-Villegas, V.; Graue-Wiechers, F.; Lozano-Rechy, D.; Robledo, V.; Rodriguez-Loaiza, J.L.; Roca, J.A.; Reategui, G.; Saravia, M.J.; Martinez-Cartier, M.; Avila, M.; Cardillo, J.; Verdaguer, J.; Verdaguer, J.I.; Filsecker, D.L.; Sepúlveda, G.; Alezzandrini, A.; Sanchez, F.; Marini, C.; Garcia, B. 2011: Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months. Retina 31(2): 353-363
Nakashima, C.; Keino, H.; Watanabe, T.; Taki, W.; Okada, A.A. 2011: Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma. Japanese Journal of Ophthalmology 55(1): 80-81
Yeung, S.N.; Paton, K.E.; Waite, C.; Maberley, D.A. 2010: Intravitreal bevacizumab for iris neovascularization following proton beam irradiation for choroidal melanoma. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 45(3): 269-273
Yokouchi, H.; Kitahashi, M.; Oshitari, T.; Yamamoto, S. 2013: Intravitreal bevacizumab for iris tumor metastasized from large cell neuroendocrine carcinoma of lung. Graefe's Archive for Clinical and Experimental Ophthalmology 251(9): 2243-2245
Parodi, M.B.; Iacono, P.; Mansour, A.; Benedetto, U.d.; Knutsson, K.A.; Bandello, F.; Ziemssen, F.; Ness, T.; Dodwell, D. 2013: Intravitreal bevacizumab for juxtafoveal choroidal neovascularization secondary to multifocal choroiditis. Retina 33(5): 953-956
Jonas, J.B. 2013: Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms. American Journal of Ophthalmology 155(4): 774
Demir, M.; Oba, E.; Gulkilik, G.ök.; Odabasi, M.; Ozdal, E. 2011: Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results. Clinical Ophthalmology 5: 745-749
DeCroos, F.C.; Ehlers, J.P.; Stinnett, S.; Fekrat, S. 2011: Intravitreal bevacizumab for macular edema due to central retinal vein occlusion: perfused vs. ischemic and early vs. late treatment. Current Eye Research 36(12): 1164-1170
Margolis, R.; Lowder, C.Y.; Sears, J.E.; Kaiser, P.K. 2007: Intravitreal bevacizumab for macular edema due to occlusive vasculitis. Seminars in Ophthalmology 22(2): 105-108
Loukianou, E.; Brouzas, D.; Georgopoulou, E.; Koutsandrea, C.; Apostolopoulos, M. 2010: Intravitreal bevacizumab for macular edema due to proton beam radiotherapy: Favorable results shown after eighteen months follow-up. Therapeutics and Clinical Risk Management 6: 249-252
Moon, S.J.; Berger, A.S.; Tolentino, M.J.; Misch, D.M. 2007: Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 38(2): 164-166
Ehlers, J.P.; Decroos, F.C.; Fekrat, S. 2011: Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Retina 31(9): 1856-1862
Rensch, F.; Spandau, U.H.M.; Schlichtenbrede, F.; von Baltz, S.; Libondi, T.; Jonas, J.B.; Vossmerbaeumer, U. 2008: Intravitreal bevacizumab for myopic choroidal neovascularization. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 39(3): 182-185
Coppens, G.; Angulo Bocco, M.I.; Spielberg, L.; Leys, A. 2010: Intravitreal bevacizumab for myopic choroidal neovascularization: 1-year and 2-year results. Bulletin de la Societe Belge d'Ophtalmologie 315: 39-45
Spielberg, L.; Leys, A. 2009: Intravitreal bevacizumab for myopic choroidal neovascularization: short-term and 1-year results. Bulletin de la Societe Belge d'Ophtalmologie 312: 17-27
Carneiro, A.M.; Falcão, M.S.; Brandão, E.M.; Falcão-Reis, F.M. 2010: Intravitreal bevacizumab for neovascular age-related macular degeneration with or without prior treatment with photodynamic therapy: one-year results. Retina 30(1): 85-92
Vasudev, D.; Blair, M.P.; Galasso, J.; Kapur, R.; Vajaranant, T. 2009: Intravitreal bevacizumab for neovascular glaucoma. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 25(5): 453-458
Vatavuk, Z.; Bencic, G.; Mandic, Z. 2007: Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. European Journal of Ophthalmology 17(2): 269-271
Yazdani, S.; Hendi, K.; Pakravan, M.; Mahdavi, M.; Yaseri, M. 2009: Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial. Journal of Glaucoma 18(8): 632-637
Battaglia Parodi, M.; Iacono, P.; La Spina, C.; Berchicci, L.; Scotti, F.; Leys, A.; Introini, U.; Bandello, F. 2014: Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks. American Journal of Ophthalmology 157(2): 374-377.E2
Zhou, Q.; Liang, J.; Lu, H. 2013: Intravitreal bevacizumab for ocular metastasis of multiple myeloma. Optometry and Vision Science: Official Publication of the American Academy of Optometry 90(9): E236
Shanmugam, M.P.; Mythri, H.M.; Shetty, N.S. 2007: Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane. Indian Journal of Ophthalmology 55(6): 490-491
Jonas, J.B.; Tao, Y.; Rensch, F. 2011: Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration. Acta Ophthalmologica 89(1): E105-E107
Salman, A.G. 2011: Intravitreal bevacizumab for pediatric exudative retinal diseases. Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society 25(2): 193-197
Jonas, J.B.; Libondi, T.; von Baltz, S.; Beutelspacher, S. 2011: Intravitreal bevacizumab for perifoveal telangiectasia. Acta Ophthalmologica 89(7): E607-E608
Davis, A.S.; Folk, J.C.; Russell, S.R.; Sohn, E.H.; Sohn, E.H.; Boldt, H.C.; Stone, E.M.; Mahajan, V.B. 2012: Intravitreal bevacizumab for peripapillary choroidal neovascular membranes. Archives of Ophthalmology 130(8): 1073-1075
Más, A.M.; Villegas, Víctor.M.; García, J.M.; Acevedo, S.; Serrano, L. 2012: Intravitreal bevacizumab for peripapillary subretinal neovascular membrane associated to papilledema: a case report. Puerto Rico Health Sciences Journal 31(3): 148-150
Gulkilik, G.; Taskapili, M.; Kocabora, S.; Muftuoglu, G.; Demirci, G. 2010: Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy. International Ophthalmology 30(6): 697-702
G Kotoula, M.; Zacharaki, F.; E Tsironi, E. 2012: Intravitreal bevacizumab for photodynamic therapy-induced massive macular detachment in acute central serous chorioretinopathy. Case Reports in Ophthalmology 3(2): 196-199
Al-Mohaimeed, M.; Al-Gehedan, S.; Dhibi, H.Al. 2010: Intravitreal bevacizumab for posterior capsule neovascularization. Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society 24(2): 63-65
Ferenchak, K.; Duval, R.; Cohen, J.A.; MacCumber, M.W. 2014: Intravitreal bevacizumab for postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy. Retina 34(6): 1177-1181
Ahmadieh, H.; Shoeibi, N.; Entezari, M.; Monshizadeh, R. 2009: Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology 116(10): 1943-1948
Carifi, G. 2012: Intravitreal bevacizumab for pseudophakic cystoid macular edema. European Journal of Ophthalmology 22(3): 513; author reply 514
Subrayan, V.; Khaw, K.W.; Peyman, M.; Koay, A.C.A.; Tajunisah, I. 2013: Intravitreal bevacizumab for radiation-induced cystoid macular oedema in patients with nasopharyngeal carcinoma: a clinical series. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 229(4): 208-211
Tran, T.H.C.; Fardeau, C.; Terrada, C.él.; Ducos De Lahitte, G.; Bodaghi, B.; Lehoang, P. 2008: Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis. Graefe's Archive for Clinical and Experimental Ophthalmology 246(12): 1685-1692
Arevalo, J.Fernando.; Maia, M.; Garcia-Amaris, R.A.; Roca, J.A.; Sanchez, J.G.; Berrocal, M.H.; Wu, L.; Wu, L.; Evans, T.; Arevalo, J.F.; Sanchez, J.G.; Garcia-Amaris, R.A.; Zeballos, D.G.; Espinoza, J.V.; Farah, M.; Maia, M.; Aggio, F.B.; Quiroz-Mercado, H.; Fromow-Guerra, J.; Morales-Canton, V.; Guerrero-Naranjo, J.L.; Rodriguez, F.J.; Infante, R.; Flores, S.; Medina, D.; Berrocal, M.H.; Cruz-Villegas, V.; Graue-Wiechers, F.; Lozano-Rechy, D.; Robledo, V.; Rodriguez-Loaiza, J.L.; Roca, J.A.; Reategui, G.; Saravia, M.J.; Martinez-Cartier, M.; Avila, M.; Costa, R.A.; Cardillo, J.; Verdaguer T, J.; Carpentier, C.; Verdaguer, J.I.; Filsecker, D.L.; Sepúlveda, G. 2009: Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology 116(8): 1481-7 1487.E1
Ach, T.; Thiemeyer, D.; Hoeh, A.E.; Schaal, K.B.; Dithmar, S. 2010: Intravitreal bevacizumab for retinal capillary haemangioma: longterm results. Acta Ophthalmologica 88(4): E137-E138
Slim, E.; Antoun, J.; Kourie, H.Raphael.; Schakkal, A.; Cherfan, G. 2014: Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 49(5): 450-457
Jonas, J.B.; Schmidbauer, M. 2010: Intravitreal bevacizumab for retinal macroaneurysm. Acta Ophthalmologica 88(7): E284
Battaglia Parodi, M.; De Benedetto, U.; Vergallo, S.; Knutsson, K.A.; Bandello, F.; Lanzetta, P.; Iacono, P. 2013: Intravitreal bevacizumab for retinal neovascularizations associated with myelinated nerve fibers. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 29(4): 442-443
Marticorena, J.; Romano, M.R.; Heimann, H.; Stappler, T.; Gibran, K.; Groenewald, C.; Pearce, I.; Wong, D. 2011: Intravitreal bevacizumab for retinal vein occlusion and early growth of epiretinal membrane: a possible secondary effect?. British Journal of Ophthalmology 95(3): 391-395
Harder, B.ör.C.; von Baltz, S.; Jonas, J.B.; Schlichtenbrede, F.C. 2011: Intravitreal bevacizumab for retinopathy of prematurity. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 27(6): 623-627
Dani, C.; Frosini, S.; Fortunato, P.; Bertini, G.; Pratesi, S.; Pollazzi, L.; Caputo, R.; La Torre, A. 2012: Intravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. a case series. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 25(11): 2194-2197
Parodi, M.B.; Iacono, P.; Cascavilla, M.; Zucchiatti, I.; Kontadakis, D.S.; Bandello, F. 2010: Intravitreal bevacizumab for subfoveal choroidal neovascularization associated with pattern dystrophy. Investigative Ophthalmology and Visual Science 51(9): 4358-4361
Mandal, S.; Sinha, S.; Abbas, Z.; Venkatesh, P. 2011: Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy. Indian Journal of Ophthalmology 59(4): 338-339
Arevalo, J.Fernando.; Sánchez, J.G.; Wu, L.; Berrocal, M.H.; Alezzandrini, A.A.; Restrepo, N.; Maia, M.; Farah, M.E.; Brito, M.; Díaz-Llopis, M.; Rodríguez, F.J.; Reategui, G.; Iturralde-Iraola, J.; Udaondo-Mirete, P.; Wu, L.; Arevalo, J.F.; Sanchez, J.G.; Espinoza, J.V.; Lasave, A.F.; Farah, M.; Maia, M.; Aggio, F.B.; Morales-Canton, V.; Quiroz-Mercado, H.; Fromow-Guerra, J.; Guerrero-Naranjo, J.L.; Rodriguez, F.J.; Infante, R.; Medina, D.; Berrocal, M.H.; Cruz-Villegas, V.; Graue-Wiechers, F.; Lozano-Rechy, D.; Robledo, V.; Rodriguez-Loaiza, J.L.; Roca, J.A.; Reategui, G.; Saravia, M.J.; Martinez-Cartier, M.; Avila, M.; Cardillo, J.; Costa, R.A.; Verdaguer T, J.; Ca 2010: Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study. Ophthalmology 117(10): 1974-81 1981.E1
Azad, R.V.; Khan, M.A.; Chanana, B.; Azad, S. 2008: Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population. Japanese Journal of Ophthalmology 52(1): 52-56
Di Lauro, R.; De Ruggiero, P.; di Lauro, R.; di Lauro, M.T.; Romano, M.R. 2010: Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 248(6): 785-791
Kishore, K. 2014: Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm. American Journal of Ophthalmology 157(1): 260
Kovacević, D.; Caljkusić-Mance, T.; Misljenović, T.; Mikulicić, M.; Alpeza-Dunato, Z. 2008: Intravitreal bevacizumab for the management of age-related macular degeneration. Collegium Antropologicum 32(Suppl 2): 5-7
Kim, M.; Kim, C.H.; Koh, H.J.; Lee, S.C.; Kim, S.S. 2014: Intravitreal bevacizumab for the treatment of choroidal metastasis. Acta Ophthalmologica 92(1): E80-E82
Rhéaume, M.-A.é; Sebag, M.ël. 2008: Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 43(5): 576-580
El Matri, L.; Kort, F.; Bouraoui, R.; Karim, B.; Chebil, A.; Chaker, N. 2011: Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up. Acta Ophthalmologica 89(7): 641-646
Jamerson, S.C.; Arunagiri, G.; Ellis, B.D.; Leys, M.J. 2009: Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to pseudotumor cerebri. International Ophthalmology 29(3): 183-185
Theodossiadis, P.G.; Grigoropoulos, V.G.; Emfietzoglou, I.; Vergados, J.; Chalkiadakis, J.; Theodossiadis, G.P. 2007: Intravitreal bevacizumab for the treatment of feeder vessel of subfoveal choroidal neovascularization. European Journal of Ophthalmology 17(5): 853-856
Loh, B.K.; Lee, S.Y.; Cheng, J.; Yeo, I.; Wong, D.; Ang, C.L. 2010: Intravitreal bevacizumab for the treatment of myopic choroidal neovascularisation in an Asian population. Annals of the Academy of Medicine Singapore 39(6): 493-494
Sagong, M.; Kim, J.; Chang, W. 2009: Intravitreal bevacizumab for the treatment of neovascular glaucoma associated with central retinal artery occlusion. Korean Journal of Ophthalmology: Kjo 23(3): 215-218
Mehta, S.; Blinder, K.J.; Shah, G.K.; Kymes, S.M.; Schlief, S.L.; Grand, M.G. 2010: Intravitreal bevacizumab for the treatment of refractory diabetic macular edema. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 41(3): 323-329
Flavahan, P.W.; Lavy, T.E.; Wykes, W. 2013: Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report. Scottish Medical Journal 58(3): 130-132
Rishi, P.; Rishi, E.; Venkatraman, A. 2012: Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta. Indian Journal of Ophthalmology 60(3): 229-231
Kianersi, F.; Naderi Beni, A.; Naderi Beni, Z.; Ghanbari, H. 2015: Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series. Seminars in Ophthalmology 30(3): 181-187
Schaal, K.B.; Hoeh, A.E.; Scheuerle, A.; Schuett, F.; Dithmar, S. 2009: Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. European Journal of Ophthalmology 19(4): 613-617
Seo, J.W.; Park, I.W. 2009: Intravitreal bevacizumab for treatment of diabetic macular edema. Korean Journal of Ophthalmology: Kjo 23(1): 17-22
Zhang, H.; Liu, Z.-L.; Sun, P.; Gu, F. 2011: Intravitreal bevacizumab for treatment of macular edema secondary to central retinal vein occlusion: eighteen-month results of a prospective trial. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 27(6): 615-621
Bashshur, Z.F.; Haddad, Z.A.; Schakal, A.R.; Jaafar, R.F.; Saad, A.; Noureddin, B.' N. 2009: Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: the second year of a prospective study. American Journal of Ophthalmology 148(1): 59-65.E1
Douat, J.; Auriol, S.; Mahieu-Durringer, L.; Ancèle, E.; Pagot-Mathis, V.; Mathis, A. 2009: Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases. Journal Francais d'Ophtalmologie 32(9): 652-663
Caccavale, A.; Imparato, M.; Negri, A. 2008: Intravitreal bevacizumab for treatment of peripapillary subretinal neovascularization. Retinal Cases and Brief Reports 2(2): 145-147
Roller, A.B.; Folk, J.C.; Patel, N.M.; Boldt, H.C.; Russell, S.R.; Abramoff, M.D.; Mahajan, V.B. 2011: Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia. Retina 31(9): 1848-1855
Entezari, M.; Ramezani, A.; Yaseri, M. 2012: Intravitreal bevacizumab for treatment of refractory central serous choroidoretinopathy. Korean Journal of Ophthalmology: Kjo 26(2): 139-142
Cinal, A.; Ziemssen, F.; Bartz-Schmidt, K.U.; Gelisken, F. 2011: Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology 249(4): 513-520
Costagliola, C.; Romano, M.; Corte, M.D.; Perrotta, R.; Menzione, M.; Rinaldi, M.; Semeraro, F.; Parmeggiani, F. 2009: Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up study. Retina 29(9): 1227-1234
Furino, C.; Boscia, F.; Recchimurzo, N.; Besozzi, G.; Cardascia, N.; Sborgia, L.; Niro, A.; Sborgia, C. 2009: Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration. Acta Ophthalmologica 87(4): 404-407
Veloso, C.E.; Vianna, R.N.; Pelayes, D.E.; Nehemy, M.ár.B. 2013: Intravitreal bevacizumab for type 2 idiopathic macular telangiectasia. Ophthalmic Research 49(4): 205-208
Doctor, P.P.; Bhat, P.; Sayed, R.; Foster, C.Stephen. 2009: Intravitreal bevacizumab for uveitic choroidal neovascularization. Ocular Immunology and Inflammation 17(2): 118-126
Jonas, J.B.; Libondi, T.; von Baltz, S.; Vossmerbaeumer, U. 2008: Intravitreal bevacizumab for vitreous haemorrhage. Acta Ophthalmologica 86(5): 585-586
Conrad, P.W.; Zacks, D.N.; Johnson, M.W. 2008: Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration. Clinical Ophthalmology 2(4): 727-733
Zucchiatti, I.; Iacono, P.; Battaglia Parodi, M.; Cascavilla, M.L.; Kontadakis, D.S.; Bandello, F. 2011: Intravitreal bevacizumab in a patient with a macular star in malignant hypertension. European Journal of Ophthalmology 21(3): 336-339
Moradian, S.; Ahmadieh, H.; Malihi, M.; Soheilian, M.; Dehghan, M.H.; Azarmina, M. 2008: Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 246(12): 1699-1705
Călugăru, D.; Călugăru, M. 2015: Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 31(2): 78-86
Parodi, M.B.; Cascavilla, M.; Papayannis, A.; Kontadakis, D.S.; Bandello, F.; Iacono, P. 2012: Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200. Archives of Ophthalmology 130(7): 934-935
Travassos, Aónio.; Teixeira, S.; Ferreira, P.; Regadas, I.; Travassos, A.Sofia.; Esperancinha, F.Esteves.; Prieto, I.; Pires, G.; van Velze, R.; Valido, A.; Machado, M.do.Céu. 2007: Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 38(3): 233-237
Algvere, P.V.; Epstein, D.; von Wendt, G.; Seregard, S.; Kvanta, A. 2011: Intravitreal bevacizumab in central retinal vein occlusion: 18-month results of a prospective clinical trial. European Journal of Ophthalmology 21(6): 789-795
Mandal, S.; Sinha, S.; Venkatesh, P.; Vashisht, N. 2011: Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy. Indian Journal of Ophthalmology 59(3): 262-263
Naithani, P.; Vashisht, N.; Mandal, S.; Sankaran, P.; Garg, S. 2010: Intravitreal bevacizumab in choroidal neovascularization associated with congenital choroidal and optic nerve coloboma in children: long-term improvement in visual acuity. Journal of Aapos: the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus 14(3): 288-290
Japiassú, R.Miguel.; Japiassú, M.Augusta.Castro.Farias.; Pecego, M.Gomes. 2008: Intravitreal bevacizumab in choroidal neovascularization secondary to Grönblad-Strandberg syndrome: case report. Arquivos Brasileiros de Oftalmologia 71(3): 427-429
Nazari, H.; Modarres, M.; Parvaresh, M.M.; Ghasemi Falavarjani, K. 2010: Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage. Graefe's Archive for Clinical and Experimental Ophthalmology 248(12): 1713-1718
Mansour, A.M.; Mackensen, F.; Arevalo, J.F.; Ziemssen, F.; Mahendradas, P.; Mehio-Sibai, A.; Hrisomalos, N.; Lai, T.Y.Y.; Dodwell, D.; Chan, W.-M.; Ness, T.; Banker, A.S.; Pai, S.A.; Berrocal, M.H.; Tohme, R.; Heiligenhaus, A.; Bashshur, Z.F.; Khairallah, M.; Salem, K.M.; Hrisomalos, F.N.; Wood, M.H.; Heriot, W.; Adan, A.; Kumar, A.; Lim, L.; Hall, A.; Becker, M. 2008: Intravitreal bevacizumab in inflammatory ocular neovascularization. American Journal of Ophthalmology 146(3): 410-416
Thapa, R.; Maharjan, N.; Paudyal, G. 2012: Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results. Clinical Ophthalmology 6: 1057-1062
Ruiz-Moreno, J.M.; López-Gálvez, M.ía.I.; Montero Moreno, J.A.; Pastor Jimeno, J.C. 2013: Intravitreal bevacizumab in myopic neovascular membranes: 24-month results. Ophthalmology 120(7): 1510
Ordóñez Fernández, L.; Celemín Viñuela, M.L.; Fernández Lisa, C.; García Alonso, A.; Fonolla Gil, M.; Fernández Bustillo, E. 2008: Intravitreal bevacizumab in neovascularisation secondary to age-related macular degeneration. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 32(1): 53-54
Arraes, J.ão.C.D.; Tedesco, R.C.; Arraes, T.A.; Silva, E.B.d.; Ventura, A.; Avila, M.P.d. 2009: Intravitreal bevacizumab in pigmented rabbit eyes: histological analysis 90 days after injection. Arquivos Brasileiros de Oftalmologia 72(5): 656-660
Spitzer, M.S.; Szurman, P.; Bartz-Schmidt, K.U. 2008: Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: does it really work?. Journal of Cataract and Refractive Surgery 34(6): 880; Author Reply 880-1
Ruiz-Moreno, J.é M.; Montero, J.A.; Lugo, F.; Amat, P.; Staicu, C. 2008: Intravitreal bevacizumab in recurrent diabetic vitreous haemorrhage after vitrectomy. Acta Ophthalmologica 86(2): 231-232
Kotecha, A.; Spratt, A.; Ogunbowale, L.; dell'Omo, R.; Kulkarni, A.; Bunce, C.; Franks, W.A. 2011: Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series. Archives of Ophthalmology 129(2): 145-150
Cervantes-Castañeda, R.A.; Giuliari, G.P.; Gallagher, M.J.; Yilmaz, T.; MacDonell, R.E.; Quinones, K.; Foster, C.S. 2009: Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up. European Journal of Ophthalmology 19(4): 622-629
Roohipoor, R.; Ghasemi, H.; Ghassemi, F.; Karkhaneh, R.; Riazi-Esfahani, M.; Nili-Ahmadabadi, M. 2011: Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series. Graefe's Archive for Clinical and Experimental Ophthalmology 249(9): 1295-1301
Narayanan, R.; Shah, V.A. 2008: Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma. European Journal of Ophthalmology 18(3): 466-468
El-Mollayess, G.M.; Mahfoud, Z.; Schakal, A.R.; Salti, H.I.; Jaafar, D.; Bashshur, Z.F. 2013: Intravitreal bevacizumab in the management of neovascular age-related macular degeneration: effect of baseline visual acuity. Retina 33(9): 1828-1835
Rishi, P.; Shroff, D.; Rishi, E. 2008: Intravitreal bevacizumab in the management of posttraumatic choroidal neovascular membrane. Retinal Cases and Brief Reports 2(3): 236-238
Song, J.H.; Bae, J.H.; Rho, M.I.; Lee, S.C. 2010: Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma. Retina 30(6): 945-951
Prasad, A.; Patel, C.C.; Puklin, J.E. 2009: Intravitreal bevacizumab in the treatment of choroidal neovascularization from a traumatic choroidal rupture in a 9-year-old child. Retinal Cases and Brief Reports 3(2): 125-127
Ababneh, O.H.; Yousef, Y.A.; Gharaibeh, A.M.; Abu Ameerh, M.A.; Abu-Yaghi, N.E.; Al Bdour, M.D. 2013: Intravitreal bevacizumab in the treatment of diabetic ocular neovascularization. Retina 33(4): 748-755
García-Ben, A.; Gómez-Ulla, F.; Rodriguez-Cid, M.J. 2014: Intravitreal bevacizumab in the treatment of idiopathic juxtafoveal telangiectasis type i. Archivos de la Sociedad Espanola de Oftalmologia 89(7): 269-271
Ouhadj, O.; Chergui, I.; Mendil, L.; Nouri, M.T. 2009: Intravitreal bevacizumab in the treatment of neovascular glaucoma. Journal Francais d'Ophtalmologie 32(2): 112-116
Alasil, T.; Rauser, M.E. 2009: Intravitreal bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: a case report. Cases Journal 2: 176
Lee, I.-J.; Maccheron, L.J.; Kwan, A.S. 2013: Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension. Journal of Neuro-Ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society 33(2): 155-157
Artunay, O.; Yuzbasioglu, E.; Rasier, R.; Sengul, A.; Bahcecioglu, H. 2010: Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study. Current Eye Research 35(2): 91-98
Ach, T.; Hoeh, A.E.; Ruppenstein, M.; Kretz, F.T.A.; Dithmar, S. 2010: Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration. Retina 30(9): 1420-1425
Jeon, S.; Lee, W.K. 2012: Intravitreal bevacizumab increases intraocular interleukin-6 levels at 1 day after injection in patients with proliferative diabetic retinopathy. Cytokine 60(2): 535-539
Kodama, A.; Sugioka, K.; Kuniyoshi, K.; Okuyama, S.; Matsumoto, C.; Shimomura, Y. 2010: Intravitreal bevacizumab injection and carotid artery stent replacement for neovascular glaucoma in internal carotid artery occlusion. Clinical Ophthalmology 4: 1177-1180
Chhablani, J.Kumar.; Narayanan, R. 2010: Intravitreal bevacizumab injection for central serous chorioretinopathy. Retina 30(8): 1323-24; author reply 1324
Nowroozzadeh, M.H. 2010: Intravitreal bevacizumab injection for central serous chorioretinopathy. Retina 30(8): 1322-3; author reply 1323
Wong, I.Y.H.; Koo, S.C.Y.; Chan, C.W.N. 2011: Intravitreal bevacizumab injection for central serous chorioretinopathy. Retina 31(1): 198-9; Author Reply 199
Li, X.-j.; Zhang, J.-s. 2010: Intravitreal bevacizumab injection for chronic central serous chorioretinopathy. Chinese Medical Journal 123(15): 2145-2147
Alforja, M.ía.S.; Sabater, N.; Giralt, J.; Adán, A.; Pelegrín, L.; Casaroli-Marano, R. 2011: Intravitreal bevacizumab injection for peripheral exudative hemorrhagic chorioretinopathy. Japanese Journal of Ophthalmology 55(4): 425-427
Park, H.S.; Nam, K.Y.; Kim, J.Y. 2011: Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease. Graefe's Archive for Clinical and Experimental Ophthalmology 249(1): 133-136
Yeh, P.-T.; Yang, C.-H.; Yang, C.-M. 2011: Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy. Acta Ophthalmologica 89(7): 634-640
Raffa, L.; Bawazeer, A. 2009: Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 44(5): 615-616
Choovuthayakorn, J.; Ubonrat, K. 2012: Intravitreal bevacizumab injection in advanced retinopathy of prematurity. Journal of the Medical Association of Thailand 95(Suppl 4): S70-S75
Artunay, O.; Rasier, R.; Yuzbasioglu, E.; Sengül, A.; Bahcecioglu, H. 2009: Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma. International Ophthalmology 29(4): 289-291
Chen, C.-H.; Wu, P.-C.; Liu, Y.-C. 2011: Intravitreal bevacizumab injection therapy for persistent macular edema after idiopathic macular epiretinal membrane surgery. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 27(3): 287-292
El Matri, L.; Chebil, A.; Bouraoui, R.; Kort, F.; Bouladi, M.; Basaraih, S. 2013: Intravitreal bevacizumab injections versus verteporferin photodynamic therapy for macular choroidal neovascularization in high myopia: 24-month follow-up. Journal Francais d'Ophtalmologie 36(1): 29-34
Ozsutcu, M.; Gulkilik, G.; Ayintap, E.; Altinisik, M.; Demirci, G.; Aras, C. 2013: Intravitreal bevacizumab may increase diabetic macular edema in eyes with attached posterior vitreous. Case Reports in Ophthalmology 4(1): 7-10
Şahin, A.; Şahin, M.; Cingü, A.K.ür.şa.; Çınar, Y.; Türkcü, F.M.; Yüksel, H.; Kaya, S.ş; Arı, Şe.; Caça, İh. 2013: Intravitreal bevacizumab monotherapy for retinopathy of prematurity. Pediatrics International: Official Journal of the Japan Pediatric Society 55(5): 599-603
Chhablani, J.K.; Narula, R.; Narayanan, R. 2014: Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy. Indian Journal of Ophthalmology 62(1): 97
Chhablani, J.K.; Narula, R.; Narayanan, R. 2013: Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy. Indian Journal of Ophthalmology 61(3): 136-138
Hayashi, K.; Ohno-Matsui, K.; Shimada, N.; Moriyama, M.; Hara, W.; Yoshida, T.; Tokoro, T.; Mochizuki, M. 2009: Intravitreal bevacizumab on myopic choroidal neovascularization that was refractory to or had recurred after photodynamic therapy. Graefe's Archive for Clinical and Experimental Ophthalmology 247(5): 609-618
Arevalo, J.Fernando.; Lasave, A.F.; Wu, L.; Diaz-Llopis, M.; Gallego-Pinazo, R.; Alezzandrini, A.A.; Berrocal, M.H.; Wu, L.; Arevalo, J..F.; Serrano, M..A.; Lasave, A.F.; Arias, J..D.; Farah, M.; Maia, M.; Morales-Canton, V.; Fromow-Guerra, J.; Guerrero-Naranjo, J..L.; Dalma-Weiszhausz, J.; Quiroz-Mercado, H.; Velez-Montoya, R.; Rodriguez, F..J.; Infante, R.; Medina, D.; Berrocal, M..H.; Cruz-Villegas, V.; Graue-Wiechers, F.; Lozano-Rechy, D.; Robledo, V.; Rodriguez-Loaiza, J..L.; Roca, J.A.; Saravia, M..J.; Martinez-Cartier, M.; Avila, M.; Cardillo, J.; Verdaguer, J.; Carpentier, C.; Verdaguer, J..I.; Filsecker, D..L.; Sepúlveda, G.; Alezzandrini, A..A.; Sanchez, F.; Marini, C.; Garcia, B.; Alvira, G.; Flor,; 2013: Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months. Retina 33(2): 403-413
Couzinet, A.; Auriol, S.; Lequeux, L.; Arné, J.-L.; Pagot-Mathis, V. 2012: Intravitreal bevacizumab pretreatment in vitrectomy for severe diabetic retinopathy: a series of six cases. Journal Francais d'Ophtalmologie 35(4): 260-265
Giansanti, F.; Virgili, G.; Bini, A.; Rapizzi, E.; Giacomelli, G.; Donati, M.C.; Verdina, T.; Menchini, U. 2007: Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study. European Journal of Ophthalmology 17(2): 230-237
Matsumoto, Y.; Yuzawa, M. 2010: Intravitreal bevacizumab therapy for idiopathic macular telangiectasia. Japanese Journal of Ophthalmology 54(4): 320-324
Galbinur, T.; Averbukh, E.; Banin, E.; Hemo, I.; Chowers, I. 2009: Intravitreal bevacizumab therapy for neovascular age-related macular degeneration associated with poor initial visual acuity. British Journal of Ophthalmology 93(10): 1351-1352
Iacono, P.; Parodi, M.B.; Papayannis, A.; Kontadakis, S.; Sheth, S.; Bandello, F. 2011: Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series. Retina 31(9): 1841-1847
Wong, R.; Gupta, B.; Stanford, M.R.; Laidlaw, D.A.H. 2010: Intravitreal bevacizumab to facilitate vitrectomy in idiopathic ischaemic retinal vasculitis. International Ophthalmology 30(4): 415-419
Seong, H.K.; Bae, J.H.; Kim, E.S.; Han, J.R.; Nam, W.H.; Kim, H.K. 2009: Intravitreal bevacizumab to treat acute central serous chorioretinopathy: short-term effect. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 223(5): 343-347
Montero, J.A.; Ruiz-Moreno, J.é M.; Fernandez-Muñoz, M. 2011: Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy. European Journal of Ophthalmology 21(4): 503-505
Wakabayashi, T.; Oshima, Y.; Sakaguchi, H.; Ikuno, Y.; Miki, A.; Gomi, F.; Otori, Y.; Kamei, M.; Kusaka, S.; Tano, Y. 2008: Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115(9): 1571-1580; 1580.E1-3
Ruiz-Moreno, J.M.; Montero, J.A. 2010: Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome. Graefe's Archive for Clinical and Experimental Ophthalmology 248(7): 937-941
Ruiz-Moreno, J.M.; Montero, J.A.; Gomez-Ulla, F.; Ares, S. 2009: Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome. British Journal of Ophthalmology 93(4): 448-451
Perol, J.; Wolff, B.; Sahel, J.-A.; Le Mer, Y. 2011: Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease. Journal Francais d'Ophtalmologie 34(5): 281-286
Gharbiya, M.; Allievi, F.; Mazzeo, L.; Gabrieli, C.B. 2009: Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results. American Journal of Ophthalmology 147(1): 84-93.E1
Axer-Siegel, R.; Bor, E.; Bourla, D.H.; Weinberger, D.; Mimouni, K. 2012: Intravitreal bevacizumab treatment for exudative age-related macular degeneration with good visual acuity. Retina 32(9): 1811-1820
Siegel, R.A.; Dreznik, A.; Mimouni, K.; Bor, E.; Weinberger, D.; Bourla, D.H. 2012: Intravitreal bevacizumab treatment for macular edema due to branch retinal vein occlusion in a clinical setting. Current Eye Research 37(9): 823-829
Yoshida, N.; Hisatomi, T.; Ikeda, Y.; Kohno, R.-i.; Murakami, Y.; Imaki, H.; Ueno, A.; Fujisawa, K.; Ishibashi, T. 2011: Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens. Graefe's Archive for Clinical and Experimental Ophthalmology 249(10): 1547-1552
Yuksel, E.; Ozdek, S.; Yuksel, N.ıl.; Hasanreisoglu, B. 2013: Intravitreal bevacizumab treatment for refractory diabetic macular edema. International Ophthalmology 33(6): 659-663
El-Batarny, A.M. 2007: Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy. Clinical Ophthalmology 1(2): 149-155
Knape, R.M.; Zavaleta, E.M.; Clark, C.L.; Khuddus, N.; Peden, M.C. 2011: Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen. Journal of Aapos: the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus 15(1): 87-90
Erdurman, F.Cüneyt.; Durukan, A.Hakan.; Mumcuoğlu, T.; Hürmeriç, V. 2009: Intravitreal bevacizumab treatment of macular edema due to optic disc vasculitis. Ocular Immunology and Inflammation 17(1): 56-58
Beutel, J.; Ziemssen, F.; Lüke, M.; Partsch, M.; Bartz-Schmidt, K.-U.; Gelisken, F. 2010: Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: one-year results. International Ophthalmology 30(1): 15-22
Cakir, M.; Bayraktar, Z.; Bayraktar, S.; Agca, A.; Yilmaz, O.F. 2008: Intravitreal bevacizumab treatment of retinal telangiectasis complicated by subretinal neovascularization. Retinal Cases and Brief Reports 2(2): 141-144
Faghihi, H.; Roohipoor, R.; Mohammadi, S.-F.; Hojat-Jalali, K.; Mirshahi, A.; Lashay, A.; Piri, N.; Faghihi, S. 2008: Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema. European Journal of Ophthalmology 18(6): 941-948
Ahmadieh, H.; Taei, R.; Riazi-Esfahani, M.; Piri, N.; Homayouni, M.; Daftarian, N.; Yaseri, M. 2011: Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial. Retina 31(9): 1819-1826
Lepore, D.; Quinn, G.E.; Molle, F.; Baldascino, A.; Orazi, L.; Sammartino, M.; Purcaro, V.; Giannantonio, C.; Papacci, P.; Romagnoli, C. 2014: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Ophthalmology 121(11): 2212-2219
Ernst, B.J.; García-Aguirre, G.; Oliver, S.C.N.; Olson, J.L.; Mandava, N.; Quiroz-Mercado, H. 2012: Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy. Acta Ophthalmologica 90(7): E573-E574
Bhayana, S.; Sood, S.; Narang, S.; Sethi, N.Khurana. 2015: Intravitreal bevacizumab versus posterior subtenon triamcinolone in diffuse diabetic macular edema. International Ophthalmology 35(4): 519-525
Lee, J.Yong.; Chae, J.Byung.; Yang, S.Jae.; Kim, J-Gone.; Yoon, Y.Hee. 2011: Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy. Acta ophthalmologica 89(3): e293-e294
Jonas, J.B.; Ihloff, A.K.; Harder, B.; Kreissig, I.; Schlichtenbrede, F.; Libondi, T.; Spandau, U.H.M.; Vossmerbaeumer, U. 2009: Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration. Ophthalmic Research 41(1): 21-27
Hou, J.; Tao, Y.; Jiang, Y.-r.; Li, X.-x.; Gao, L. 2009: Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study. Chinese Medical Journal 122(22): 2695-2699
Soheilian, M.; Rabbanikhah, Z.; Ramezani, A.; Kiavash, V.; Yaseri, M.; Peyman, G.A. 2010: Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 26(2): 199-206
Hahn, R.; Sacu, S.; Michels, S.; Varga, A.; Weigert, G.; Geitzenauer, W.; Vécsei-Marlovits, P.; Schmidt-Erfurth, U. 2007: Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 104(7): 588-593
Wakabayashi, T.; Ikuno, Y.; Gomi, F.; Hamasaki, T.; Tano, Y. 2009: Intravitreal bevacizumab vs sub-tenon triamcinolone acetonide for choroidal neovascularization attributable to pathologic myopia. American Journal of Ophthalmology 148(4): 591-596.E1
Moradian, S.; Faghihi, H.; Sadeghi, B.; Piri, N.; Ahmadieh, H.; Soheilian, M.; Dehghan, M.Hossein.; Azarmina, M.; Esfahani, M.Riazi. 2011: Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1). Graefe's Archive for Clinical and Experimental Ophthalmology 249(2): 193-200
Marey, H.M.; Ellakwa, A.F. 2011: Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma. Clinical Ophthalmology 5: 841-845
Liu, X.; Zhou, X.; Wang, Z.; Li, T.; Jiang, B. 2014: Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials. Chinese Medical Journal 127(19): 3471-3476
Synek, S.; Vojniković, B. 2010: Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema. Collegium Antropologicum 34(Suppl 2): 99-103
Chen, T.-L.; Sun, M.-H.; Lin, K.-K.; Lai, C.-C.; Chen, K.-J. 2010: Intravitreal bevacizumab with regression of subretinal neovascularization after intraocular foreign body trauma. Journal of Trauma 68(3): 747
Smit, D.P.; Meyer, D. 2007: Intravitreal bevacizumab: an analysis of the evidence. Clinical Ophthalmology 1(3): 273-284
Ng, D.S.; Kwok, A.K.H.; Chan, C.W.; Li, W.W.T. 2012: Intravitreal bevacizumab: safety of multiple doses from a single vial for consecutive patients. Hong Kong Medical Journal 18(6): 488-495
Yata, K.; Tanikawa, A.; Hori, K.; Nakamura, A.; Yamada, H.; Horiguchi, M. 2009: Intravitreal bimanual surgery for residual lens fragments and displaced crystalline lenses. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 40(3): 331-335
Pochop, P.; Darsova, D.; Kukacka, J.; Tesfaye, H.; Vajner, L.; Uhlik, J.; Kodetová, D.; Malis, J.; Dotrelova, D. 2010: Intravitreal carboplatin concentration and area under concentration versus time curve after intravitreal and periocular delivery. European Journal of Ophthalmology 20(4): 745-751
Zhang, R.; Zhang, H.; Xu, L.; Ma, K.; Wallrapp, C.; Jonas, J.B. 2011: Intravitreal cell-based production of glucagon-like peptide-1. Retina 31(4): 785-789
Saito, M.; Barbazetto, I.A.; Spaide, R.F. 2013: Intravitreal cellular infiltrate imaged as punctate spots by spectral-domain optical coherence tomography in eyes with posterior segment inflammatory disease. Retina 33(3): 559-565
Lasave, A.és.F.; Díaz-Llopis, M.; Muccioli, C.; Belfort, R.; Arevalo, J.F. 2010: Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months. Ophthalmology 117(9): 1831-1838
Tsilimbaris, M.K.; Pandeleondidis, V.; Panagiototglou, T.; Arvanitaki, V.; Fragiskou, S.; Eleftheriadou, M.; Tsika, C.; Papadaki, T. 2009: Intravitreal combination of triamcinolone acetonide and bevacizumab (Kenacort-Avastin) in diffuse diabetic macular edema. Seminars in Ophthalmology 24(6): 225-230
Basile, A.S.; Glazier, G.; Lee, A.; Jiang, L.-Y.; Johnson, T.R.; Shields, M.J.; Vezina, M.; Doppalapudi, V.R. 2011: Intravitreal concentrations of a near-infrared fluorescence-labeled biotherapeutic determined in situ using confocal scanning laser ophthalmoscopy. Investigative Ophthalmology and Visual Science 52(9): 6949-6958
Han, D.P.; Heuer, D.K. 2012: Intravitreal corticosteroid therapy: putting the problem of glaucoma in perspective. Archives of Ophthalmology 130(3): 380-382
Smiddy, W.E. 2009: Intravitreal corticosteroids for diabetic retinopathy prevention. Archives of Ophthalmology 127(12): 1672-1673
Buzzacco, D.M.; Carroll, C.P. 2012: Intravitreal daptomycin in a case of bilateral endogenous endophthalmitis. Archives of Ophthalmology 130(7): 940-941
Comer, G.M.; Miller, J.B.; Schneider, E.W.; Khan, N.W.; Reed, D.M.; Elner, V.M.; Zacks, D.N. 2011: Intravitreal daptomycin: a safety and efficacy study. Retina 31(6): 1199-1206
Christoforidis, J.B.; Chang, S.; Jiang, A.; Wang, J.; Cebulla, C.M. 2012: Intravitreal devices for the treatment of vitreous inflammation. Mediators of Inflammation 2012: 126463
Baillif, S.ép.; Maschi, C.; Gastaud, P.; Caujolle, J.P. 2013: Intravitreal dexamethasone 0.7-mg implant for radiation macular edema after proton beam therapy for choroidal melanoma. Retina 33(9): 1784-1790
Gallego-Pinazo, R.; Marín-Lambíes, C.; Marín-Olmos, F.; Martínez, R.; Fons, R.; Díaz-Llopis, M.L.; Díaz-Llopis, M.L.; Díaz-Llopis, M.L. 2010: Intravitreal dexamethasone as an enhancer for the anti-VEGF treatment in neovascular ARMD: recovering an old ally. Archivos de la Sociedad Espanola de Oftalmologia 85(2): 79-80
Chan, C.K.M.; Mohamed, S.; Lee, V.Y.W.; Lai, T.Y.Y.; Shanmugam, M.P.; Lam, D.S.C. 2010: Intravitreal dexamethasone for diabetic macular edema: a pilot study. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 41(1): 26-30
Cebeci, Z.; Oray, M.; Tuncer, S.; Tugal Tutkun, I.; Kir, N. 2014: Intravitreal dexamethasone implant (Ozurdex) and photodynamic therapy for vasoproliferative retinal tumours. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 49(4): E83-E84
Saatci, A.O.; Doruk, H.C.; Yaman, A. 2013: Intravitreal dexamethasone implant (ozurdex) in coats' disease. Case Reports in Ophthalmology 4(3): 122-128
Alten, F.; Clemens, C.R.; Heiduschka, P.; Eter, N. 2014: Intravitreal dexamethasone implant [Ozurdex] for the treatment of nonarteritic anterior ischaemic optic neuropathy. Documenta Ophthalmologica. Advances in Ophthalmology 129(3): 203-207
Scupola, A.; Abed, E.; Sammarco, M.G.; Traina, S.; Villano, A.; Grimaldi, G.; Blasi, M.A. 2014: Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy. European Journal of Ophthalmology 24(5): 803-807
Furino, C.; Boscia, F.; Recchimurzo, N.; Sborgia, C.; Alessio, G. 2014: Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification. European Journal of Ophthalmology 24(3): 387-391
Furino, C.; Boscia, F.; Recchimurzo, N.; Sborgia, C.; Alessio, G. 2014: Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker. Retina 34(8): 1612-1616
Zucchiatti, I.; Lattanzio, R.; Querques, G.; Querques, L.; Del Turco, C.; Cascavilla, M.L.; Bandello, F. 2012: Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 228(2): 117-122
Sorkin, N.; Loewenstein, A.; Habot-Wilner, Z.; Goldstein, M. 2014: Intravitreal dexamethasone implant in patients with persistent macular edema of variable etiologies. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 232(2): 83-91
Jacobs, D.J.; Pathengay, A.; Flynn, H.W.; Leng, T.; Miller, D.; Shi, W. 2012: Intravitreal dexamethasone in the management of delayed-onset bleb-associated endophthalmitis. International Journal of Inflammation 2012: 503912
Ramezani, A.; Fard Esmaeilpour, N.; Eskandari, A.; Rabbanikhah, Z.; Soheilian, R.; Soheilian, M. 2013: Intravitreal diclofenac for refractory uveitic cystoid macular edema. Journal of Ophthalmic and Vision Research 8(1): 47-52
Soheilian, M.; Karimi, S.; Ramezani, A.; Montahai, T.; Yaseri, M.; Soheilian, R.; Peyman, G.A. 2015: Intravitreal diclofenac versus intravitreal bevacizumab in naive diabetic macular edema: a randomized double-masked clinical trial. International Ophthalmology 35(3): 421-428
Cuevas, P.; Outeiriño, L.; Azanza, C.; Giménez-Gallego, G. 2012: Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two cases. BMJ Case Reports
Dolz-Marco, R.; Gallego-Pinazo, R.; Pinazo-Duran, M.D.; Pons-Vázquez, S.; Domingo-Pedro, J.C.; Díaz-Llopis, M. 2014: Intravitreal docosahexaenoic acid in a rabbit model: preclinical safety assessment. Plos one 9(5): E96872
Thakur, S.S.; Barnett, N.L.; Donaldson, M.J.; Parekh, H.S. 2014: Intravitreal drug delivery in retinal disease: are we out of our depth?. Expert Opinion on Drug Delivery 11(10): 1575-1590
Montero, J.A.; Merino-Iglesias, A.A.; Pérez-Martín, S.; Ruiz-Moreno, J.é M. 2013: Intravitreal drug dispersion and needle gauge. Acta Ophthalmologica 91(8): E646-E647
Chen, T.-C.; Yang, C.-H.; Yang, C.-M. 2012: Intravitreal expansile gas in the treatment of early macular hole: reappraisal. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 228(3): 159-166
Ahmadieh, H.; Nourinia, R.; Hafezi-Moghadam, A. 2013: Intravitreal fasudil combined with bevacizumab for persistent diabetic macular edema: a novel treatment. JAMA Ophthalmology 131(7): 923-924
Nourinia, R.; Ahmadieh, H.; Shahheidari, M.-H.; Zandi, S.; Nakao, S.; Hafezi-Moghadam, A. 2013: Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study. Journal of Ophthalmic and Vision Research 8(4): 337-340
Bertelmann, T.; Stief, T.; Sekundo, W.; Witteborn, M.; Strodthoff, S.; Mennel, S.; Nguyen, N.; Koss, M. 2015: Intravitreal fibrinolysis and retinal vein occlusion. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 112(2): 155-161
Sigler, E.J.; Randolph, J.C.; Charles, S.; Calzada, J.I. 2012: Intravitreal fluorinated gas preference and occurrence of rare ischemic postoperative complications after pars plana vitrectomy: a survey of the american society of retina specialists. Journal of ophthalmology 2012: 230596
Tawse, K.L.; Baumal, C.R. 2014: Intravitreal foscarnet for recurring CMV retinitis in a congenitally infected premature infant. Journal of Aapos: the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus 18(1): 78-80
Lee, M.Y.; Kim, K.S.; Lee, W.K. 2011: Intravitreal foscarnet for the treatment of acyclovir-resistant acute retinal necrosis caused by varicella zoster virus. Ocular Immunology and Inflammation 19(3): 212-213
Bertelmann, T.; Sekundo, W.; Strodthoff, S.; Witteborn, M.C.P.; Stief, T.; Irle, S.; Nguyen, N.; Koss, M.J.; Mennel, S. 2014: Intravitreal functional plasminogen in eyes with branch retinal vein occlusion. Ophthalmic Research 52(2): 74-80
Bertelmann, T.; Mennel, S.; Sekundo, W.; Strodthoff, S.; Witteborn, M.C.P.; Stief, T.; Nguyen, N.; Koss, M.J. 2013: Intravitreal functional plasminogen is elevated in central retinal vein occlusion. Ophthalmic Research 50(3): 151-159
Kishore, K.; Jain, S.; Zarbin, M.A. 2011: Intravitreal ganciclovir and dexamethasone as adjunctive therapy in the management of acute retinal necrosis caused by varicella zoster virus. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 42 Online: E87-E90
Langner-Wegscheider, B.J.; ten Dam-van Loon, N.; Mura, M.; Faridpooya, K.; de Smet, M.D. 2010: Intravitreal ganciclovir in the management of non-AIDS-related human cytomegalovirus retinitis. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 45(2): 157-160
Teoh, S.C.; Ou, X.; Lim, T.H. 2012: Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen. Ophthalmology 119(3): 588-595
Georgalas, I.; Koutsandrea, C.; Ladas, I. 2011: Intravitreal gas injection for macular hole with localized retinal detachment in highly myopic patients. Acta Ophthalmologica 89(4): E380; Author Reply E380-1
McHugh, D.; Gupta, B.; Saeed, M. 2011: Intravitreal gas injection for the treatment of diabetic macular edema. Clinical Ophthalmology 5: 1543-1548
Akiyama, H.; Shimoda, Y.; Fukuchi, M.; Kashima, T.; Mayuzumi, H.; Shinohara, Y.; Kishi, S. 2014: Intravitreal gas injection without vitrectomy for macular detachment associated with an optic disk pit. Retina 34(2): 222-227
Shirodkar, A.R.; Pathengay, A.; Flynn, H.W. 2011: Intravitreal gentamicin-induced macular infarction: SD-OCT features. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 42 Online: E67-E70
Insull, E.; Guest, S.; Samarasinghe, D. 2011: Intravitreal haemoglobin spherulosis: an unusual sequela of intraocular haemorrhage. International Ophthalmology 31(6): 477-479
Chang, H.-H.; Lin, D.P.-C.; Chen, Y.-S.; Liu, H.-J.; Lin, W.; Tsao, Z.-J.; Teng, M.-C.; Chen, B.-Y. 2011: Intravitreal homocysteine-thiolactone injection leads to the degeneration of multiple retinal cells, including photoreceptors. Molecular Vision 17: 1946-1956
Turaka, K.; Kwong, H.M.; De Souza, S. 2013: Intravitreal implant migration into anterior chamber in a post-vitrectomy eye with central retinal vein occlusion and persistent macular edema. Ophthalmic Surgery Lasers and Imaging Retina 44(2): 196-197
Buchaim, G.; Rezende, M.Palata.; Maia, Mício. 2013: Intravitreal implantation of Ozurdex® chronic delivery system for management of macular edema related to retinitis pigmentosa: case report. Arquivos Brasileiros de Oftalmologia 76(6): 377-379
Winterhalter, S.; Ruokonen, P.; van der Velden, K.H.; Pleyer, U.; Joussen, A.M. 2011: Intravitreal implants: drug carriers and carriers of hope?. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 108(3): 222-229
Romano, M.R.; Christoforidis, J.; Abu El-Asrar, A.M. 2013: Intravitreal inflammation: from benchside to bedside. Mediators of Inflammation 2013: 758035
Romano, M.R.; Christoforidis, J. 2014: Intravitreal inflammation: from benchside to bedside 2013. Mediators of Inflammation 2014: 286571
Giansanti, F.; Ramazzotti, M.; Giuntoli, M.; Virgili, G.; Vannozzi, L.; Degl'Innocenti, D.; Menchini, U. 2009: Intravitreal infliximab clearance in a rabbit model: different sampling methods and assay techniques. Investigative Ophthalmology and Visual Science 50(11): 5328-5335
Semeraro, F.; Romano, M.R.; Danzi, P.; Angi, M.; Costagliola, C. 2013: Intravitreal infliximab for choroidal neovascularization in patients refractory to conventional treatments. International Journal of Immunopathology and Pharmacology 26(3): 765-768
Markomichelakis, N.; Delicha, E.; Masselos, S.; Sfikakis, P.P. 2012: Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients. American Journal of Ophthalmology 154(3): 534-541.E1
Farvardin, M.; Afarid, M.; Mehryar, M.; Hosseini, H. 2010: Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis. Retina 30(9): 1530-1535
Hosseini, H.; Safaei, A.; Khalili, M.R.; Nowroozizadeh, B.; Eghtedari, M.; Farvardin, M.; Nowroozizadeh, S.; Tolide-Ie, H.R. 2009: Intravitreal infliximab in experimental endotoxin-induced uveitis. European Journal of Ophthalmology 19(5): 818-823
Arias, L.; Caminal, J.M.; Badia, M.B.; Rubio, M.J.; Catala, J.; Pujol, O. 2010: Intravitreal infliximab in patients with macular degeneration who are nonresponders to antivascular endothelial growth factor therapy. Retina 30(10): 1601-1608
Cavalcante, L.L.; Cavalcante, M.L.; Murray, T.G.; Vigoda, M.M.; Piña, Y.; Decatur, C.L.; Davis, R.Prince.; Olmos, L.C.; Schefler, A.C.; Parrott, M.B.; Alliman, K.J.; Flynn, H.W.; Moshfeghi, A.A. 2010: Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clinical Ophthalmology 4: 519-524
Yau, G.L.; Jackman, C.S.; Hooper, P.L.; Sheidow, T.G. 2011: Intravitreal injection anesthesia--comparison of different topical agents: a prospective randomized controlled trial. American Journal of Ophthalmology 151(2): 333-7.E2
Lai, K.; Jin, C.; Tu, S.; Xiong, Y.; Huang, R.; Ge, J. 2014: Intravitreal injection of (99)Tc-MDP inhibits the development of laser-induced choroidal neovascularization in rhesus monkeys. Graefe's Archive for Clinical and Experimental Ophthalmology 252(7): 1049-1057
Itakura, H.; Kishi, S. 2009: Intravitreal injection of 0.3 ml of SF6 gas for persistent subfoveal fluid after scleral buckling for rhegmatogenous retinal detachment. Graefe's Archive for Clinical and Experimental Ophthalmology 247(8): 1147-1150
Chen, C.-H.; Wu, P.-C.; Chen, Y.-J.; Liu, Y.-C.; Kuo, H.-K. 2011: Intravitreal injection of 2.5 mg bevacizumab for treatment of myopic choroidal neovascularization in treatment-naive cases: a 2-year follow-up. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 27(4): 395-400
Modarres, M.; Naseripour, M.; Falavarjani, K.G.; Nikeghbali, A.; Hashemi, M.; Parvaresh, M.M. 2009: Intravitreal injection of 2.5 mg versus 1.25 mg bevacizumab (Avastin) for treatment of CNV associated with AMD. Retina 29(3): 319-324
Yin, L.; Greenberg, K.; Hunter, J.J.; Dalkara, D.; Kolstad, K.D.; Masella, B.D.; Wolfe, R.; Visel, M.; Stone, D.; Libby, R.T.; Diloreto, D.; Schaffer, D.; Flannery, J.; Williams, D.R.; Merigan, W.H. 2011: Intravitreal injection of AAV2 transduces macaque inner retina. Investigative Ophthalmology and Visual Science 52(5): 2775-2783
Guo, L.-b.; Sun, D.; Ye, J.-j.; Geng, S.; Xu, H.-y.; Zhang, M.-f. 2007: Intravitreal injection of Ganciclovir in the treatment of acute retinal necrosis. Chinese Journal of Ophthalmology 43(7): 631-637
Jiang, Y.; Zhang, Q.; Steinle, J.J. 2014: Intravitreal injection of IGFBP-3 restores normal insulin signaling in diabetic rat retina. Plos one 9(4): E93788
Hewing, N.J.; Weskamp, G.; Vermaat, J.; Farage, E.; Glomski, K.; Swendeman, S.; Chan, R.V.P.; Chiang, M.F.; Khokha, R.; Anand-Apte, B.; Blobel, C.P. 2013: Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice. Investigative Ophthalmology and Visual Science 54(1): 864-870
Cornut, P.-L.; Chiquet, C. 2008: Intravitreal injection of antibiotics in endophthalmitis. Journal Francais d'Ophtalmologie 31(8): 815-823
Siqueira, R.C.; Messias, A.é; Voltarelli, J.C.; Scott, I.U.; Jorge, R. 2011: Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase i trial. Retina 31(6): 1207-1214
Udaondo, P.; Garcia-Delpech, S.; Salom, D.; Garcia-Pous, M.; Díaz-Llopis, M. 2011: Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion. American journal of ophthalmology 152(2): 326-7; author reply 327-8
Amselem, L.; Díaz-Llopis, M.; Cervera, E.; García-Delpech, S.; Moratal-Peiro, B.; Palomares, P. 2008: Intravitreal injection of bevacizumab (Avastin) for retinal angiomatous proliferation. Archivos de la Sociedad Espanola de Oftalmologia 83(1): 53-56
Hosseini, H.; Khalili, M.Reza.; Nowroozizadeh, S. 2009: Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 29(4): 562
Nowroozzadeh, M.H. 2009: Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 29(4): 564-5; Author Reply 565-8
Wang, H.-Y.; Li, X.; Wang, Y.-S.; Zhang, Z.-F.; Li, M.-H.; Su, X.-N.; Zhu, J.-T. 2011: Intravitreal injection of bevacizumab alone or with triamcinolone acetonide for treatment of macular edema caused by central retinal vein occlusion. International Journal of Ophthalmology 4(1): 89-94
Shih, C.-W.; Yang, C.-M.; Chen, M.-S.; Wang, T.-J. 2008: Intravitreal injection of bevacizumab and gas for diabetic premacular hemorrhage with active fibrovascular proliferation. Graefe's Archive for Clinical and Experimental Ophthalmology 246(11): 1547-1551
Park, D.H.; Shin, J.P.; Kim, S.Y. 2010: Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study. Graefe's Archive for Clinical and Experimental Ophthalmology 248(5): 641-650
Modarres, M.; Nazari, H.; Falavarjani, K.G.; Naseripour, M.; Hashemi, M.; Parvaresh, M.M. 2009: Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. European Journal of Ophthalmology 19(5): 848-852
Mercé, E.; Korobelnik, J.-F.; Delyfer, M.-N.; Rougier, M.-B. 2012: Intravitreal injection of bevacizumab for CNV secondary to choroidal osteoma and follow-up by Spectral-Domain OCT. Journal Francais d'Ophtalmologie 35(7): 508-513
Kondo, M.; Kondo, N.; Ito, Y.; Kachi, S.; Kikuchi, M.; Yasuma, T.R.; Ota, I.; Kensaku, M.; Terasaki, H. 2009: Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion:results after 12 months and multiple regression analysis. Retina 29(9): 1242-1248
De Bats, F.; Grange, J.-D.; Denis, P.; Kodjikian, L. 2013: Intravitreal injection of bevacizumab for naive myopic choroidal neovascularization: 19-month results. Journal Francais d'Ophtalmologie 36(1): 12-18
Díaz-Llopis, M.; Amselem, L.; Cervera, E.; García-Delpech, S.; Torralba, C.; Montero, J. 2007: Intravitreal injection of bevacizumab for pseudophakic cystoid macular edema resistant to steroids. Archivos de la Sociedad Espanola de Oftalmologia 82(7): 447-450
Kuniyoshi, K.; Sugioka, K.; Sakuramoto, H.; Kusaka, S.; Wada, N.; Shimomura, Y. 2014: Intravitreal injection of bevacizumab for retinopathy of prematurity. Japanese Journal of Ophthalmology 58(3): 237-243
Minami, T.; Kuniyoshi, K.; Kusaka, S.; Sugioka, K.; Sakuramoto, H.; Sakamoto, M.; Izu, A.; Wada, N.; Shimomura, Y. 2014: Intravitreal injection of bevacizumab for retinopathy of prematurity in an infant with peters anomaly. Case Reports in Ophthalmology 5(3): 318-324
Liu, Y.-C.; Yang, C.-S.; Shyong, M.-P.; Lee, F.-L.; Lee, S.-M. 2009: Intravitreal injection of bevacizumab for the treatment of choroidal neovascularization in a patient with angioid streaks. Journal of the Chinese Medical Association: Jcma 72(2): 98-102
Küçükerdönmez, C.; Akova, Y.A.; Yilmaz, Gürsel. 2008: Intravitreal injection of bevacizumab in Eales disease. Ocular Immunology and Inflammation 16(1): 63-65
Ishijima, K.; Namba, K.; Ohno, S.; Mochizuki, K.; Ishida, S. 2012: Intravitreal injection of bevacizumab in a case of occlusive retinal vasculitis accompanied by syphilitic intraocular inflammation. Case Reports in Ophthalmology 3(3): 434-437
Johnsen-Soriano, S.; Arnal, E.; Sancho-Tello, M.ía.; Muriach, M.ía.; Almansa, I.; Bosch-Morell, F.; Navea, A.; Romero, F.J. 2011: Intravitreal injection of bevacizumab induces inflammatory alterations in a uveitis experimental model. European Journal of Ophthalmology 21(4): 427-433
Kubota, T.; Aoki, R.; Harada, Y.; Tou, N.; Tawara, A. 2008: Intravitreal injection of bevacizumab to treat neovascular glaucoma. Japanese Journal of Ophthalmology 52(5): 410-412
Maldonado, R.M.; Vianna, R.N.G.; Cardoso, G.P.; de Magalhães, A.éi.V.; Burnier, M.N. 2011: Intravitreal injection of commercially available ketorolac tromethamine in eyes with diabetic macular edema refractory to laser photocoagulation. Current Eye Research 36(8): 768-773
Fenicia, V.; Balestrieri, M.; Perdicchi, A.; MauriziEnrici, M.; DelleFave, M.; Recupero, S.M. 2014: Intravitreal injection of dexamethasone implant and ranibizumab in cystoid macular edema in the course of irvine-gass syndrome. Case Reports in Ophthalmology 5(2): 243-248
Tanito, M.; Li, F.; Anderson, R.E. 2012: Intravitreal injection of erythropoietin glycosylation analogs does not protect rod photoreceptor cells from light-induced damage. Advances in Experimental Medicine and Biology 723: 137-143
Zhang, Y.; Zhang, J.; Wang, Q.; Lei, X.; Chu, Q.; Xu, G.-T.; Ye, W. 2011: Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats. Investigative Ophthalmology and Visual Science 52(1): 278-285
Reis, A.d.C.A.; Vianna, R.N.G.; Reis, R.S.M.d.; Cardoso, G.P. 2010: Intravitreal injection of ketorolac tromethamine in patients with diabetic macular edema refractory to retinal photocoagulation. Arquivos Brasileiros de Oftalmologia 73(4): 338-342
Sun, Y.-b.; Hui, P.; Punyara, K.; Bi, M.-c.; Li, S.-h.; Teng, S.-y.; Song, E. 2013: Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding. Chinese Medical Journal 126(8): 1587
Ozkan, E.B.; Ozcan, A.A.; Alparslan, N. 2011: Intravitreal injection of methotrexate in an experimental rabbit model: determination of pharmacokinetics. Indian Journal of Ophthalmology 59(3): 197-200
Ozkan, E.B.; Ozcan, A.A.; Sekeroglu, H.T.; Kuyucu, Y.; Ozgun, H.; Polat, S. 2013: Intravitreal injection of methotrexate in an experimental rabbit model: determination of ultrastructural changes. Indian Journal of Ophthalmology 61(7): 329-333
Stalmans, P.; Delaey, C.; de Smet, M.D.; van Dijkman, E.; Pakola, S. 2010: Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase Ii trial (the MIVI-IIT trial). Retina 30(7): 1122-1127
González, V.H.; Giuliari, G.P.; Banda, R.M.; Guel, D.A. 2009: Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy. British Journal of Ophthalmology 93(11): 1474-1478
Feigenbaum, A.; Kornbluth, W. 1945: Intravitreal injection of penicillin in a case of incipient abscess of the vitreous following extracapsular cataract extraction; perfect cure. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 110: 300-305
Hu, B.; Zhang, Y.; Zeng, Q.; Han, Q.; Zhang, L.; Liu, M.; Li, X. 2014: Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes. International Journal of Molecular Sciences 15(1): 1606-1624
Rauen, P.I.; Ribeiro, J.A.S.; Almeida, F.P.P.; Scott, I.U.; Messias, A.é; Jorge, R. 2012: Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema. Retina 32(9): 1799-1803
Ventura, A.Augusto.Cabral.de.Mello.; Grant, L.Winifred.; Dadgostar, H.; Lewis, H. 2011: Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report. Arquivos Brasileiros de Oftalmologia 74(4): 289-291
Ogino, K.; Tsujikawa, A.; Yamashiro, K.; Ooto, S.; Oishi, A.; Nakata, I.; Miyake, M.; Yoshimura, N. 2013: Intravitreal injection of ranibizumab for recovery of macular function in eyes with subfoveal polypoidal choroidal vasculopathy. Investigative Ophthalmology and Visual Science 54(5): 3771-3779
Gu, X.; Yu, X.; Dai, H. 2014: Intravitreal injection of ranibizumab for treatment of age-related macular degeneration: effects on serum VEGF concentration. Current Eye Research 39(5): 518-521
Inoue, M.; Arakawa, A.; Yamane, S.; Kadonosono, K. 2014: Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life. Clinical Ophthalmology 8: 1711-1716
Fadhilah, M.; Mimiwati, Z.; Fong, K.C.S. 2010: Intravitreal injection of recombinant tissue plasminogen activator and pneumatic displacement of submacular haemorrhage. Medical Journal of Malaysia 65(4): 271-272
Chen, F.; Xie, Z.; Wu, X.; Du, W.; Wang, J.; Zhu, J.; Ji, H.; Wang, Y. 2012: Intravitreal injection of soluble erythropoietin receptor exacerbates photoreceptor cell apoptosis in a rat model of retinal detachment. Current Eye Research 37(12): 1156-1164
Singh, P.K.; Donovan, D.M.; Kumar, A. 2014: Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis. Antimicrobial Agents and ChemoTherapy 58(8): 4621-4629
Peyman, G.A.; Lad, E.M.; Moshfeghi, D.M. 2009: Intravitreal injection of therapeutic agents. Retina 29(7): 875-912
Tsui, I.; Airiani, S.; Wen, A.; El-Sawy, T.; Fine, H.F.; Maris, P.J.G. 2009: Intravitreal injection of tissue plasminogen activator as treatment for an occluded pars plana glaucoma tube. Clinical Ophthalmology 3: 91-93
Hernaez-Ortega, M.Concepcion.; Soto-Pedre, E. 2008: Intravitreal injection of triamcinolone acetonide and intraocular pressure. Acta Ophthalmologica 86(6): 693; Author Reply 692-3
Peng, C.-H.; Cheng, C.-K. 2008: Intravitreal injection of triamcinolone acetonide for serous macular detachment in a patient with systemic lupus erythematosus. Retinal Cases and Brief Reports 2(1): 36-38
Myers, A.C.; Bruun, A.; Ghosh, F.; Adrian, M.L.öv.; Andréasson, S.; Ponjavic, V. 2013: Intravitreal injection of triamcinolone acetonide into healthy rabbit eyes alters retinal function and morphology. Current Eye Research 38(6): 649-661
Kimura, T.; Takagi, H.; Kita, M.; Watanabe, D.; Yoshimura, N. 2009: Intravitreal injection of triamcinolone acetonide to treat cystoid foveal edema associated with coats' disease. Retinal Cases and Brief Reports 3(2): 167-169
El Matri, L.; Chebil, A.; Kort, F.; Bouraoui, R.; Baklouti, K.; Mghaieth, F. 2010: Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology 248(6): 779-784
Garay-Aramburu, G.; Cabrerizo, J. 2012: Intravitreal injection technique. Ophthalmology 119(12): 2654-5.e1; author reply 2655
Modorati, G.; Miserocchi, E. 2012: Intravitreal injection therapy in the treatment of noninfectious uveitis. Developments in Ophthalmology 51: 110-121
Takata, C.éc.; Messias, A.; Folgosa, M.S.; Lucena, L.R.; Lucena, D.R.; Scott, I.U.; Jorge, R. 2010: Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema. Retina 30(4): 562-569
Hesse, L. 2012: Intravitreal injection. Drugs to treat subretinal hemorrhage. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 109(7): 644-647
Meyer, C.H.; Ziemssen, F.; Heimann, H. 2008: Intravitreal injection. Monitoring to avoid postoperative complications. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 105(2): 143-155; 157
Pescosolido, N.; Pranno, F.; Buomprisco, G. 2013: Intravitreal injections and diabetic macular edema: actual and new therapeutic options. Current Diabetes Reviews 9(6): 491-498
Demols, P. 2007: Intravitreal injections of corticoids. Bulletin de la Societe Belge d'Ophtalmologie 304: 117-123
Ziemssen, F.; Wiedemann, P.; Kampik, A.; Holz, F.; Bartz-Schmidt, K.U. 2009: Intravitreal injections of medications in Germany. Contract situation and legal conditions. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 106(5): 465-470
Levkovitch-Verbin, H.; Sadan, O.; Vander, S.; Rosner, M.; Barhum, Y.; Melamed, E.; Offen, D.; Melamed, S. 2010: Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. Investigative Ophthalmology and Visual Science 51(12): 6394-6400
Nochez, Y.; Le Lez, M.-L.; Pisella, P.-J. 2009: Intravitreal injections of ranibizumab in treatment of large peripapillary choroidal neovascularization. Journal Francais d'Ophtalmologie 32(1): 25-31
Bodaghi, B.; Korobelnik, J.F.; Cochereau, I.; Hajjar, J.; Goebel, F.; Dumarcet, N. 2012: Intravitreal injections: AFSSAPS guide to good practice. Journal Francais d'Ophtalmologie 35(1): 69-71
Lanzetta, P.; Holz, F.; Monés, J.; Querques, G.; Stanga, P.; Veritti, D.; Barbone, F.; Brusaferro, S.; Isola, M. 2013: Intravitreal injections: a healthcare failure modes and effects analysis. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 230(3): 151-164
Grzybowski, A.; Ascaso, F.J. 2013: Intravitreal injections: a most recent evidence for best practice. Clinical and Experimental Ophthalmology 41(8): 816-817
Rodríguez Ramírez, M.; del Barrio Manso, M.I.; Martín Sánchez, M.D. 2014: Intravitreal injections: what do patients prefer? Analysis of patient's satisfaction and preferences about where to perform intravitreal injections. Archivos de la Sociedad Espanola de Oftalmologia 89(12): 477-483
Hatori, T.; Imai, M.; Iijima, H. 2011: Intravitreal intrusion of an intrascleral MIRAgel buckling implant. Japanese Journal of Ophthalmology 55(3): 310-311
Srirangam, R.; Hippalgaonkar, K.; Majumdar, S. 2012: Intravitreal kinetics of hesperidin, hesperetin, and hesperidin G: effect of dose and physicochemical properties. Journal of Pharmaceutical Sciences 101(4): 1631-1638
Mendrinos, E.; Petropoulos, I.K.; Mangioris, G.; Papadopoulou, D.N.; Pournaras, C.J. 2010: Intravitreal l-Arginine injection reverses the retinal arteriolar vasoconstriction that occurs after experimental acute branch retinal vein occlusion. Experimental Eye Research 91(2): 205-210
Rao, N.G.; Mahapatra, S.K.; Pattnayak, S.; Pattnaik, K. 2008: Intravitreal live adult Brugian filariasis. Indian Journal of Ophthalmology 56(1): 76-78
Hwang, Y.-S.; Lin, K.-K.; Lee, J.-S.; Chang, S.H.L.; Chen, K.-J.; Lai, C.-C.; Huang, J.C.-C.; Kuo, Y.-H.; Hsiao, C.-H. 2010: Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis. Graefe's Archive for Clinical and Experimental Ophthalmology 248(2): 263-269
Sundaram, V.; Barsam, A.; Virgili, G. 2013: Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery. Cochrane Database of Systematic Reviews 2013(1): Cd006421
Harder, B.ör.C.; von Baltz, S.; Jonas, J.B.; Schlichtenbrede, F.C. 2014: Intravitreal low-dosage bevacizumab for retinopathy of prematurity. Acta Ophthalmologica 92(6): 577-581
Shields, C.L.; Manjandavida, F.P.; Arepalli, S.; Kaliki, S.; Lally, S.E.; Shields, J.A. 2014: Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results. JAMA Ophthalmology 132(3): 319-325
Ghassemi, F.; Shields, C.L. 2012: Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Archives of Ophthalmology 130(10): 1268-1271
Wickremasinghe, S.S.; Ojaimi, E.; Lim, L.; Stawell, R.; McKelvie, P.; Zamir, E. 2010: Intravitreal methotrexate as adjunctive, palliative therapy in intraocular T-cell lymphoma. Ocular Immunology and Inflammation 18(3): 184-186
Kivelä, T.; Eskelin, S.; Paloheimo, M. 2011: Intravitreal methotrexate for retinoblastoma. Ophthalmology 118(8): 1689; 1689.E1-6
Julian, K.; Langner-Wegscheider, B.-J.; Haas, A.; De Smet, M.D. 2013: Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis. Retina 33(9): 1943-1948
Kurup, S.K.; Gee, C.; Greven, C.M. 2010: Intravitreal methotrexate in therapeutically resistant exudative age-related macular degeneration. Acta Ophthalmologica 88(4): E145-E146
Taylor, S.R.J.; Habot-Wilner, Z.; Pacheco, P.; Lightman, S. 2012: Intravitreal methotrexate in uveitis. Ophthalmology 119(4): 878-879
Sen, H.Nida.; Chan, C-Chao.; Byrnes, G.; Fariss, R.N.; Nussenblatt, R.B.; Buggage, R.R. 2008: Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma. Ocular Immunology and Inflammation 16(1): 29-33
Jacobs, D.J.; Grube, T.J.; Flynn, H.W.; Greven, C.M.; Pathengay, A.; Miller, D.; Sanke, R.F.; Thorman, J. 2013: Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body. Clinical Ophthalmology 7: 1727-1730
Molina Guilabert, I.; Calvo-González, C.; Reche-Frutos, J.; Donate-López, J.; García-Feijoó, J.án.; Leila, M.; García-Sánchez, J.án. 2009: Intravitreal pegabtanib sodium in choroidal neovascularization secondary to angioid streaks. Acta Ophthalmologica 87(5): 581-582
Mintz-Hittner, H.A. 2012: Intravitreal pegaptanib as adjunctive treatment for stage 3+ ROP shown to be effective in a prospective, randomized, controlled multicenter clinical trial. European Journal of Ophthalmology 22(5): 685-686
Autrata, R.; Krejcírová, I.; Senková, K.; Holoušová, M.; Doležel, Z.; Borek, I. 2012: Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II. European Journal of Ophthalmology 22(5): 687-694
Udaondo, P.; Garcia-Delpech, S.; Salom, D.; Garcia-Pous, M.; Diaz-Llopis, M. 2011: Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion. Clinical Ophthalmology 5: 941-944
Vianna, R.N.G.; Squeri, G.; Turquetti, R.; Brasil, O.F.M.; Burnier, M.N. 2008: Intravitreal pegaptanib reduces fluorescein leakage in idiopathic parafoveal telangiectasis. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 43(4): 492-493
Querques, G.; Bux, A.V.; Martinelli, D.; Iaculli, C.; Noci, N.D. 2009: Intravitreal pegaptanib sodium (Macugen) for diabetic macular oedema. Acta Ophthalmologica 87(6): 623-630
Querques, G.; Prascina, F.; Iaculli, C.; Delle Noci, N. 2008: Intravitreal pegaptanib sodium (Macugen) for radiation retinopathy following episcleral plaque radiotherapy. Acta Ophthalmologica 86(6): 700-701
Querques, G.; Prascina, F.; Iaculli, C.; Noci, N.D. 2009: Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa. International Ophthalmology 29(2): 103-107
Rinaldi, M.; Chiosi, F.; DellʼOmo, R.; Romano, M.R.; Parmeggiani, F.; Semeraro, F.; Menzione, M.; Costagliola, C. 2013: Intravitreal pegaptanib sodium (Macugen) for treatment of myopic choroidal neovascularization: a morphologic and functional study. Retina 33(2): 397-402
Rinaldi, M.; Chiosi, F.; dell'Omo, R.; Romano, M.R.; Parmeggiani, F.; Semeraro, F.; Mastropasqua, R.; Costagliola, C. 2012: Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study. British Journal of Clinical Pharmacology 74(6): 940-946
Querques, G.; Iaculli, C.; Delle Noci, N. 2008: Intravitreal pegaptanib sodium for Irvine-Gass syndrome. European Journal of Ophthalmology 18(1): 138-141
Kitagawa, T.; Yuzawa, M. 2013: Intravitreal pegaptanib sodium for myopic choroidal neovascularization: 1 year results of a prospective pilot study. Nippon Ganka Gakkai Zasshi 117(4): 344-350
Leopold, I.H. 1946: Intravitreal penetration of penicillin and penicillin therapy of infections of the vitreous. American Journal of Ophthalmology 29: 599-601
Soliman Mahdy, M.; Eid, M.Zakaria.; Shalaby, K.Abdel-Gelil.; Hegazy, H.Mohamed. 2010: Intravitreal phacoemulsification with pars plana vitrectomy for management of posteriorly dislocated nucleus or lens fragments. European Journal of Ophthalmology 20(1): 115-119
Park, H.Jun.; Lee, J.Eun.; Kim, S.Il.; Pak, K.Yeun.; Oum, B.Sup.; Lee, J.Su.; Jung, J.Ho.; Lee, J-Eun. 2014: Intravitreal pharmacokinetics after posterior subtenon triamcinolone acetonide injection in vitrectomized rabbit eyes. Retina 34(4): 801-806
Prasad, A.G.; Schadlu, R.; Apte, R.S. 2007: Intravitreal pharmacotherapy: applications in retinal disease. Comprehensive Ophthalmology Update 8(5): 259-269
Pathengay, A.; Mathai, A.; Shah, G.Y.; Ambatipudi, S. 2010: Intravitreal piperacillin/tazobactam in the management of multidrug-resistant Pseudomonas aeruginosa endophthalmitis. Journal of Cataract and Refractive Surgery 36(12): 2210-2211
Diaz-Llopis, M.; Udaondo, P.; Arevalo, F.; Salom, D.; Garcia-Delpech, S.; Quijada, A.; Romero, F.J. 2009: Intravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edema. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 25(4): 379-384
Udaondo, P.; Díaz-Llopis, M.; García-Delpech, S.; Salom, D.; Romero, F.J. 2011: Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion. Archives of Ophthalmology 129(3): 283-287
Pang, C.E.; Freund, K.B. 2014: Intravitreal polypoidal choroidal vasculopathy in radiation retinopathy. Ophthalmic Surgery Lasers and Imaging Retina 45(6): 585-588
Rouvas, A.; Petrou, P.; Ntouraki, A.; Douvali, M.; Ladas, I.; Vergados, I. 2010: Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study. Retina 30(6): 893-902
Querques, G.; Bocco, M.C.A.; Soubrane, G.; Souied, E.H. 2008: Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with vitelliform macular dystrophy. Acta Ophthalmologica 86(6): 694-695
Konstantinidis, L.; Mantel, I.; Pournaras, J.-A.C.; Zografos, L.; Ambresin, A. 2009: Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization. Graefe's Archive for Clinical and Experimental Ophthalmology 247(3): 311-318
Rouvas, A.; Petrou, P.; Vergados, I.; Pechtasides, D.; Liarakos, V.; Mitsopoulou, M.; Ladas, I. 2009: Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study. Graefe's Archive for Clinical and Experimental Ophthalmology 247(12): 1609-1616
Konstantinidis, L.; Mameletzi, E.; Mantel, I.; Pournaras, J.-A.; Zografos, L.; Ambresin, A. 2009: Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). Graefe's Archive for Clinical and Experimental Ophthalmology 247(9): 1165-1171
Valverde Megías, A.; Arriola Villalobos, P.; Reche Frutos, J.; Donate López, J.; Calvo González, C.; García Feijoo, J. 2010: Intravitreal ranibizumab (Lucentis®) in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy. Archivos de la Sociedad Espanola de Oftalmologia 85(4): 149-152
Wang, H.; Sun, X.; Liu, K.; Xu, X. 2012: Intravitreal ranibizumab (lucentis) for the treatment of diabetic macular edema: a systematic review and meta-analysis of randomized clinical control trials. Current Eye Research 37(8): 661-670
Lin, S.; George, B.Z.; Wilson-Holt, N.J. 2014: Intravitreal ranibizumab (lucentis) for whole brain radiotherapy-induced maculopathy. Clinical Oncology 26(4): 236-238
Mavrakanas, N.; Mendrinos, E.; Pournaras, C.J.; Salzmann, J. 2009: Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A. Acta Ophthalmologica 87(8): 930-932
Roller, A.B.; Amaro, M.H. 2009: Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration. Arquivos Brasileiros de Oftalmologia 72(5): 677-681
Forte, R.; Bonavolontà, P.; Benayoun, Y.; Adenis, J.P.; Robert, P.-Y. 2011: Intravitreal ranibizumab and bevacizumab in combination with full-fluence verteporfin therapy and dexamethasone for exudative age-related macular degeneration. Ophthalmic Research 45(3): 129-134
Amaro, M.H.; Roller, A.B. 2012: Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy. Arquivos Brasileiros de Oftalmologia 75(4): 273-276
Dafer, R.M.; Schneck, M.; Friberg, T.R.; Jay, W.M. 2007: Intravitreal ranibizumab and bevacizumab: a review of risk. Seminars in Ophthalmology 22(3): 201-204
Ciarnella, A.; Verrilli, S.; Fenicia, V.; Mannino, C.; Cutini, A.; Perdicchi, A.; Recupero, S.Maria. 2012: Intravitreal ranibizumab and laser photocoagulation in the management of idiopathic juxtafoveolar retinal telangiectasia type 1: a case report. Case Reports in Ophthalmology 3(3): 298-303
Nghiem-Buffet, S.; Fajnkuchen, F.; Buffet, M.; Ayrault, S.; Le Gloahec-Lorcy, A.; Grenet, T.; Delahaye-Mazza, C.; Quentel, G.; Cohen, S.Y. 2014: Intravitreal ranibizumab and/or dexamethasone implant for macular edema secondary to retinal vein occlusion. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 232(4): 216-222
Desai, R.U.; Singh, K.; Lin, S.C. 2013: Intravitreal ranibizumab as an adjunct for Ahmed valve surgery in open-angle glaucoma: a pilot study. Clinical and Experimental Ophthalmology 41(2): 155-158
Lazaros, K.; Leonidas, Z. 2010: Intravitreal ranibizumab as primary treatment for neovascular membrane associated with angioid streaks. Acta Ophthalmologica 88(3): E100-E101
Konstantinidis, L.; Mantel, I.; Zografos, L.; Ambresin, A. 2009: Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia. Graefe's Archive for Clinical and Experimental Ophthalmology 247(11): 1567-1569
Lin, C.-J.; Chen, S.-N.; Hwang, J.-F. 2012: Intravitreal ranibizumab as salvage therapy in an extremely low-birth-weight infant with rush type retinopathy of prematurity. Oman Journal of Ophthalmology 5(3): 184-186
Lee, Y.H.; Lee, E.-K.; Shin, K.S.; Lee, K.-M.; Kim, J.Y. 2011: Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy. Retina 31(7): 1287-1293
Kim, M.; Lee, S.-C.; Lee, S.-J. 2013: Intravitreal ranibizumab for acute central serous chorioretinopathy. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 229(3): 152-157
Sørensen, T.L.; Kemp, H. 2010: Intravitreal ranibizumab for age-related macular degeneration. Ugeskrift for Laeger 172(22): 1685-1689
Yilmaz, I.; Ozkaya, A.; Alkin, Z.; Yazici, A.T. 2014: Intravitreal ranibizumab for bilateral choroidal neovascularisation in a patient with angioid streaks. BMJ Case Reports
Querques, G.; Forte, R.; Querques, L.; Souied, E.H. 2011: Intravitreal ranibizumab for choroidal neovascularization associated with circumscribed choroidal haemangioma. Clinical and Experimental Ophthalmology 39(9): 916-918
Querques, G.; Kerrate, H.; Leveziel, N.; Coscas, G.; Soubrane, G.; Souied, E.H. 2010: Intravitreal ranibizumab for choroidal neovascularization associated with retinal astrocytic hamartoma. European Journal of Ophthalmology 20(4): 789-791
Lalloum, F.; Souied, E.H.; Bastuji-Garin, S.; Puche, N.; Querques, G.; Glacet-Bernard, A.; Coscas, G.; Soubrane, G.; Leveziel, N. 2010: Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia. Retina 30(3): 399-406
Mimoun, G.; Tilleul, J.; Leys, A.; Coscas, G.; Soubrane, G.; Souied, E.H. 2010: Intravitreal ranibizumab for choroidal neovascularization in angioid streaks. American Journal of Ophthalmology 150(5): 692-700.E1
Liang, F.; Puche, N.; Soubrane, G.èl.; Souied, E.H. 2009: Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture. Graefe's Archive for Clinical and Experimental Ophthalmology 247(9): 1285-1288
Mavrakanas, N.; Mendrinos, E.; Tabatabay, C.; Pournaras, C.J. 2010: Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy. Acta Ophthalmologica 88(2): E54-E55
Guigui, B.; Souied, E.H.; Cohen, S.Y. 2009: Intravitreal ranibizumab for choroidal neovascularization secondary to choroidal nevus. Retinal Cases and Brief Reports 3(4): 412-414
Lorenzo, D.; Arias, L.; Alcubierre, R.; Pujol, O.; Caminal, J.M.; Rubio, M.; Català, J.; Garcia-Bru, P.; Arruga, J. 2011: Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month follow-up. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 226(3): 103-109
Cornut, P.-L.; Poli, M.; Feldman, A.; El Chehab, H.; Swalduz, B.; Burillon, C.; Denis, P. 2010: Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month results. Journal Francais d'Ophtalmologie 33(5): 327-333
Iacono, P.; Parodi, M.B.; Introini, U.; La Spina, C.; Varano, M.; Bandello, F. 2014: Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration. Retina 34(2): 281-287
Alpatov, S.A.; Zlobin, I.V.; Shchuko, A.G.; Malyshev, V.V. 2011: Intravitreal ranibizumab for diabetic macula edema. Vestnik Oftalmologii 127(5): 34-38
Elman, M.J.; Qin, H.; Aiello, L.P.; Beck, R.W.; Bressler, N.M.; Ferris, F.L.; Glassman, A.R.; Maturi, R.K.; Melia, M. 2012: Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology 119(11): 2312-2318
Brynskov, T.; Laugesen, C.S.; Sørensen, T.L. 2013: Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting. Acta Ophthalmologica 91(3): E243-E244
Saito, M.; Iida, T.; Kano, M. 2012: Intravitreal ranibizumab for exudative age-related macular degeneration with good baseline visual acuity. Retina 32(7): 1250-1259
Risard, S.M.; Pieramici, D.J.; Rabena, M.D.; Basefsky, J.C.; Avery, R.L.; Castellarin, A.A.; Nasir, M.'a.A.; See, R.F.; Couvillion, S.S. 2011: Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusion. Retina 31(6): 1060-1067
Kim, M.; Yu, S.-Y.; Kim, E.-S.; Bae, S.H.; Park, J.H.; Yu, H.G.; Kwak, H.-W. 2012: Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 227(3): 132-138
Puche, N.; Glacet, Aès.; Mimoun, Gérard.; Zourdani, A.; Coscas, G.; Soubrane, Gèle. 2012: Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes. Acta Ophthalmologica 90(4): 357-361
Wolff, B.; Sahel, J-A.; Mateo-Montoya, A.; Mauget-Faÿsse, M.; Baillif, S.; Le Mer, Y. 2013: Intravitreal ranibizumab for management of choroidal neovascularization secondary to angioid streaks: a case report. Journal Francais d'Ophtalmologie 36(1): e5-e9
Silva, R.M.; Ruiz-Moreno, J.é M.; Rosa, P.; Carneiro, A.; Nascimento, J.ão.; Rito, L.ís.F.; Cachulo, M.L.; Carvalheira, F.; Murta, J.N. 2010: Intravitreal ranibizumab for myopic choroidal neovascularization: 12-month results. Retina 30(3): 407-412
Calvo-Gonzalez, C.; Reche-Frutos, J.; Donate, J.; Fernandez-Perez, C.; Garcia-Feijoo, J. 2011: Intravitreal ranibizumab for myopic choroidal neovascularization: factors predictive of visual outcome and need for retreatment. American Journal of Ophthalmology 151(3): 529-534
Parodi, M.B.; Iacono, P.; La Spina, C.; Iuliano, L.; Lo Giudice, G.; Introini, U.; Bandello, F. 2014: Intravitreal ranibizumab for naive extrafoveal choroidal neovascularization secondary to age-related macular degeneration. Retina 34(11): 2167-2170
Ozkaya, A.; Alkin, Z.; Osmanbasoglu, O.A.; Ozkaya, H.M.; Demirok, A. 2014: Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes. Journal Francais d'Ophtalmologie 37(4): 280-287
Kato, A.; Yasukawa, T.; Suga, K.; Hirano, Y.; Nozaki, M.; Yoshida, M.; Ogura, Y. 2015: Intravitreal ranibizumab for patients with neovascular age-related macular degeneration with good baseline visual acuity. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 233(1): 27-34
Parodi, M.B.; Iacono, P.; Papayannis, A.; Kontadakis, S.D.; Cascavilla, M.; Pierro, L.; Gagliardi, M.; Bandello, F. 2013: Intravitreal ranibizumab for pigment epithelium detachment with subfoveal occult choroidal neovascularization: a prospective 24-month case series. American Journal of Ophthalmology 155(1): 103-108.E2
Marcus, D.M.; Singh, H.; Lott, M.N.; Singh, J.; Marcus, M.D. 2013: Intravitreal ranibizumab for polypoidal choroidal vasculopathy in non-Asian patients. Retina 33(1): 35-47
Saito, M.; Iida, T.; Kano, M. 2011: Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation. Retina 31(8): 1589-1597
Brynskov, T.; Kemp, H.; Sørensen, T.L. 2014: Intravitreal ranibizumab for retinal vein occlusion through 1 year in clinical practice. Retina 34(8): 1637-1643
Gallego-Pinazo, R.; Marina, A.; Suelves-Cogollos; Francés-Muñoz, E.; Millán, J.María.; Arevalo, J.Fernando.; Mullor, J.Luis.; Díaz-Llopis, M. 2011: Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration. Clinical Ophthalmology 5: 161-165
Lai, T.Y.Y.; Chan, W.-M.; Liu, D.T.L.; Lam, D.S.C. 2009: Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia. Retina 29(6): 750-756
Sheu, S.-J. 2009: Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to endogenous endophthalmitis. Kaohsiung Journal of Medical Sciences 25(11): 617-621
Pandey, N.; Dwivedi, V. 2013: Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis. Indian Journal of Ophthalmology 61(2): 86
Demirel, S.; Batioğlu, F.; Özmert, E. 2012: Intravitreal ranibizumab for the treatment of cystoid macular edema in Irvine-Gass syndrome. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 28(6): 636-639
Iordanous, Y.; Powell, A.-M.; Mao, A.; Hooper, P.L.; Eng, K.T.; Schwartz, C.; Kertes, P.J.; Sheidow, T.G. 2014: Intravitreal ranibizumab for the treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 49(4): 367-376
Rouvas, A.; Petrou, P.; Douvali, M.; Ntouraki, A.; Vergados, I.; Georgalas, I.; Markomichelakis, N. 2011: Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Retina 31(5): 871-879
Yang, X.; Dai, H. 2014: Intravitreal ranibizumab for the treatment of pathological myopia associated with choroidal neovascularization in Chinese patients. Chinese Medical Journal 127(16): 2906-2910
Zebardast, N.; Adelman, R.A. 2012: Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum: five-year follow-up. Seminars in Ophthalmology 27(3-4): 61-64
Rouvas, A.A.; Ladas, I.D.; Papakostas, T.D.; Moschos, M.M.; Vergados, I. 2007: Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to multiple evanescent white dot syndrome. European Journal of Ophthalmology 17(6): 996-999
Soucek, P.; Soucková, I. 2008: Intravitreal ranibizumab in combination with verteporfin photodynamic therapy in neovascular macular degeneration. Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 64(4): 135-140
Kubicka-Trzaska, A. 2010: Intravitreal ranibizumab in diabetic macular edema. Klinika Oczna 112(10-12): 333-336
Wenkstern, A.R.; Petersen, H. 2010: Intravitreal ranibizumab in retinal macroaneurysm. Graefe's Archive for Clinical and Experimental Ophthalmology 248(11): 1667-1670
Teh, S.S.; Ahem, A.; Bastion, M.-L.C. 2013: Intravitreal ranibizumab in the management of stage 2B Coats disease in a young adult Malay man. BMJ Case Reports
Empeslidis, T.; Vardarinos, A.; Deane, J.; Banerjee, S. 2012: Intravitreal ranibizumab in the treatment of butterfly-shaped pattern dystrophy associated with choroidal neovascularization: a case report. Case Reports in Ophthalmology 3(1): 77-82
Leung, A.K.; Weisbrod, D.J.; Schwartz, C. 2010: Intravitreal ranibizumab in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 45(3): 300-301
Konstantinidis, L.; Mantel, I.; Zografos, L.; Ambresin, A. 2010: Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy. European Journal of Ophthalmology 20(5): 955-958
Salom, D.; Diaz-Llopis, M.; García-Delpech, S.; Udaondo, P.; Romero, F.J.; Millan, J.M.; Arevalo, J.F. 2010: Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 26(5): 531-532
Nachiappan, K.; Kadekar, A.; Gopal, L.; Sharma, T. 2011: Intravitreal ranibizumab in the treatment of fungal endophthalmitis scar-related choroidal neovascular membrane. Retinal Cases and Brief Reports 5(2): 175-178
Jiménez, B.; Pinilla, I.; Cristóbal, J.A.; Mínguez, E.; Pérez, D.; Cruz, N.; Peiro, C. 2014: Intravitreal ranibizumab in the treatment of subretinal neovascularization in a case of punctate inner choroidopathy. Archivos de la Sociedad Espanola de Oftalmologia 89(3): 130-132
Abdul-Salim, I.; Embong, Z.; Khairy-Shamel, S.-T.; Raja-Azmi, M.-N. 2013: Intravitreal ranibizumab in treating extensive traumatic submacular hemorrhage. Clinical Ophthalmology 7: 703-706
Tran, T.H.C.; Baglin, G.; Querques, G. 2012: Intravitreal ranibizumab injection for choroidal neovascularization in Strümpell-Lorrain Syndrome. Journal Francais d'Ophtalmologie 35(5): 353-355
Kim, R.; Kim, Y.C. 2014: Intravitreal ranibizumab injection for idiopathic choroidal neovascularization in children. Seminars in Ophthalmology 29(3): 178-181
Baek, J.S.; Cho, H.J.; Cho, S.W.; Kim, C.G.; Kim, J.W. 2013: Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes. Retina 33(3): 467-473
Pece, A.; Querques, G.; Quinto, A.; Isola, V. 2010: Intravitreal ranibizumab injection for nonarteritic ischemic optic neuropathy. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 26(5): 523-527
Ouhadj, O.; Degheb, N.; Idir, S.; Nebab, A.; Nouri, M.T. 2012: Intravitreal ranibizumab injection for the treatment of idiopathic choroidal neovascularisation in young patients. Journal Francais d'Ophtalmologie 35(7): 514-522
Ouhadj, O.; Bouarfa, A.; Akel, S.; Mendil, L.; Nebab, A.; Nouri, M.T. 2010: Intravitreal ranibizumab injections for the treatment of choroidal neovascularization complicating high myopia. Journal Francais d'Ophtalmologie 33(9): 649-654
Cho, H.J.; Koh, K.M.; Kim, J.H.; Kim, H.S.; Han, J.I.; Lew, Y.J.; Lee, T.G.; Kim, J.W. 2015: Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration. Retina 35(2): 205-212
Papadopoulou, D.N.; Mendrinos, E.; Mangioris, G.; Donati, G.; Pournaras, C.J. 2009: Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration. Ophthalmology 116(9): 1755-1761
Wong, W.T.; Liang, K.J.; Hammel, K.; Coleman, H.R.; Chew, E.Y. 2008: Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease. Ophthalmology 115(11): 1957-1964
Shi, X.; Wei, W.; Zhang, C. 2014: Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness. Chinese Medical Journal 127(12): 2279-2285
Ladas, I.D.; Kotsolis, A.I.; Ladas, D.S.; Niskopoulou, M.; Georgalas, I.; Papakonstantinou, D.; Rouvas, A.A. 2010: Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study. Retina 30(8): 1185-1189
Kramann, C.A.; Schöpfer, K.; Lorenz, K.; Zwiener, I.; Stoffelns, B.M.; Pfeiffer, N. 2012: Intravitreal ranibizumab treatment of retinal angiomatous proliferation. Acta Ophthalmologica 90(5): 487-491
Iacono, P.; Parodi, M.B.; Papayannis, A.; Kontadakis, S.; Sheth, S.; Cascavilla, M.L.; Bandello, F. 2012: Intravitreal ranibizumab versus bevacizumab for treatment of myopic choroidal neovascularization. Retina 32(8): 1539-1546
Ladas, I.D.; Chatziralli, I.P.; Kotsolis, A.I.; Douvali, M.; Georgalas, I.; Theodossiadis, P.G.; Rouvas, A.A. 2012: Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 228(2): 93-101
Lai, T.Y.Y.; Lee, G.K.Y.; Luk, F.O.J.; Lam, D.S.C. 2011: Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy. Retina 31(8): 1581-1588
Rouvas, A.A.; Papakostas, T.D.; Vavvas, D.; Vergados, I.; Moschos, M.M.; Kotsolis, A.; Ladas, I.D. 2009: Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina 29(4): 536-544